| 10976 |
10-HDA
New |
|
14113-05-4 |
≥98%
|
|
|
2011-10-13
|
2.886165015296
|
10-hda
|
|
fatty acids royal jelly lifespan MMP RA, rheumatoid arthritis VEGF angiogenesis antitumor neurogenesis collagen |
2.886165015296
|
| 33400 |
(±)10-HDoHE
|
|
90780-50-0 |
≥98%
|
|
|
|
12.843563535912
|
-10-hdohe
|
10-hydroxy Docosahexaenoic Acid
|
racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)10-HDoHEs (+/-)HDoHEs neurochemistry |
12.843563535912
|
| 10008598 |
(±)11(12)-EET Ethanolamide
|
|
- |
≥98%
|
|
|
2007-01-16
|
20.371491712707
|
-11-12-eet-ethanolamide
|
(±)11(12)-EpETrE Ethanolamide
|
AEA endocannabinoids Arachidonoyl ethanolamides CYP450 cytochromes metabolism neurochemistry anxiety depression 14,15-EET 14,15-EpETrE 14,15-EET-EA 14,15-EET-ethanolamide 14,15-epetre-ea 14,15-ethanolamide anandamides lipids neurotransmitters cannabinergic cannabinoids CBs FAAH inhibitor fatty acids hydrolases cbs synthetic |
20.371491712707
|
| 10010101 |
11-cis Vaccenyl Acetate
Exclusive |
|
6186-98-7 |
>98%
|
|
✓ |
2007-08-06
|
40.569631675874
|
11-cis-vaccenyl-acetate
|
|
d. melanogaster pheromones olfactory receptors mating male female specific insects flys fruit flies Or67d odorant hydrocarbon 865721-11-5 |
40.569631675874
|
| 33450 |
(±)11-HDoHE
|
|
87018-59-5 |
≥98%
|
|
|
|
11.408922651933
|
-11-hdohe
|
11-hydroxy Docosahexaenoic Acid
|
racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)11-HDoHEs (+/-)HDoHEs neurochemistry |
11.408922651933
|
| 10009897 |
(−)-11-nor-9-carboxy-Δ9-THC (solution)
|
|
56354-06-4 |
≥98%
|
|
|
2010-11-11
|
6.639502762431
|
-11-nor-9-carboxy-9-thc-solution
|
|
THC metabolites Delta9-THC Δ9-THC tetrahydrocannabinols marijuana cannabinoids cbs synthetic 10915 |
6.639502762431
|
| 10009473 |
1,2-dipalmitoyl-sn-glycero-3-PC
|
|
63-89-8 |
>98%
|
|
|
2007-01-19
|
7.301464088397
|
1-2-dipalmitoyl-sn-glycero-3-pc
|
L-dipalmitoyl Lecithin; L-DPPC; 1,2-dipalmitoyl-sn-glycero-3-Phosphatidylcholine
|
antigens phosphatidylcholines zwitterionic phosphoglycerides proteoliposomes liposomal enzymes g-glutamyl gamma-glutamyl .gamma.-glutamyl transpeptidase erythrocytes immunotherapy immunotherapies GSLs glycosphingolipids phospholipids polyenylphosphatidylcholine |
7.301464088397
|
| 90377 |
13-Docosenamide
|
|
112-84-5 |
≥98%
|
|
|
|
2.151104972375
|
13-docosenamide
|
Erucamide; Armoslip E
|
CSF sleep fatty acids neurochemistry neuroscience |
2.151104972375
|
| 33500 |
(±)13-HDoHE
|
|
90780-53-3 |
≥98%
|
|
|
|
11.307265193370
|
-13-hdohe
|
13-hydroxy Docosahexaenoic Acid
|
racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)13-HDoHEs (+/-)HDoHEs neurochemistry |
11.307265193370
|
| 10008599 |
(±)14(15)-EET Ethanolamide
|
|
- |
≥95%
|
|
|
2006-08-07
|
14.656841620625
|
-14-15-eet-ethanolamide
|
(±)14(15)-Epoxy Eicosatrienoyl Ethanolamide; (±)14(15)-EpETrE Ethanolamide
|
CYP450 cytochrome P450 metabolites AEA arachidonoyl ethanolamides anandamide lipids neurotransmitter cannibinergic cannabinoid CB1 CB2 receptors enzymatic metabolism FAAH fatty acid amide hydrolases endocannabinoid neurochemistry anxiety depression neuroscience 14,15-EET 14,15-EpETrE 14,15-EET-EA 14,15-EET-ethanolamide 14,15-epetre-ea 14,15-ethanolamide cbs synthetic cannabinoids |
14.656841620625
|
| 33550 |
(±)14-HDoHE
|
|
87042-40-8 |
≥98%
|
|
|
|
12.088759876324
|
-14-hdohe
|
14-hydroxy Docosahexaenoic Acid
|
racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)14-HDoHEs (+/-)HDoHEs neurochemistry |
12.088759876324
|
| 10010132 |
15-deoxy-Δ12,14-Prostaglandin J2-2-glycerol ester
|
|
- |
≥98% (isomer mixture)
|
|
|
2008-06-09
|
26.555457335788
|
15-deoxy-12-14-prostaglandin-j2-2-glycerol-ester
|
15-deoxy-Δ12,14-PGJ2-2-glycerol ester
|
PPARgamma PPAR.gamma. PPARg PGD2 PGJ2 lipolysis prostaglandins adipocyte endocannabinoid metabolism diabetes obesity nuclear receptors COX-2 COX2 2-AG 2AG cannabinoids cbs synthetic |
26.555457335788
|
| 10169 |
15(S)-HETE Ethanolamide
|
|
161744-53-2 |
≥98%
|
|
|
|
19.968830570902
|
15-s-hete-ethanolamide
|
15(S)-HAEA
|
neurotransmitters ethanolamides fatty acids endocannabinoids CB receptors amide hydrolases FAAH neurochemistry neuroscience ethanolamines 15HETE cannabinoids cbs synthetic |
19.968830570902
|
| 10174 |
16(17)-EpDPE
|
|
- |
≥90%
|
|
|
2004-01-14
|
24.917596685082
|
16-17-epdpe
|
16,17-epoxy Docosapentaenoic Acid; 16,17 EDP
|
epoxides epoxygenases cytochrome P450 (±)16,17-EpDPEs (+/-)16,17-EpDPEs fatty acids (+/-)16(17)EpDPEs 16(17)EETs eicosatrienoic neurochemistry 16,17-EDP 16,17EDP |
24.917596685082
|
| 33600 |
(±)16-HDoHE
|
|
90780-51-1 |
≥98%
|
|
|
|
10.762974217311
|
-16-hdohe
|
16-hydroxy Docosahexaenoic Acid
|
racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)16-HDoHEs (+/-)HDoHEs neurochemistry |
10.762974217311
|
| 33650 |
(±)17-HDoHE
|
|
90780-52-2 |
≥98%
|
|
|
|
13.732331066723
|
-17-hdohe
|
17-hydroxy Docosahexaenoic Acid
|
racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)17-HDoHEs (+/-)HDoHEs neurochemistry |
13.732331066723
|
| 14810 |
17-phenyl trinor Prostaglandin E2
|
|
38315-43-4 |
>98%
|
|
|
|
56.688241252302
|
17-phenyl-trinor-prostaglandin-e2
|
17-phenyl trinor PGE2
|
agonists EP1 EP3 prostaglandins receptors 17-phenyl-trinor-PGE2 |
56.688241252302
|
| 10004238 |
17-phenyl trinor Prostaglandin E2 serinol amide
|
|
- |
≥95%
|
|
|
2004-05-13
|
117.110243093922
|
17-phenyl-trinor-prostaglandin-e2-serinol-amide
|
17-phenyl trinor PGE2-SA
|
agonists EP1 EP3 prostaglandins receptors 17-phenyl-trinor-PGE2 analogs 17-phenyl-PGE2SA 17-phenyl-PGE2-SA amides cannabinoids Cbs sythetic |
117.110243093922
|
| 10004237 |
17-phenyl trinor Prostaglandin F2α serinol amide
|
|
- |
>98%
|
|
|
2004-03-15
|
7.416194751381
|
17-phenyl-trinor-prostaglandin-f2-serinol-amide
|
17-phenyl trinor PGF2α-SA; 17-phenyl trinor PGF2α serinol amide; Bimatoprost serinol amide
|
analogs agonists receptors 17-phenyl-PGF2.alpha.SA 17-phenyl-PGF2alphaSA 17-phenyl-PGF2a-SA prostaglandins cannabinoids CBs synthetic |
7.416194751381
|
| 10005099 |
17(R)-HDoHE
Exclusive |
|
155976-53-7 |
≥98%
|
|
✓ |
2005-01-05
|
24.270205209155
|
17-r-hdohe
|
17(R)-hydroxy Docosahexaenoic Acid
|
resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry |
24.270205209155
|
| 10009799 |
17(S)-HDoHE
|
|
- |
≥98%
|
|
|
2007-03-12
|
10.232854511970
|
17-s-hdohe
|
17(S)-hydroxy Docosahexaenoic Acid
|
resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry 17(s)-hdohe |
10.232854511970
|
| 10175 |
19(20)-EpDPE
|
|
- |
≥98%
|
|
|
2004-01-14
|
34.789093922651
|
19-20-epdpe
|
19,20-epoxy Docosapentaenoic Acid; 19,20 EDP
|
metabolites epoxides epoxygenases cytochrome P450 (±)19,20-EpDPEs (+/-)19,20-EpDPEs fatty acids (+/-)19(20)EpDPEs 19(20)EETs eicosatetraenoic 19,20-EETs neurochemistry 19,20-EDP 19,20EDP |
34.789093922651
|
| 62150 |
1-Arachidonoyl Glycerol
Exclusive |
|
35474-99-8 |
>95% (as a 9:1 mixture of the 1-AG and 2-AG)
|
|
✓ |
|
9.433922651934
|
1-arachidonoyl-glycerol
|
1-AG
|
cannabinoids glycerol anandamides fatty acids neurochemistry neuroscience |
9.433922651934
|
| 362152 |
1-Arachidonoyl Glycerol-d5
|
|
- |
≥99% deuterated product
|
|
|
|
29.892113259668
|
1-arachidonoyl-glycerol-d5
|
1-AG-d5
|
deuterium isotopes GC/MS endocannabinoids anandamides 1AG-d5 GC-MS mass spectrometry LC/MS LC-MS deuterated standards 1-AG-d5 internal fatty acids cannabinoids cbs synthetic |
29.892113259668
|
| 33750 |
(±)20-HDoHE
|
|
90906-41-5 |
≥98%
|
|
|
|
12.469972375690
|
-20-hdohe
|
20-hydroxy Docosahexaenoic Acid
|
racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)20-HDoHEs (+/-)HDoHEs neurochemistry |
12.469972375690
|
| 10008602 |
20-HETE Ethanolamide
|
|
- |
≥98%
|
|
|
2006-09-26
|
32.682062615101
|
20-hete-ethanolamide
|
20-hydroxy AEA; 20-hydroxy Arachidonoyl Ethanolamide
|
hydroxy fatty acids omega-oxidation .omega.-oxidation w-oxidation cytochrome P450 CYP450 arachidonic HETEs metabolites P-450 vasoconstrictors vasoconstriction ethanolamides cannabinoids cbs synthetic |
32.682062615101
|
| 10009501 |
20-hydroxy N-Arachidonoyl Taurine
|
|
- |
>95%
|
|
|
2008-04-23
|
10.447243707796
|
20-hydroxy-n-arachidonoyl-taurine
|
|
metabolism metabolites CYP450 20-HETE taurines vasoconstrictors TRPV1 TRPV4 FAAH |
10.447243707796
|
| 10009962 |
2-(14,15-Epoxyeicosatrienoyl) Glycerol
|
|
848667-56-1 |
≥95%
|
|
|
2008-04-03
|
28.374088397789
|
2-14-15-epoxyeicosatrienoyl-glycerol
|
2-14,15-EG
|
2-AG CYP450 metabolism mitogens cancers kidneys endocannabinoids cannabinoids cbs synthetic |
28.374088397789
|
| 9001133 |
2,3-Methylenedioxymethcathinone (hydrochloride)
New |
|
- |
≥98%
|
|
|
2012-01-26
|
188.724570602383
|
2-3-methylenedioxymethcathinone-hydrochloride
|
2,3-MDMC
|
forensics phenethylamines cathinones designer drugs amphetamines bath salts party pills plants food hydrochloride HCl |
188.724570602383
|
| 9000683 |
25-hydroxy Vitamin D3
New |
|
19356-17-3 |
≥98%
|
|
|
2012-01-12
|
69.944444444444
|
25-hydroxy-vitamin-d3
|
RO 8-8892; Rovimix Hy-D; U 32070E; 25-hydroxy Cholecalciferol
|
25631-40-7 calcidiol calcifediol calderol dedrogyl didrogyl hidroferol Hy-D Ro 8-8892 Rovimix Hy-D U 32070E U-32070E U32070E 25-OH cholecalciferol 25-OH vitamin D3 25-hydroxyvitamin D3 phosphorus metabolism neuromuscular inflammatory intermediates receptors livers kidneys plasma serum |
69.944444444444
|
| 9001128 |
25I-NMBOMe
New |
|
1043868-97-8 |
≥98%
|
|
|
2012-02-06
|
232.472329749104
|
25i-nmbome
|
|
919797-19-6 serotonin 5-HT2A hallucinogenic frontal cortex agonists forensic sciences phenethylamines neuroscience receptors brains memory schizophrenia hallucinogenic drugs |
232.472329749104
|
| 64970 |
2-APB
|
|
524-95-8 |
>98%
|
|
|
|
65.262099447514
|
2-apb
|
|
receptors inositol-1,4,5-triphosphates calcium signalling ins(1,4,5)IP3 blocked inositols antagonists Ca2+ neurochemistry neuroscience |
65.262099447514
|
| 62160 |
2-Arachidonoyl Glycerol
|
|
53847-30-6 |
>95% (as a 9:1 mixture of the 2-AG and 1-AG)
|
|
|
|
41.965750591949
|
2-arachidonoyl-glycerol
|
2-AG
|
endocannabinoids anandamides 2AG fatty acids CB1 neuroscience neurochemistry endocrinology cannabinoids cbs synthetic |
41.965750591949
|
| 362162 |
2-Arachidonoyl Glycerol-d5
|
|
- |
≥99% deuterated product
|
|
|
|
46.147099447513
|
2-arachidonoyl-glycerol-d5
|
2-AG-d5
|
deuterium isotopes GC/MS endocannabinoids anandamides 2AG-d5 GC-MS mass spectrometry LC/MS LC-MS deuterated standards 2-AG-d5 internal fatty acids lipids neurochemistry neuroscience endocrinology cannabinoids cbs synthetic |
46.147099447513
|
| 362160 |
2-Arachidonoyl Glycerol-d8
|
|
- |
≥99% deuterated product
|
|
|
|
71.042030386740
|
2-arachidonoyl-glycerol-d8
|
2-AG-d8
|
deuterium isotopes GC/MS endocannabinoids anandamides 2AG-d8 GC-MS mass spectrometry LC/MS LC-MS deuterated standards internal neurochemistry neuroscience endocrinology cannabinoids cbs synthetic |
71.042030386740
|
| 62165 |
2-Arachidonyl Glycerol ether
|
|
222723-55-9 |
>98%
|
|
|
|
27.766740331492
|
2-arachidonyl-glycerol-ether
|
Noladin; 2-AG ether
|
endocannabinoids 2AG anandamides CB1 receptor selective selectivity agonists stable 2-AG-ether analogs fatty acids neurochemistry neuroscience lipids cannabinoids cbs synthetic |
27.766740331492
|
| 10395 |
2C-E
New |
|
71539-34-9 |
≥95%
|
|
|
2012-01-11
|
134.150318586106
|
2c-e
|
2,5-Dimethoxy-4-ethylphenethylamine
|
forensics designer drugs phenethylamines serotonin norepinephrine dopamine monoamines oxidase inhibitors 2Cs psychoactive metabolism 4-ethyl-2,5-dimethoxy-phenethylamine 4-ethyl-2,5-dimethoxy-β-phenethylamine |
134.150318586106
|
| 9000787 |
2-chloro Adenosine
|
|
40656-71-1 |
≥98%
|
|
|
2011-06-29
|
0.741560773480
|
2-chloro-adenosine
|
2-CADO; NSC 158900; 6-Amino-2-chloropurine riboside
|
adenosine receptors analogs agonists seizures neuroscience NSC158900 NSC-158900 neurotransmission A1 A2A A2B A3 G protein-coupled 2-chloroadenosine 2CA 2-CA 2 CA CADO |
0.741560773480
|
| 11113 |
2C-I (hydrochloride)
New |
|
64584-32-3 |
≥98%
|
|
|
2012-01-17
|
204.681218637992
|
2c-i-hydrochloride
|
|
forensics designer drugs phenethylamines serotonin norepinephrine dopamine monoamine oxidase inhibitors hydrochloride HCl psychoactive metabolism 2CI 2C I |
204.681218637992
|
| 11199 |
2-Ethylethcathinone (hydrochloride)
New |
|
- |
≥98%
|
|
|
2012-02-10
|
48.152438155136
|
2-ethylethcathinone-hydrochloride
|
2-EEC
|
forensics phenethylamines amphetamines cathinones designer drugs ethcathinones hydrochloride HCl 2EEC 2 EEC |
48.152438155136
|
| 11419 |
2-Fluoroamphetamine (hydrochloride)
New |
|
1626-69-3 |
≥98%
|
|
|
2012-02-07
|
168.532669142288
|
2-fluoroamphetamine-hydrochloride
|
2-FA
|
1716-60-5 designer drugs amphetamines phenethylamines bath salts monoamine neurotransmitters isomers 4-FA 4 FA 2 FA forensics hydrochloride HCl |
168.532669142288
|
| 11229 |
2-Fluoroethcathinone (hydrochloride)
Exclusive New |
|
- |
≥98%
|
|
✓ |
2012-01-27
|
134.362783009654
|
2-fluoroethcathinone-hydrochloride
|
2-FEC
|
forensics phenethylamine cathinones designer drugs amphetamines hydrochloride HCl bath salts plants food pills |
134.362783009654
|
| 11420 |
2-Fluoromethamphetamine (hydrochloride)
Exclusive New |
|
- |
≥98%
|
|
✓ |
2012-02-09
|
127.104559268987
|
2-fluoromethamphetamine-hydrochloride
|
2-FMA
|
methamphetamines forensic science stimulant 4-fluoromethamphetamine 4-FMA MDMA amphetamines 4FMA FMAs |
127.104559268987
|
| 62260 |
2-Linoleoyl Glycerol
Exclusive |
|
3443-82-1 |
>98%
|
|
✓ |
|
14.702549329124
|
2-linoleoyl-glycerol
|
2-LG
|
CB1 glycerols 2LG cannabinoids 2-Linoleoyl-Glycerol reuptake endocannabinoids receptors congeners fatty acids neurochemistry neuroscience lipids cannabinoids cbs synthetic |
14.702549329124
|
| 9001186 |
2-Methoxymethcathinone (hydrochloride)
New |
|
- |
≥98%
|
|
|
2012-02-06
|
263.450466910299
|
2-methoxymethcathinone-hydrochloride
|
2-MMC
|
forensics phenethylamines amphetamines cathinones designer drugs isomers methedrone party pills bath salts hydrochloride HCl bronchodilator receptors agonists methoxyphenamine 2MMC 2 MMC |
263.450466910299
|
| 90055 |
(±)-2-Methyl Arachidonoyl-2'-Fluoroethylamide
|
|
166100-39-6 |
>95%
|
|
|
|
18.838038674033
|
-2-methyl-arachidonoyl-2-fluoroethylamide
|
O-689; 2-Methyl-2'-fluoro Anandamide; 2-methyl-2'-fluoro AEA
|
anandamides ethanolamides AEA cannabinoids receptors CB1 binding affinity faah fatty acid hydrolases .DELTA.9-THC .DELTA.9THC DELTA9-THC DELTA9THC D9-THC D9THC tetrahydrocannabidiol selective analogs neurochemistry neuroscience fluoromethanandamide |
18.838038674033
|
| 11223 |
2-Methylmethcathinone (hydrochloride)
New |
|
1246815-51-9 |
≥98%
|
|
|
2012-02-09
|
140.295513958342
|
2-methylmethcathinone-hydrochloride
|
2-MMC
|
forensics science phenethylamines cathinones designer drugs amphetamines bath salts mephedrone 3MMC 4MMC MMCs 4-MMC 1246911-71-6 HCl cathinones |
140.295513958342
|
| 10007980 |
3,4-DAA
|
|
- |
≥95%
|
|
|
2006-08-09
|
3.768259668508
|
3-4-daa
|
|
Trp tryptophan Multiple Sclerosis MS T helper-1 TH1 cytokines EAE encephalomyelitis inflammation immunity autoimmune autoimmunity cells cytokines |
3.768259668508
|
| 11228 |
3,4-Dimethylethcathinone (hydrochloride)
New |
|
- |
≥95%
|
|
|
2012-01-23
|
126.364948789933
|
3-4-dimethylethcathinone-hydrochloride
|
3,4-DMEC
|
hydrochloride HCl forensics phenethylamines cathinones designer drugs amphetamines psychoactive |
126.364948789933
|
| 9001098 |
3,4-Dimethylmethcathinone (hydrochloride)
New |
|
1081772-06-6 |
≥98%
|
|
|
2012-01-19
|
177.839535004769
|
3-4-dimethylmethcathinone-hydrochloride
|
3,4-DMMC
|
1082110-00-6 forensics phenethylamines cathinones designer drugs amphetamines hydrochloride HCl 4-methylmethcathinone 4-MMC 4 MMC 4MMC psychoactive bath salts plants food research 3,4 DMMC 3,4DMMC |
177.839535004769
|
| 10397 |
3-amino Benzamide
New |
|
3544-24-9 |
≥98%
|
|
|
2011-10-07
|
2.289024419063
|
3-amino-benzamide
|
3-(Aminocarbonyl) Aniline; 3-Carboxamidoaniline
|
poly(ADP-ribose) polymerases PARPs DNA repairs DNA strands breaks apoptosis inflammation atherosclerosis neruogenesis cancers angiogenesis signaling cellular responses inhibits inhibitor inhibition telomere shortening shortens stimulates mediated mediates PARP-mediated |
2.289024419063
|
| 10918 |
(±)3-epi CP 47,497-C8-homolog
|
|
- |
≥98%
|
|
|
2011-05-06
|
12.267457068203
|
-3-epi-cp-47-497-c8-homolog
|
|
(±)-trans-CAY10596 (±)-3-epi CP 47,497-C8 analogs trans-CAY10596 cannabinoids analogs receptors by-product standards (+)-CP 47,497-C8 CB2 CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 13802 |
12.267457068203
|
| 13802 |
(±)3-epi CP 47,497-C8-homolog (solution)
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-08-04
|
11.371533840622
|
-3-epi-cp-47-497-c8-homolog-solution
|
|
(±)-trans-CAY10596 (±)-3-epi CP 47,497-C8 analogs trans-CAY10596 cannabinoids analogs receptors by-product standards (+)-CP 47,497-C8 CB2 CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 10918 |
11.371533840622
|
| 11198 |
3-Ethylethcathinone (hydrochloride)
New |
|
- |
≥98%
|
|
|
2012-01-24
|
156.618991201291
|
3-ethylethcathinone-hydrochloride
|
3-EEC
|
3EEC EECs forensics phenethylamines amphetamines cathinones designer drugs ethcathinones psychoactive |
156.618991201291
|
| 9001082 |
3-Ethylmethcathinone (hydrochloride)
New |
|
- |
≥98%
|
|
|
2012-01-27
|
164.896184086192
|
3-ethylmethcathinone-hydrochloride
|
3-EMC
|
designer drugs forensics hydrochloride HCl stimulants entactogen amphetamines phenethylamines cathinones mephedrone bath salts plants food tablets |
164.896184086192
|
| 9001191 |
3-Fluoroamphetamine (hydrochloride)
New |
|
1716-59-2 |
≥98%
|
|
|
2012-02-07
|
210.199335808955
|
3-fluoroamphetamine-hydrochloride
|
3-FA
|
1626-71-7 designer drugs amphetamines phenethylamines bath salts isomers 3 FA 4-FA 4 FA monoamine neurotransmitters hydrochloride HCl |
210.199335808955
|
| 11230 |
3-Fluoroethcathinone (hydrochloride)
New |
|
- |
≥98%
|
|
|
2012-02-03
|
157.530908009654
|
3-fluoroethcathinone-hydrochloride
|
3-FEC
|
forensics phenethylamine cathinones designer drugs amphetamines bath salts plants food pills hydrochloride HCl |
157.530908009654
|
| 9001185 |
3-Fluoromethamphetamine (hydrochloride)
New |
|
- |
≥98%
|
|
|
2012-02-10
|
11.798895027624
|
3-fluoromethamphetamine-hydrochloride
|
3-FMA
|
designer drugs amphetamines phenethylamines bath salts 4 FMA 4FMA stimulants methamphetamines powders isomers hydrochloride HCl forensics 3FMA 3 FMA |
11.798895027624
|
| 10730 |
3-Fluoromethcathinone (hydrochloride)
|
|
- |
≥98%
|
|
|
2011-04-26
|
100.924141257072
|
3-fluoromethcathinone-hydrochloride
|
3-FMC
|
flephedrones cathinones analogs designer drugs plant feeders forensic analysis CMF-3 1049677-77-1 |
100.924141257072
|
| 11222 |
3-Methylethcathinone (hydrochloride)
New |
|
- |
≥98%
|
|
|
2012-02-06
|
155.204106125184
|
3-methylethcathinone-hydrochloride
|
3-MEC
|
forensics phenethylamines cathinones designer drugs amphetamines 3MEC 3 MEC hydrochloride HCl |
155.204106125184
|
| 11224 |
3-Methylmethcathinone (hydrochloride)
New |
|
1246816-62-5 |
≥97%
|
|
|
2012-02-03
|
200.664023225790
|
3-methylmethcathinone-hydrochloride
|
3-MMC
|
1246911-86-3 forensics phenethylamines cathinones designer drugs amphetamines synthetic bath salts powders mephedrone 3 MMC 4-MMC 4 MMC 4-methylmethcathinone |
200.664023225790
|
| 90312 |
4,5-dehydro Docosahexaenoic Acid
|
|
- |
≥98%
|
|
|
|
20.457495395948
|
4-5-dehydro-docosahexaenoic-acid
|
4,5-dehydro Cervonic Acid; 4,5-dehydro DHA
|
w-3 fatty acids omega-3 .omega.-3 n-3 analogs acetylene 5-LO 5-lipoxygenases inhibits inhibitors |
20.457495395948
|
| 90314 |
4(5)-EpDPE methyl ester
|
|
121818-29-9 |
≥98%
|
|
|
|
24.003793738489
|
4-5-epdpe-methyl-ester
|
4,5-epoxy Docosapentaenoic Acid methyl ester
|
cytochrome P450 metabolites epoxide epoxygenase neurochemistry |
24.003793738489
|
| 11231 |
4-Fluoroethcathinone (hydrochloride)
New |
|
- |
≥98%
|
|
|
2012-01-16
|
130.117004166755
|
4-fluoroethcathinone-hydrochloride
|
4-FEC
|
forensics phenethylamine cathinones designer drugs amphetamines psychoactive plants feeder capsules analogs ehtyl groups methyl amino flephedrone 4 FMC 4 FEC |
130.117004166755
|
| 9001070 |
4-Fluoromethamphetamine (hydrochloride)
|
|
52063-62-4 |
≥98%
|
|
|
2011-08-08
|
68.252000772342
|
4-fluoromethamphetamine-hydrochloride
|
4-FMA
|
methamphetamines forensic sciences stimulants 4 fluoromethamphetamine 4FMA FMA MDMA amphetamines 4-fluoroamphetamine 351-03-1 |
68.252000772342
|
| 10859 |
4-Fluoromethcathinone (hydrochloride)
|
|
7589-35-7 |
≥98%
|
|
|
2011-05-31
|
102.008874562155
|
4-fluoromethcathinone-hydrochloride
|
4-FMC; Flephedrone
|
flephedrones 4-FMC cathionones analogs 4 FMC 4FMC derivatives drugs plants feeders forensics 447-40-5 |
102.008874562155
|
| 33200 |
(±)4-HDoHE
|
|
90906-40-4 |
≥98%
|
|
|
|
12.785344703339
|
-4-hdohe
|
4-hydroxy Docosahexaenoic Acid
|
racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)4-HDoHEs (+/-)HDoHEs neurochemistry |
12.785344703339
|
| 13265 |
4-hydroxy Nonenal Alkyne
Exclusive |
|
1011268-23-7 |
≥98%
|
|
✓ |
2010-06-16
|
121.635972989564
|
4-hydroxy-nonenal-alkyne
|
Click Tag™ 4-HNE alkyne
|
lipids peroxidation inflammation neurodegeneration atherosclerosis diabetes cancers click chemistry Click Tag™ 4-HNEs alkynes IT |
121.635972989564
|
| 9000895 |
4-methoxy DMT
New |
|
3965-97-7 |
≥98%
|
|
|
2011-11-21
|
96.998213852581
|
4-methoxy-dmt
|
4-MeO DMT; 4-methoxy-N,N-Dimethyltryptamine
|
hallucinogen DMT dimethyltryptamine 5-HT receptors agonists 5-hydroxytryptamine behavior neuroscience forensics 4-OMe DMT 4 OMe DMT 4OMe DMT tryptamine |
96.998213852581
|
| 9001069 |
4-Methylethcathinone (hydrochloride)
Exclusive |
|
1266688-86-1 |
≥98%
|
|
✓ |
2011-07-18
|
83.281241722824
|
4-methylethcathinone-hydrochloride
|
4-MEC; 4-methyl-N-ethyl Cathinone
|
forensic sciences designer drugs methamphetamines 4methylethcathinone 4 methylethcathinones mephedrones cathinones analogs MDMA amphetamines plant feeders 1225617-18-4 |
83.281241722824
|
| 10801 |
4-Methylmethcathinone (hydrochloride)
|
|
1189726-22-4 |
≥98%
|
|
|
2011-06-17
|
83.647718190009
|
4-methylmethcathinone-hydrochloride
|
4-MMC; 4-Methylephedrone; Mephedrone
|
designer drugs methcathinone cathinones methamphetamine bath salts plants food feeder forensics psychoactive analysis hallucinogen meow bounce bubbles mad cow 4MMC MMC methylephedrone 1189805-46-6 4-methyl-methcathinone |
83.647718190009
|
| 10448 |
4'-Methyl-α-pyrrolidinohexanophenone (hydrochloride)
New |
|
- |
≥98%
|
|
|
2011-10-21
|
21.055398696870
|
4-methyl-pyrrolidinohexanophenone-hydrochloride
|
MPHP
|
34138-58-4 designer drugs forensics pyrovalerone bath salts MPPP PPP α-PPP α PPP psychostimulant toxic liver damage
rabdomyloysis |
21.055398696870
|
| 13140 |
4-(n-nonyl) Benzeneboronic Acid
|
|
256383-45-6 |
≥98%
|
|
|
2009-11-04
|
6.668687845304
|
4-n-nonyl-benzeneboronic-acid
|
|
fatty acids amide hydrolase FAAH endocannabinoids arachidonoyl ethanolamides AEA inhibitors inhibit monoacylglycerol lipase MAGL 2-arachidonoyl glycerol 2-AG 2AG 2 AG inhibition cannabinoids cbs synthetic |
6.668687845304
|
| 11093 |
4-Quinolone-3-Carboxamide Derivative
New |
|
1314230-69-7 |
≥98%
|
|
|
2012-01-30
|
128.388330263966
|
4-quinolone-3-carboxamide-derivative
|
|
CB1 CB2 cannabinoid CBs central peripheral receptors inverse agonists antinociception AM630 analgesic pain osteoporosis synthetic ligands mice analgesic AM 630 AM-630 |
128.388330263966
|
| 10008596 |
(±)5(6)-EET Ethanolamide
|
|
- |
≥95%
|
|
|
2006-10-20
|
8.898524072612
|
-5-6-eet-ethanolamide
|
(±)5(6)-EpETrE Ethanolamide
|
epoxides epoxygenases 5,6-EETs cytochrome P450 (+/-)5(6)-EpETrEs (+/-)5,6-EpETrEs fatty acids esters ethanolamides metabolites AEA anandamides arachidonoyl neurotransmitters cannabinergic endocannabinoids CB1 CB2 receptors central peripheral FAAH hydrolases metabolism lipoxygenases inhibition (±)5(6)-Epoxy eicosatrienoyl 14,15-EET 14,15-EpETrE 14,15-EET-EA 14,15-EET-ethanolamide 14,15-epetre-ea 14,15-ethanolamide cannabinoids cbs synthetic |
8.898524072612
|
| 11134 |
5-APB (hydrochloride)
New |
|
286834-80-8 |
≥95%
|
|
|
2012-01-13
|
82.780268199234
|
5-apb-hydrochloride
|
5-(2-aminopropyl)benzofuran
|
6-APB benzofurans amphetamines phenethylamines MDA 5-APDB forensics designer drugs analogs stimulants entactogens 1-benzofuran-5yl-propan-2-amine |
82.780268199234
|
| 13803 |
(±)5-epi CP 55,940
|
|
- |
≥98%
|
|
|
2010-08-04
|
7.455193370166
|
-5-epi-cp-55-940
|
|
(±)-5-trans-CP 55,940 (±)-CP 55,940 cannabinoids analogs receptors pains analgesics by-products standards Δ9-THC delta-tetrahydrocannabidiol CP 55940 CP44950 CP-55940 CP55,940 |
7.455193370166
|
| 11035 |
5-IAI (hydrochloride)
New |
|
- |
≥98%
|
|
|
2011-12-09
|
115.824291554659
|
5-iai-hydrochloride
|
5-iodo-2-Aminoindan
|
132367-76-1 phenethylamines phenylethylamines forensics indans indanes analogs MDMA rats serotonin hi hydrochloride hcl AI 5IAI psychoactive alkaloids 3,4-methylenedioxymethamphetamine |
115.824291554659
|
| 10729 |
5-methoxy DALT
Exclusive |
|
928822-98-4 |
≥95%
|
|
✓ |
2011-04-05
|
97.452586634441
|
5-methoxy-dalt
|
N,N-Diallyl-5-Methoxytryptamine
|
tryptamines neuroscience forensics designer drugs 5-MeO-DALT MeO TRYPTAMINE, n,n-DIALLYL-5-METHOXY N,N-DIALLYL-5-METHOXYTRYPTAMINE INDOLE, 3-[2-(DIALLYLAMINO)ETHYL]-5-METHOXY 3-[2-(DIALLYLAMINO)ETHYL]-5-METHOXYINDOLE 5-Methoxy-DALT 5-MeO-DALT DALT |
97.452586634441
|
| 90195 |
5(Z),8(Z),11(Z)-Eicosatrienoic Acid Ethanolamide
|
|
169232-04-6 |
≥98%
|
|
|
|
9.294045898852
|
5-z-8-z-11-z-eicosatrienoic-acid-ethanolamide
|
Mead Acid Ethanolamide
|
cannabinoids neurotransmitter CB1 CB2 receptors ligands acids ethanolamides eicosatrienoyl fatty acids neurochemistry neuroscience ethanolamines |
9.294045898852
|
| 10009315 |
6-Aminonicotinamide
|
|
329-89-5 |
≥98%
|
|
|
2008-11-21
|
2.086464088398
|
6-aminonicotinamide
|
6-AN; NSC 21206; SR 4388
|
inhibitors inhibits inhibition 6-phosphoguconate dehydrogenase cancers ATPs oxidative injury neurodegeneration cardiovascular |
2.086464088398
|
| 10010670 |
7-Aminoclonazepam-d4
|
|
- |
≥99% deuterated product
|
|
|
2009-04-17
|
5.674033149171
|
7-aminoclonazepam-d4
|
|
seizures myotonic atonic epilepsy receptors acids deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry |
5.674033149171
|
| 33300 |
(±)7-HDoHE
|
|
90780-55-5 |
≥98%
|
|
|
|
12.675405156537
|
-7-hdohe
|
7-hydroxy Docosahexaenoic Acid
|
racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)7-HDoHEs (+/-)HDoHEs neurochemistry |
12.675405156537
|
| 81340 |
7-Nitroindazole
|
|
2942-42-9 |
>98%
|
|
|
|
7.590122774708
|
7-nitroindazole
|
|
nitric oxide synthases inhibitors nNOS eNOS iNOS inhibits anti-nociceptive antinociceptive neurochemistry |
7.590122774708
|
| 10006878 |
8,12-iso-iPF2α-VI-d11
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2005-09-01
|
7.075386740332
|
8-12-iso-ipf2-vi-d11
|
8,12-epi-iPF2α-VI-d11
|
GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry analogs internal standards isoprostanes prostaglandins free-radical lipid peroxidation stero- regioisomers arachidonic acids 8-isoprostane 8-epi-PGF2.alpha. iPF2.alpha.-III oxidative stress Type VI class internal lactones facilitates extraction and purification neurochemistry neuroscience |
7.075386740332
|
| 10008597 |
(±)8(9)-EET Ethanolamide
|
|
- |
≥98%
|
|
|
2007-07-05
|
15.558743093922
|
-8-9-eet-ethanolamide
|
(±)8(9)-EpETrE Ethanolamide
|
AEA endocannabinoids arachidonoyl ethanolamide CYP450 cytochrome P450 metabolism ethanolamides hypertension cannabinoids cbs synthetic |
15.558743093922
|
| 10010109 |
8-DY547-cGMP
|
|
- |
≥98%
|
|
|
2008-10-23
|
736.127458563536
|
8-dy547-cgmp
|
|
CNGA2 channels activators fluorescences cyclic nucleotides |
736.127458563536
|
| 33350 |
(±)8-HDoHE
|
|
90780-54-4 |
≥98%
|
|
|
|
10.762974217311
|
-8-hdohe
|
8-hydroxy Docosahexaenoic Acid
|
racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)8-HDoHEs (+/-)HDoHEs neurochemistry |
10.762974217311
|
| 316350 |
8-iso Prostaglandin F2α-d4
|
|
211105-40-7 |
≥99% deuterated product
|
|
|
|
50.421588397790
|
8-iso-prostaglandin-f2-d4
|
15-F2t-Isoprostane-d4; iPF2α-III-d4; 8-epi PGF2α-d4; 8-Isoprostane-d4
|
GC/MS deuterium isotopes 8-isoprostanes 8-epi-PGF2.alpha.-d4 8-epi-PGF2alpha-d4 8-iso-PGF2.alpha.-d4 8-iso-PGF2alpha-d4 internal standards prostaglandins mass spectrometry LC/MS GC-MS LC-MS deuterated 8-iso-PGF2a-d4 8-epi-PGF2a-d4 ipf2a neurochemistry 316351 |
50.421588397790
|
| 10005764 |
8-iso Prostaglandin F2α Ethanolamide
|
|
- |
>98%
|
|
|
2004-09-24
|
17.166390423573
|
8-iso-prostaglandin-f2-ethanolamide
|
8-Isoprostane Ethanolamide; 8-epi PGF2α Ethanolamide; 8-iso PGF2α Ethanolamide; iPF2α-III Ethanolamide
|
ethanolamides prostaglandins anandamides AEA COX-2 cox2 cyclooxygenases synthases isoprostanes 8-epi-PGF2alpha 8-iso-PGF2alpha arachidonoyl prostamides congeners decomposition standards non-enzymatic iPF2a-III PGHS2 PGHS-2 ethanolamines 714966-38-8 cannabinoids cbs sythetic |
17.166390423573
|
| 516351 |
8-Isoprostane EIA Kit
|
|
- |
|
|
|
|
898.138721844454
|
8-isoprostane-eia-kit
|
iPF2α-III EIA Kit; 8-epi Prostaglandin F2α EIA Kit; 8-iso Prostaglandin F2α EIA Kit; 8-Isoprostane ELISA Kit
|
solid plates oxidative injury stress reactive oxygen species 8-isoprostanes 8-epi-PGF2.alpha. 8-epi-PGF2alpha 8-iso-PGF2.alpha. 8-iso-PGF2alpha prostaglandins free radicals ROS peroxidation lipids measures kits eias enzyme immunoassays ELISAs assays |
898.138721844454
|
| 516360 |
8-Isoprostane Express EIA Kit
|
|
- |
|
|
|
2009-10-26
|
177.831516825716
|
8-isoprostane-express-eia-kit
|
8-epi Prostaglandin F2α Express EIA Kit; iPF2α-III Express EIA Kit; 8-Isoprostane Express ELISA Kit; 8-iso Prostaglandin F2α Express EIA Kit
|
solid plates oxidative injury stress reactive oxygen species 8-isoprostanes 8-epi-PGF2.alpha. 8-epi-PGF2alpha 8-iso-PGF2.alpha. 8-iso-PGF2alpha prostaglandins free radicals ROS peroxidation lipids measures kits eias enzyme immunoassays ELISAs |
177.831516825716
|
| 90375 |
9-Octadecenamide
|
|
301-02-0 |
>98%
|
|
|
|
4.123281767955
|
9-octadecenamide
|
Oleamide; cis-9-octadecenamide
|
CSF sleep 9Z-octadecenamide fatty acids neurochemistry neuroscience |
4.123281767955
|
| 10012588 |
A-803467
|
|
944261-79-4 |
≥98%
|
|
|
2009-02-14
|
0.216574585635
|
a-803467
|
|
Nav1.8 sodium channels neuropathic pain inflammatory blockers inhibitors inhibits inhibition TTX-resistance TTX-R |
0.216574585635
|
| 10092 |
Adenosine Receptor A2A Blocking Peptide
|
|
- |
|
|
|
2009-04-03
|
152.562306629834
|
adenosine-receptor-a2a-blocking-peptide
|
A2AR
|
blocking peptides Western blots immunoblotting ARA2A |
152.562306629834
|
| 10005254 |
AFMK
|
|
52450-38-1 |
>98%
|
|
|
2004-10-28
|
2.185055248618
|
afmk
|
|
melatonin metabolites metabolism radicals scavengers neurotransmitters eukaryotes circadean rhythms antioxidants plasma synthesis endocrinology neurochemistry |
2.185055248618
|
| 13203 |
Agomelatine
|
|
138112-76-2 |
≥98%
|
|
|
2009-11-06
|
3.236961325967
|
agomelatine
|
Valdoxan®
|
melatonin circadian rhythm MT1 MT2 serotonin 5-HT noradrenaline dopamine antidepressant anti-depressant S20098 S-20098 S 20098 |
3.236961325967
|
| 10011546 |
AL 34662
|
|
210580-75-9 |
≥98%
|
|
|
2008-11-12
|
22.488281767955
|
al-34662
|
AL 34497
|
serotonins 5-HTs 5HT 5-hydroxy trptamine IOPs intraocular pressure glaucoma ophthalmology lower 5-hydroxytrptamine |
22.488281767955
|
| 10005223 |
AM1172
|
|
251908-92-6 |
>98%
|
|
|
2004-09-01
|
25.692268262737
|
am1172
|
|
cannabinoids neurotransmitters inhibitors AEA lipids CB1 CB2 receptors anandamide hydrolysis fatty acids inhibits arachidonoyl ethanolamides reuptake FAAH-resistant amide hydrolases neuroscience neurochemistry cannabinoids cbs synthetic |
25.692268262737
|
| 9001055 |
AM1220
Exclusive New |
|
137642-54-7 |
≥98%
|
|
✓ |
2011-10-11
|
118.380461040369
|
am1220
|
[1-[(1-methyl-2-piperidinyl)methyl]-1H-indol-3-yl]-1-naphthalenyl-methanone
|
AM-2201 AM 2201 AM-1220 AM 1220 cannabinoids CB1 CB2 CBs receptors pains forensic science forensics |
118.380461040369
|
| 10010118 |
AM1241
|
|
444912-48-5 |
>97%
|
|
|
2007-08-29
|
104.824301021262
|
am1241
|
|
CB1 CB2 cannabinoids receptors agonists antagonists antinociception AM630 AM251 AM-1241 AM 1241 cannabinoids cbs synthetic |
104.824301021262
|
| 11282 |
AM1248
Exclusive New |
|
335160-66-2 |
≥98%
|
|
✓ |
2012-02-06
|
128.785932020974
|
am1248
|
|
CBs cannabinoids synthetic agonist AM-1248 AMs 1248 forensic sciences receptors CB1 CB2 1-pentyl-3-(1-adamantoyl)indole AM679 AM-679 679 |
128.785932020974
|
| 11193 |
AM2201 7-hydroxyindole metabolite
New |
|
- |
≥98%
|
|
|
2012-01-16
|
119.790823986937
|
am2201-7-hydroxyindole-metabolite
|
|
forensics sciences AM-2201 AM 2201 isomers cannabinoids receptors pain CBs CB1 CB2 metabolites urinary urine metabolism synthetic central peripheral |
119.790823986937
|
| 9001031 |
AM2201 N-(2-fluoropentyl) isomer
New |
|
- |
≥95%
|
|
|
2011-12-15
|
125.960721783419
|
am2201-n-2-fluoropentyl-isomer
|
|
forensics AM-2201 AM 2201 isomers cannabinoids receptors pain CBs CB1 CB2 synthetic isomers fluorine pentyl chains synthetic central peripheral |
125.960721783419
|
| 9001029 |
AM2201 N-(4-fluoropentyl) isomer
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-08-11
|
65.690699556963
|
am2201-n-4-fluoropentyl-isomer
|
|
forensics sciences AM-2201 AM 2201 isomers cannabinoids receptors pain CBs CB1 CB2 central peripheral |
65.690699556963
|
| 10203 |
AM2201 N-(4-hydroxypentyl) metabolite
Exclusive New |
|
- |
≥98%
|
|
✓ |
2011-10-11
|
105.795305348014
|
am2201-n-4-hydroxypentyl-metabolite
|
|
AM-2201 AM 2201 cannabinoids cannabimimetic metabolites CB1 CB2 CBS receptors forensics synthetics smoking urinary urine potent synthetic |
105.795305348014
|
| 11008 |
AM2233
New |
|
444912-55-4 |
≥98%
|
|
|
2011-10-24
|
100.230828316970
|
am2233
|
|
769958-75-0 forensic science cannabinoid receptors CB1 agonists WIN 55,212-2 WIN 55212-2 radioligands neuroscience |
100.230828316970
|
| 71670 |
AM251
|
|
183232-66-8 |
>98%
|
|
|
|
76.381213014119
|
am251
|
|
cannabinoids receptors antagonists CB1 analogs selective SR-141716-A AM-251 SR141716A neuroscience neurochemistry endocrinology |
76.381213014119
|
| 13452 |
AM3102
Exclusive |
|
213182-22-0 |
≥98%
|
|
✓ |
2009-08-11
|
45.108392879067
|
am3102
|
KDS-5104
|
OEA PPARs PPARα KDS5104 antiobesity anti-obesity CB1 CB2 endocannabinoids obesity cannabinoids inhibitors agonists receptors cbs synthetic |
45.108392879067
|
| 90060 |
AM404
|
|
183718-77-6 |
>98%
|
|
|
|
37.788228974830
|
am404
|
N-(4-hydroxyphenyl)-Arachidonoyl Amide; 4-HPA
|
cannabinoids neurotransmitter inhibitors AEA lipids CB1 CB2 receptors anandamide hydrolysis fatty acids neuroscience neurochemistry |
37.788228974830
|
| 10006974 |
AM630
|
|
164178-33-0 |
≥98%
|
|
|
2009-02-09
|
47.163132289748
|
am630
|
Iodopravadoline
|
neurochemistry neuroscience cannabinoids CB1 CB2 antagonist inverse agonist antinociception pain receptors |
47.163132289748
|
| 10567 |
AM694
Exclusive |
|
335161-03-0 |
≥95%
|
|
✓ |
2011-01-31
|
55.781724575096
|
am694
|
|
cannabinoids CB1 CB2 receptors pain JWH neuroscience AM-694 AM 694 |
55.781724575096
|
| 10869 |
AM694 4-iodo isomer
Exclusive |
|
- |
≥97%
|
|
✓ |
2011-06-21
|
29.220392980301
|
am694-4-iodo-isomer
|
|
cannabinoids CBs cannabimimetics CB1 CB2 pain spices forensics synthetic receptors agonists AM-694 AM 694 analogs neuroscience |
29.220392980301
|
| 10005098 |
AMC Arachidonoyl Amide
|
|
- |
>98%
|
|
|
2004-08-31
|
12.158132596685
|
amc-arachidonoyl-amide
|
7-amino-4-methyl Coumarin-Arachidonamide; AMC-AA
|
fatty acid amides hydrolases FAAH anandamides fluorescence coumarin |
12.158132596685
|
| 11001 |
Anatabine
New |
|
2743-90-0 |
≥95%
|
|
|
2011-11-10
|
0.311827956989
|
anatabine
|
|
alkaloids solanaceae tobacco Alzheimer’s diseases amyloid beta Aβ β-secretase BACE-1 NF-κB inflammation urine nicotine transcription proteins SHSY-5Y cells |
0.311827956989
|
| 13523 |
Apelin-13
|
|
217082-58-1 |
≥95%
|
|
|
2010-06-29
|
51.080481452249
|
apelin-13
|
|
ligands APJ receptors central nervous system cardiovascular functions fluid homeostasis neurosciences hypertension diabetes metabolic syndrome insulin HIV aids Peptide Factors Paracrine
Paracrine Protein Factors
Paracrine Peptide Factors
Growth Factors
|
51.080481452249
|
| 13524 |
Apelin-36
|
|
252642-12-9 |
≥95%
|
|
|
2011-04-04
|
55.485883977900
|
apelin-36
|
|
agonists receptors APJ cardiovascular functions fluids homeostasis hypertension insulin sensitivity apelin-17 apelins 17 13 36 apelin-13 HIV infections peptides mature G protein-coupled GPCR c-protein coupled |
55.485883977900
|
| 10008617 |
Arachidonic Acid Leelamide
|
|
- |
≥95%
|
|
|
2006-09-27
|
13.333687845304
|
arachidonic-acid-leelamide
|
|
AA cannabinoids central peripheral CB1 CB2 CP55940 PDK pyruvates dehydrogenases kinases anti-inflammatory inflammation phospholipases PLA2 inhibits inhibitors inhibition cannabinoids cbs sythetic |
13.333687845304
|
| 10007904 |
Arachidonoyl-1-thio-Glycerol
Exclusive |
|
- |
>98%
|
|
✓ |
2006-01-24
|
18.352375690608
|
arachidonoyl-1-thio-glycerol
|
1-S-Arachidonoyl-1-mercapto-2,3-propanediol
|
cannabinoids monoacylglycerols monoglycerol monoglyceride anandamides fatty acids neurochemistry neuroscience chromogenic substrates lipases 2-arachidonoyls 2-AG agonists central CB1 nervous system CNS rat brains MGL hydrolyzes arachidonic acids thioesters analogs thiols DTNB Ellman's reagents yellow cannabinoids cbs synthetic |
18.352375690608
|
| 91054 |
Arachidonoyl 2'-Chloroethylamide
|
|
220556-69-4 |
>96%
|
|
|
|
22.960930018415
|
arachidonoyl-2-chloroethylamide
|
2'-chloro-AEA; ACEA
|
agonists selective CB1 receptors AEA arachidonoyl ethanolamides cannabinoids selectivity hypothermia FAAH fatty acid amide hydrolases neurochemistry neuroscience thc tetrahydrocannabinoids ethanolamines |
22.960930018415
|
| 90054 |
Arachidonoyl-2'-Fluoroethylamide
|
|
166100-37-4 |
>98%
|
|
|
|
5.036048269845
|
arachidonoyl-2-fluoroethylamide
|
2'-fluoro Anandamide; 2'-fluoro AEA
|
anandamides cannabinoids neurotransmitters ligands AEA lipids CB1 CB2 receptors neurochemistry neuroscience |
5.036048269845
|
| 10007295 |
Arachidonoyl amide
|
|
85146-53-8 |
>98%
|
|
|
2006-01-18
|
7.823456985003
|
arachidonoyl-amide
|
Arachidonamide; Arachidonic Acid amide
|
anandamides arachidonoyl ethanolamides AEA endogenous endocannabinoids CB1 CB2 receptors cellular uptake hydrolysis bonds enzymes fatty acids hydrolases FAAH N,N-dimethyl analogs human inhibits inhibition rat glial gap junction cell-cells communications neurochemistry hydroxyethyl moiety transporter astrocytoma neuroscience cannabinoids inhibitors |
7.823456985003
|
| 91053 |
Arachidonoyl Cyclopropylamide
|
|
229021-64-1 |
>98%
|
|
|
|
19.122202052091
|
arachidonoyl-cyclopropylamide
|
ACPA
|
cannabinoids receptors CB1 agonists AEA FAAH fatty acid hydrolases substrates selective analogs anandamide arachiodonyl ethanolamides neurochemistry neuroscience thc tetrahydrocannabinoids ethanolamines |
19.122202052091
|
| 90050 |
Arachidonoyl Ethanolamide
|
|
94421-68-8 |
≥98%
|
|
|
|
35.180919814842
|
arachidonoyl-ethanolamide
|
Anandamide; AEA
|
cannabinoids neurotransmitter ligands lipids CB1 CB2 receptors AEA fatty acids neuroscience neurochemistry ethanolamines ethanolamides endocrinology |
35.180919814842
|
| 10011178 |
Arachidonoyl Ethanolamide-d4
|
|
946524-40-9 |
≥99% deuterated product
|
|
|
2008-03-04
|
35.926298342541
|
arachidonoyl-ethanolamide-d4
|
AEA-d4; Anandamide-d4
|
deuterium GC/MS internal isotopes standards ethanolamides LC/MS mass spectrometry cannabinoids fatty acids deuterated neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic |
35.926298342541
|
| 390050 |
Arachidonoyl Ethanolamide-d8
|
|
- |
≥99% deuterated product
|
|
|
|
35.021906077348
|
arachidonoyl-ethanolamide-d8
|
Anandamide-d8; AEA-d8
|
deuterium GC/MS internal isotopes standards ethanolamides GC-MS LC/MS LC-MS mass spectrometry cannabinoids deuterated fatty acids neurochemistry neuroscience ethanolamines endocrinology |
35.021906077348
|
| 10007270 |
Arachidonoyl Ethanolamide Lipid Maps MS Standard
|
|
94421-68-8 |
≥98%
|
|
|
2009-02-18
|
6.314611134721
|
arachidonoyl-ethanolamide-lipid-maps-ms-standard
|
AEA; Anandamide
|
cannabinoids neurotransmitter ligands lipids CB1 CB2 receptors AEA fatty acids neuroscience neurochemistry ethanolamines ethanolamides endocrinology MS mass spectrometry standards |
6.314611134721
|
| 10180 |
Arachidonoyl Ethanolamide Phosphate
|
|
183323-26-4 |
>98%
|
|
|
2004-08-19
|
15.640524861879
|
arachidonoyl-ethanolamide-phosphate
|
AEA-P; Anandamide Phosphate
|
endocannabinoids neurotransmitters ligands lipids CB1 CB2 receptors fatty acids phosphates anandamides LPA lysophosphatidic ethanolamines ethanolamides cannabinoids cbs synthetic |
15.640524861879
|
| 90051 |
Arachidonoyl Glycine
|
|
179113-91-8 |
>98%
|
|
|
|
22.298044198895
|
arachidonoyl-glycine
|
NAGly; N-Arachidonyl Glycine
|
cannabinoids ligands lipids CB1 receptors AEA anandamides ethanolamides fatty acids neurochemistry neuroscience |
22.298044198895
|
| 10007531 |
Arachidonoyl Glycine-d8
|
|
- |
≥99% deuterated product
|
|
|
2005-09-13
|
17.672720994475
|
arachidonoyl-glycine-d8
|
N-Arachidonyl Glycine-d8; NAGly-d8
|
deuterium GC/MS internal isotopes standards GC-MS LC/MS LC-MS mass spectrometry deuterated cannabinoids ligands lipids CB1 receptors AEA anandamides ethanolamides fatty acids neurochemistry neuroscience |
17.672720994475
|
| 90059 |
Arachidonoyl m-Nitroaniline
Exclusive |
|
- |
>98%
|
|
✓ |
|
5.256883977900
|
arachidonoyl-m-nitroaniline
|
AmNA
|
FAAH substrates anandamides hydrolases colorimetric cannabinoids fatty acids meta-nitroaniline aea nitroanilines nitroanalines neurochemistry neuroscience |
5.256883977900
|
| 10007294 |
Arachidonoyl-N-methyl amide
|
|
156910-29-1 |
>98%
|
|
|
2006-01-18
|
7.114112075769
|
arachidonoyl-n-methyl-amide
|
|
acids anandamides arachidonoyl ethanolamides AEA endogenous endocannabinoids CB1 CB2 receptors cellular uptake hydrolysis bonds enzymes fatty acids hydrolases FAAH N,N-dimethyl analogs human inhibits inhibition rat glial gap junction cell-cells comunications neurochemistry neuroscience inhibitors |
7.114112075769
|
| 10007293 |
Arachidonoyl-N,N-dimethyl amide
|
|
45280-17-9 |
>98%
|
|
|
2006-01-11
|
7.195374901341
|
arachidonoyl-n-n-dimethyl-amide
|
Arachidonic Acid-N,N-dimethyl amide
|
anandamides arachidonoyl ethanolamides AEA endogenous endocannabinoids CB1 CB2 receptors cellular uptake hydrolysis bonds enzymes fatty acids hydrolases FAAH N,N-dimethyl analogs human inhibits inhibition rat glial gap junction cell-cells comunications neurochemistry neuroscience cannabinoids cbs synthetic |
7.195374901341
|
| 10168 |
Arachidonoyl p-Nitroaniline
|
|
119520-58-0 |
>98%
|
|
|
2004-12-01
|
8.814443567482
|
arachidonoyl-p-nitroaniline
|
ApNA
|
FAAH substrates anandamides hydrolases colorimetric cannabinoids fatty acids para-nitroaniline aea nitroanilines arachidonoyl ethanolamides neurochemistry neuroscience |
8.814443567482
|
| 62170 |
Arachidonoyl Serinol
|
|
183718-70-9 |
>98%
|
|
|
|
32.943646408840
|
arachidonoyl-serinol
|
|
endocannabinoids anandamides 2AG CB1 receptors neurochemistry neuroscience cannabinoids cbs synthetic |
32.943646408840
|
| 70665 |
Arachidonoyl Serotonin
|
|
187947-37-1 |
>98%
|
|
|
|
12.063613761929
|
arachidonoyl-serotonin
|
AA-5HT
|
inhibitors fatty acids amides hydrolase FAAH inactivation cannabinoids AA-5HT neurochemistry neuroscience |
12.063613761929
|
| 62120 |
Arachidonyl Trifluoromethyl Ketone
|
|
149301-79-1 |
>98%
|
|
|
|
30.507655003069
|
arachidonyl-trifluoromethyl-ketone
|
ATK; AATFMK
|
ATK AACOCF3 inhibitors PLA2 analogs fatty acids lipoxygenases inhibition inhibits LOs neurochemistry neuroscience |
30.507655003069
|
| 10005765 |
Arachidoyl Ethanolamide
Exclusive |
|
94421-69-9 |
>98%
|
|
✓ |
2005-06-22
|
11.432394106814
|
arachidoyl-ethanolamide
|
N-Arachidoylethanolamine
|
arachidoyls ethanolamides N-acyls saturated anandamides analogs enocannabinoids CB1 CB2 memory weight loss appetite neurodegeneration tumors arachidoylethanolamide surveillance analgesia inflammations fatty hydrolytic enzymes FAAH acid amides hydrolases AEA neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic |
11.432394106814
|
| 9000325 |
Arachidoyl glycine
|
|
617703-96-5 |
≥98%
|
|
|
2008-12-02
|
1.094232044199
|
arachidoyl-glycine
|
|
arachidic acid glycine fatty acids PUFAs polyunsaturated fatty acids |
1.094232044199
|
| 13662 |
Arecoline (hydrobromide)
|
|
300-08-3 |
≥95%
|
|
|
2010-08-19
|
0.299079189687
|
arecoline-hydrobromide
|
|
63-75-2 alkaloids betel nuts Areca agonists muscarinic acetylcholine receptors M1 M2 M3 M4 M5 smooth muscles contractions learning memory dementia Alzheimer’s diseases Methylarecaidin Arecholine Arecoline Arecholin Arecaline Arecolin |
0.299079189687
|
| 90052 |
Arvanil
|
|
128007-31-8 |
>98%
|
|
|
|
10.947914364641
|
arvanil
|
N-Vanillylarachidonamide
|
capsaicin capsicum vanilloids receptors agonists cannabinoids analgesia anandamides analgesic vanillylamines amides neurochemistry neuroscience |
10.947914364641
|
| 13644 |
Aspalatone
Exclusive |
|
147249-33-0 |
≥98%
|
|
✓ |
2010-02-19
|
3.789786898184
|
aspalatone
|
Acetylsalicylic Acid Matol ester
|
antioxidants platelet aggregation thrombosis epilepsy kainic acid thromboembolism anti-platelets antiplateles 2-(Acetyloxy)benzoic Acid
Acid, Acetylsalicylic
Acetylsalicylic Acid
Aloxiprimum Polopiryna
Polopirin Micristin Endosprin Acylpyrin Solupsan Magnecyl
Colfarit Acetysal Zorprin
Solprin Ecotrin Easprin
Dispril Aspirin |
3.789786898184
|
| 13160 |
AT-56
Exclusive |
|
162640-98-4 |
≥95%
|
|
✓ |
2010-06-22
|
14.424548802946
|
at-56
|
|
Prostaglandins D synthases L-PGDS PGD2 lipocalin-type inflammation inhibition inhibitors inhibits PGs eosinophils LPGDs bronchoalveolar lavage fluid Lysosomal Proton Translocating ATPases Vacuolar Proton-Translocating ATPases Vacuolar Membrane H(+)-ATPase Proteins Membrane-Associated Membrane-Associated Proteins Membrane Associated Proteins Tacrolimus Binding Proteins Proteins Rapamycin-Binding Proteins Integral Membrane Membrane Proteins Integral Binding Proteins Rapamycin Rapamycin-Binding Proteins Rapamycin Binding Proteins Protein Integral Membrane Integral Membrane Proteins Vacuolar F(1)F(0) ATPasesLysosomal F(1)F(0) ATPase Integral Membrane Protein Vacuolar F(1)F(0) ATPase Proteins Cell Membrane Protein FK-506-Binding Proteins Cell Surface Protein FK506-Binding FK-506-Binding ProteinFK506 Binding Proteins FK 506 Binding Protein Cell Membrane Proteins FK506-Binding ProteinFK506 Binding Protein Cell Surface Proteins H+-ATPase, Vacuolar Vacuolar H+-ATPase Vacuolar H+ ATPase Proteins Membrane Proteins Vacuolar ATPase Rotamase FKBP V Type ATPase FKBP Rotamase Membrane FKBP |
14.424548802946
|
| 10009410 |
ATF2 (Phospho-Ser490,498) Polyclonal Antibody
|
|
- |
|
|
|
2006-11-28
|
0.870165745856
|
atf2-phospho-ser490-498-polyclonal-antibody
|
Activating Transcription Factor 2
|
wb western blotting blots ihc immunohistochemistry antibodies activating transcriptional factors CRE-BP1 AP-1 DNA response elements ATF/CREB leucine zipper proteins regulating regulation genes cytokines cells cycles controls apoptosis death cellular stress inflammatory UV irradiation activity phosphorylation serines brains substrates neuronal neurons growth differentiation human depression phospho-specific immunoblotting |
0.870165745856
|
| 10009021 |
AVE-1625
Exclusive |
|
358970-97-5 |
>98%
|
|
✓ |
2008-04-03
|
121.810082872928
|
ave-1625
|
|
cannabinoids CB1 receptors schizophrenia parkinsons disease alzheimers disease metabolism obesity SR-141716 lipolysis glycogenolysis antagonist endocrinology neurochemistry |
121.810082872928
|
| 13823 |
AX 048
Exclusive |
|
873079-69-7 |
≥98%
|
|
✓ |
2010-09-15
|
9.193425414365
|
ax-048
|
|
Inflammation antihyperalgesia cPLA2 phospholipases inhibitors inhibition inhibits AX048 AX-048 signaling signalling group IVA PLA2 cannabinoids cbs synthetic Acids Octanoic Octanoic Acids |
9.193425414365
|
| 10227 |
BACE (human recombinant)
|
|
- |
≥95%
|
|
|
2009-03-09
|
18.321469613259
|
bace-human-recombinant
|
Membrane-bound Aspartic Protease; BACE-1; ASP-2; β-Secretase; Memapsin-2
|
proteins amyloids peptides C-terminus terminal alzheimers neurochemistry |
18.321469613259
|
| 600070 |
BACE Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2009-03-26
|
29.692872928176
|
bace-inhibitor-screening-assay-kit
|
β-Secretase Inhibitor Screening Assay Kit
|
inhibitors inhibition inhibits assays kits β-sites .beta.-sites b-sites APP cleaving enzymes β-amyloids .beta.-amyloids b-amyloids peptides Ab A.beta. brain neurodegeneration Alzheimer's Diseases AD proteolytic cleavages precursors β-secretases b-secretases γ-secretases .gamma.-secretases g-secretases membranes aspartic C-terminal C-terminus fragments proteolysis therapeutics therapy cascade pathogenesis mice mouse murine transgenics cholinergic dysfunctions HIV humans fluorescents fluorescences fluorometer assays |
29.692872928176
|
| 10011135 |
BAY-60-7550
|
|
439083-90-6 |
≥95%
|
|
|
2009-03-13
|
62.156844151329
|
bay-60-7550
|
|
inhibitors inhibits inhibition cyclic nucleotides cGMP cAMP cells signalling signaling PDE2 memory memories phosphodiesterase |
62.156844151329
|
| 10506 |
Bio-active Lipid I Screening Library (96-Well)
|
|
- |
|
|
|
2010-06-15
|
44.241464088397
|
bio-active-lipid-i-screening-library-96-well
|
|
vasoconstriction bronchoconstriction prostaglandins endocrinology prostaglandins HTS high thoroughput screening cannabinoids cbs synthetic |
44.241464088397
|
| 10005836 |
bis(7)-Tacrine
|
|
224445-12-9 |
>98%
|
|
|
2005-04-15
|
4.350110497238
|
bis-7-tacrine
|
1,7-N-heptylene-bis-9,9'-amino-1,2,3,4-tetrahydro-acridine
|
dimeric congeners amino acridines inhibits inhibitors inhibition acetylcholinesterases Alzheimer's disease hydrogen peroxides apoptosis pheochromocytoma cells neurochemistry neuroscience |
4.350110497238
|
| 11283 |
Buphedrone (hydrochloride)
New |
|
166593-10-8 |
≥98%
|
|
|
2012-01-23
|
147.413092335708
|
buphedrone-hydrochloride
|
MABP; α-methylamino-Butyrophenone
|
forensics phenethylamines amphetamines cathinones designer drugs ethcathinones psychoactive hydrochloride HCl stimulants 408332-79-6 |
147.413092335708
|
| 10488 |
Bupropion (hydrochloride)
|
|
31677-93-7 |
≥98%
|
|
|
2010-08-16
|
24.251151406400
|
bupropion-hydrochloride
|
NSC 315851
|
34841-36-6 Zyban Wellbatrin inhibitors inhibits inhibition reuptake dopamine norepinephrine Voxra Aplenzin Amfebutamone antagonists neuronal acetylcholine nicotinic receptors nAChR antidepressant depression neurosciences Wellbutrin 1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone
GlaxoSmithKline Brand 2 of Bupropion Hydrochloride
GlaxoSmithKline Brand 1 of Bupropion Hydrochloride
Glaxo Wellcome Brand 3 of Bupropion Hydrochloride
Glaxo Wellcome Brand 2 of Bupropion Hydrochloride
Glaxo Wellcome Brand 1 of Bupropion Hydrochloride
Esteve Brand of Bupropion Hydrochloride Bupropion Hydrochloride Bupropion Hydrochloride Zyban (Anti-Smoking) Amfebutamone Wellbutrin Bupropion Bupropion Zyntabac Quomen Isomer |
24.251151406400
|
| 70090 |
BW 723C86
|
|
160521-72-2 |
>98%
|
|
|
|
22.502430939226
|
bw-723c86
|
|
bw-723c86 bw723-c86 5-ht2b agonist anxiolytic serotonin 5-hydroxy-tryptamine 5-OH-tryptamine bw723c86 receptors selective endocrinology neurochemistry neuroscience |
22.502430939226
|
| 10011437 |
CaMKII Monoclonal Antibody (Clone 6G9)
|
|
- |
|
|
|
2008-05-20
|
20.143646408839
|
camkii-monoclonal-antibody-clone-6g9
|
Calcium/Calmodulin-dependent Protein Kinase II
|
calcium calmodulin signalling signaling WB IHC IP EIA IF western blots immunohistochemistry immunoprecipitation immunofluorescence antibodies antiserum kinases neurochemistry enzyme immunoassays immunoblotting PPI PKA blotting |
20.143646408839
|
| 10011438 |
CaMKII (Phospho-Thr286/Thr287) Monoclonal Antibody (Clone 22B1)
|
|
- |
|
|
|
2008-05-20
|
20.143646408839
|
camkii-phospho-thr286-thr287-monoclonal-antibody-clone-22b1
|
Calcium/Calmodulin-dependent Protein Kinase II
|
calcium calmodulin signalling signaling WB IHC IP EIA IF western blots immunohistochemistry immunoprecipitation immunofluorescence antibodies antiserum kinases neurochemistry immunoblotting enzyme immunoassays PPI PKa blotting |
20.143646408839
|
| 10489 |
Candesartan cilexetil
|
|
145040-37-5 |
≥98%
|
|
|
2011-04-08
|
7.204143646409
|
candesartan-cilexetil
|
TCV-116
|
angiotensin II receptors antagonists hypertension diabetes AT1 type 1 stress diastolic blood pressure anti-hypertensive antihypertensive |
7.204143646409
|
| 90080 |
Cannabidiol
|
|
13956-29-1 |
>99%
|
|
|
|
26.647332280978
|
cannabidiol
|
CBD
|
delta9-THC .DELTA.9-THC delta9THC .DELTA.9THC marijuana neuroprotective tetrahydrocannabidiol d9-THC d9THC neurochemistry neuroscience synthetic cbs cannabinoids |
26.647332280978
|
| 13285 |
Cannabidiol dimethyl ether
|
|
1242-67-7 |
≥98%
|
|
|
2009-05-19
|
12.557320441989
|
cannabidiol-dimethyl-ether
|
Cannabidiol-2',6'-dimethyl ether; CBDD
|
15-lipoxygenases 15-LOs dioxygenase fatty acids inflammation thrombosis cancer LDL oxidation inhibitions inhibition inhibiting cannabinoids cbs synthetic |
12.557320441989
|
| 90081 |
Cannabidiol (solution)
|
|
13956-29-1 |
≥99%
|
|
|
2011-03-03
|
33.602882973380
|
cannabidiol-solution
|
CBD
|
delta9-THC .DELTA.9-THC delta9THC .DELTA.9THC marijuana neuroprotective tetrahydrocannabidiol d9-THC d9THC neurochemistry neuroscience synthetic cbs cannabinoids |
33.602882973380
|
| 92350 |
Capsaicin
|
|
404-86-4 |
>95%
|
|
|
2004-04-01
|
7.223272127169
|
capsaicin
|
|
Capsicum peppers VR1 vanilloid receptors pain heat hot extracts nociceptive burning neurochemistry neuroscience lipid-soluble extracts calcium ca+ ion channels pathways desensitization non-myelinatedpolymomdal c-type nerve fibers |
7.223272127169
|
| 10010743 |
Capsaicin (technical grade)
|
|
404-86-4 |
>60%
|
|
|
2007-11-27
|
5.491588397789
|
capsaicin-technical-grade
|
|
Capsicum peppers VR1 vanilloid receptors pain heat hot extracts nociceptive burning neurochemistry neuroscience lipid-soluble extracts calcium ca+ ion channels pathways desensitization non-myelinatedpolymomdal c-type nerve fibers |
5.491588397789
|
| 10007518 |
Capsazepine
|
|
138977-28-3 |
>98%
|
|
|
2006-03-29
|
10.181482504603
|
capsazepine
|
|
vanilloid receptors 1 VR1 transient potential TRP endogenous stimuli tissues injury inflammation pain antagonists capsaicin Ca2+ neonatal rats dorsal root ganglias Chinese hamsters ovary ovaries cells |
10.181482504603
|
| 13702 |
Cav1.2 Calcium Channel Monoclonal Antibody (Clone S57-46)
|
|
- |
|
|
|
2009-11-05
|
1.922651933701
|
cav1-2-calcium-channel-monoclonal-antibody-clone-s57-46
|
|
antibodies western blotting blots immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC channels ions fusion proteins gated voltage-gated ligand-gated voltage ligand |
1.922651933701
|
| 13703 |
Cav1.3 Calcium Channel Monoclonal Antibody (Clone S38-8)
|
|
- |
|
|
|
2009-11-05
|
0.640883977900
|
cav1-3-calcium-channel-monoclonal-antibody-clone-s38-8
|
|
antibodies channels ions fusion proteins CACNAID western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC gated voltage-gated ligand-gated voltage ligand |
0.640883977900
|
| 13706 |
Cav1.3 Calcium Channel Monoclonal Antibody (Clone S48A-9)
|
|
- |
|
|
|
2009-11-12
|
0.640883977900
|
cav1-3-calcium-channel-monoclonal-antibody-clone-s48a-9
|
|
antibodies channels ions fusion proteins CACNAID western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC gated voltage-gated ligand-gated voltage ligand |
0.640883977900
|
| 13704 |
Cav3.2 Calcium Channel Monoclonal Antibody (Clone S55-10)
|
|
- |
|
|
|
2009-11-12
|
1.922651933701
|
cav3-2-calcium-channel-monoclonal-antibody-clone-s55-10
|
|
antibodies CACNA1H genes epilepsy up-regulations up regulations upregulations prostate cancers androgen-independent androgen independent western blotting blots WB fusion protein immunohistochemistry IHC immunocytochemistry ICC |
1.922651933701
|
| 13701 |
Cavβ4 Calcium Channel Monoclonal Antibody (Clone S10-7)
|
|
- |
|
|
|
2009-11-05
|
0.640883977900
|
cav-4-calcium-channel-monoclonal-antibody-clone-s10-7
|
|
western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels antibodies epilepsy IGE JME subunits gated voltage-gated ligand-gated ligand voltage |
0.640883977900
|
| 71652 |
CAY10401
|
|
288862-89-5 |
>98%
|
|
|
2005-02-02
|
8.948825046040
|
cay10401
|
|
FAAH inhibitors analgesics fatty acids amides hydrolases inhibits inhibition hydrolysis hydrolyze CAY-10401 inactivation anandamides AEA arachidonoyl ethanolamides neuroscience neurochemistry cannabinoids cbs synthetic |
8.948825046040
|
| 72620 |
CAY10412
Exclusive |
|
390824-17-6 |
>98%
|
|
✓ |
|
12.422866022099
|
cay10412
|
|
endocannabinoids neurotransmitters ligands lipids CB1 CB2 receptors AEA fatty acids neurochemistry neuroscience cannabinoids inhibitors |
12.422866022099
|
| 10004259 |
CAY10429
|
|
22972-55-0 |
>98%
|
|
|
2005-02-09
|
24.387769964841
|
cay10429
|
Abnormal Cannabidiol; Abn-CBD
|
endocannabinoids cannabidiols abnormal abn-cbd non-CB1 non-CB2 receptors agonists BV-2 microglials hypotensives GPCR neurochemistry neuroscience |
24.387769964841
|
| 10009523 |
CAY10429-d3
|
|
- |
≥99% deuterated product
|
|
|
2007-10-02
|
1.414364640884
|
cay10429-d3
|
Abnormal Cannabidiol-d3; Abn-CBD-d3
|
endocannabinoids cannabidiols abnormal abn-cbd non-CB1 non-CB2 receptors agonists BV-2 microglials hypotensives GPCR neurochemistry neurosciences cannabindoids CB1 CB2 deuterated deuterium mass spectrometry LC-MS GC-MS AbnCBD LC/MS GC/MS cannabinoids cbs synthetic |
1.414364640884
|
| 10005102 |
CAY10435
|
|
288862-73-7 |
>98%
|
|
|
2004-07-06
|
8.888496009822
|
cay10435
|
|
fatty acid amide inhibitors FAAH hydrolases inhibition inhibits hydrolysis hydrolyze CAY-10435 1-(Oxazolo[4,5-b]pyridin-2-yl)-1-oxo-dodecane neurochemistry neuroscience |
8.888496009822
|
| 10005186 |
CAY10441
Exclusive |
|
221529-58-4 |
>98%
|
|
✓ |
2004-09-16
|
119.233397790055
|
cay10441
|
RO1138452
|
receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma cyclic AMP cAMP adenylate cyclase 4,5-dihydro-1H-imidazol-2-yl-4-4-isopropoxy benzyl phenylamine atherosclerosis |
119.233397790055
|
| 10005633 |
CAY10448
|
|
- |
>98%
|
|
|
2004-10-01
|
4.013453038673
|
cay10448
|
|
capsaicin capsicum vanilloids receptors antagonists cannabinoids analgesia anandamides analgesic vanillylamines amides analogs transient potential VR1 pain TRPV1 neurochemistry neuroscience |
4.013453038673
|
| 10005913 |
CAY10449
Exclusive |
|
- |
>98%
|
|
✓ |
2004-10-26
|
93.114659300184
|
cay10449
|
|
receptors antagonists IPs prostaglandins carbaprostacyclins inhibits inhibitors inhibition analgesics high-affinity ligands neuroblastoma adenylate cyclase cyclic AMP cAMP iloprost athersclerosis CAY 10449 |
93.114659300184
|
| 10005072 |
CAY10455
|
|
290374-09-3 |
>98%
|
|
|
2004-11-09
|
5.969205801104
|
cay10455
|
SKM 4-45-1
|
anandamides AEAs neurons fatty acid amide hydrolase FAAH analogs arachidonyl ethanolamides transporters acyl fluorescent fluorescence substrates cellular trafficking neurochemistry neuroscience |
5.969205801104
|
| 10007955 |
CAY10498
|
|
863202-33-9 |
>98%
|
|
|
2006-08-02
|
31.301583793738
|
cay10498
|
2-phenyl-amino-N6-endo-norbornyladenine
|
adenosine receptor antagonist A1 A2A A2B A3 AR G-protein stroke inflammation glaucoma neurodegenerative disease reversine dedifferentiation neurochemistry ophthalmology |
31.301583793738
|
| 10008669 |
CAY10508
|
|
878533-35-8 |
>98%
|
|
|
2006-08-04
|
27.353314917127
|
cay10508
|
|
1,3-bis(4-bromophenyl)-5-phenyl-Imidazolidine-2,4-dione central peripheral cannabinoids receptors inverse agonists antagonists therapeutic therapy obesity drug dependence CB1 CB2 CP-55,940 cannabinoids cbs synthetic |
27.353314917127
|
| 10010740 |
CAY10550
|
|
34320-83-7 |
≥98%
|
|
|
2008-07-14
|
5.031674723756
|
cay10550
|
3-(4-Nitrophenyl)-1-phenyl-2-pyrazolin-5-one
|
prion PrPc PrPsc PrPres mad cow disease scrapie creutzfeldt-jakob disease spongigorm encephalopathy radical scavenger inhibitors inhibits inhibition |
5.031674723756
|
| 10012565 |
CAY10568
|
|
22913-17-3 |
≥98%
|
|
|
2008-05-28
|
4.645377532228
|
cay10568
|
Santinamide
|
TRPV1 QX314 cationic lidocaine capsaicin pain ion channel anesthetics analgesia nociception CAY10568 |
4.645377532228
|
| 10010032 |
CAY10570
Exclusive |
|
875014-22-5 |
>98%
|
|
✓ |
2008-06-03
|
16.145870165746
|
cay10570
|
|
FAAH fatty acids amides AEA anandamides CB1 inhibitors inhibits inhibition endocannabinoids hydrolases cannabinoids |
16.145870165746
|
| 13281 |
CAY10598
Exclusive |
|
346673-06-1 |
≥98%
|
|
✓ |
2010-05-07
|
73.670928176795
|
cay10598
|
|
Prostaglandins E2 PGE2 receptors EP4 bone formation cancers atherosclerosis agonists EP1 EP2 EP3 DP FP IP TP neuroprotection renal dysfunction inflammation neuro-protection |
73.670928176795
|
| 13358 |
CAY10608
Exclusive |
|
457897-92-6 |
≥98%
|
|
✓ |
2010-04-29
|
0.652624309392
|
cay10608
|
|
N-Methyl-D-aspartate NMDA receptors antagonists glutamate glycine propanolamine NR2B subunit AMPA kainate neuroprotection neurochemistry antagonizes potently selectively non-competitively |
0.652624309392
|
| 10743 |
CAY10650
Exclusive |
|
1233706-88-1 |
≥98%
|
|
✓ |
2011-06-14
|
23.657458563536
|
cay10650
|
|
cPLA2α cPLA2 inhibitors inflammation anti-inflammatory dermatitis metabolite phospholipase cytosolic prostaglandins PGs leukotrienes synthesis 10662 CAY-10650 CAY10641 CAY-10641 |
23.657458563536
|
| 10820 |
CAY10651
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-06-15
|
0.911602209945
|
cay10651
|
|
Glutamate neurotransmitters receptors mGlu5 pain anxiety antagonists gastresophageal reflux diseases dyskinesia fragile X syndromes drug addictions cortical astrocytes functional binding assays mobilization calcium CNS |
0.911602209945
|
| 10010398 |
CB-13
|
|
432047-72-8 |
≥98%
|
|
|
2009-06-30
|
30.332404939876
|
cb-13
|
CRA-13
|
cannabinoids CB1 CB2 central peripheral receptors agonists pains hyperalgesia blocks blocking CB13 CB 13 CRA13 CRA 13 |
30.332404939876
|
| 10006590 |
CB1 Receptor (C-Term) Polyclonal Antibody
|
|
- |
|
|
|
2005-05-10
|
58.365460405156
|
cb1-receptor-c-term-polyclonal-antibody
|
Cannabinoid Receptor 1
|
cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC western blots blotting antisera antiserum WB IHC immunohistochemistry neuroscience neurochemistry endocrinology immunoblotting cannabinoids cbs synthetic |
58.365460405156
|
| 101500 |
CB1 Receptor Polyclonal Antibody
|
|
- |
|
|
|
|
31.096256906077
|
cb1-receptor-polyclonal-antibody
|
Cannabinoid Receptor 1 Polyclonal Antibody
|
cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC western blots blotting antisera antiserum WB neuroscience neurochemistry endocrinology immunoblotting |
31.096256906077
|
| 10010116 |
CB-25
Exclusive |
|
869376-63-6 |
>98%
|
|
✓ |
2007-10-25
|
16.706774861878
|
cb-25
|
|
cannabinoids ligands receptors CB1 CB2 THC anandamides AEA inverse agonists cannabinoids cbs synthetic |
16.706774861878
|
| 101550 |
CB2 Receptor Polyclonal Antibody
|
|
- |
|
|
|
|
50.664741336012
|
cb2-receptor-polyclonal-antibody
|
Cannabinoid Receptor 2
|
cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC antisera antiserum western blots blotting WB neuroscience neurochemistry endocrinology immunoblotting IHC immunohistochemistry |
50.664741336012
|
| 10010712 |
CB2 Receptor Polyclonal FITC Antibody
|
|
- |
|
|
|
2008-01-15
|
33.902596685083
|
cb2-receptor-polyclonal-fitc-antibody
|
Cannabinoid Receptor 2
|
cannabis .DELTA.9-tetrahydrocannabinol anandamides D9-THC antibodies receptors DELTA9-tetrahydrocannabinol D9-tetrahydrocannabinol .DELTA.9-THC DELTA9-THC antisera antiserum western blots blotting WB neuroscience neurochemistry GPCRs FC flow cytometry immunoblotting IF immunofluorescence |
33.902596685083
|
| 10010117 |
CB-52
Exclusive |
|
869376-90-9 |
≥98%
|
|
✓ |
2007-10-25
|
16.798142265193
|
cb-52
|
|
cannabinoids ligands receptors CB1 CB2 THCs anandamides AEAs partial agonists neutral antagonists cannabinoids cbs synthetic |
16.798142265193
|
| 13289 |
CB-86
Exclusive |
|
1150586-64-3 |
≥98%
|
|
✓ |
2010-05-03
|
17.649021310181
|
cb-86
|
|
cannabinoids receptors CB1 CB2 antinociception agonists resorcinol anandamides hybrids CB86 CB 86 partial agonist neural antagonist antinociceptive effects 2-beta-D-Ribofuranosyl-1,2,4-triazine-3,5(2H,4H)-dione
6-Azauridine 6 Azauridine
Azauridine cannabinoids cbs synthetic |
17.649021310181
|
| 589101 |
CGRP (human) EIA Kit
|
|
- |
|
|
|
|
279.802209944751
|
cgrp-human-eia-kit
|
Calcitonin Gene-Related Peptide (human) EIA Kit; CGRP (human) ELISA Kit
|
calcitonin peptides measures kits eias enzyme immunoassays ELISAs spi-bio neurochemistry neuroscience spibio A05481 endocrinology assays |
279.802209944751
|
| 589001 |
CGRP (rat) EIA Kit
|
|
- |
|
|
|
|
400.126519337016
|
cgrp-rat-eia-kit
|
Calcitonin Gene-Related Peptide (rat) EIA Kit; CGRP (rat) ELISA Kit
|
calcitonin peptides measures kits eias enzyme immunoassays ELISAs spi-bio neurochemistry neuroscience spibio A05482 endocrinology assays |
400.126519337016
|
| 700610 |
Chloride Colorimetric Assay Kit
New |
|
- |
|
|
|
2011-11-18
|
99.084969590039
|
chloride-colorimetric-assay-kit
|
|
chlorides Cl assays kits measures measurements plasma serums urine saliva cells cultures lysates Hg2+ Fe2+ mercury iron mercury-thiocyanate Hg-thiocyanate thiocyanates mercuric mineral humans anions hydration osmotic pressure cation-anion balance vascular intestinal fluids compartments hypochloremia hyperchloremia vomiting renal diseases metabolic acidosis burns dehydration diarrhea congestive heart failure hyperventilation kidneys Lightwood syndromes parathyroid glands pathological ions channels Cystic Fibrosis myotonia congenita Barter's Syndrome 2002 bestrophins proteins hbest1 retinal progressive vision loss vitelliform macular dystrophy Best |
99.084969590039
|
| 10011126 |
Clobenpropit (hydrobromide)
|
|
145231-35-2 |
>98%
|
|
|
2008-12-04
|
6.820027624309
|
clobenpropit-hydrobromide
|
Carbamimidothioic Acid; VUF-9153
|
histamines receptors antagonist GABA neurons brains seizures |
6.820027624309
|
| 580110 |
Clusterin (human) EIA Kit
|
|
- |
|
|
|
2011-08-02
|
2.154696132597
|
clusterin-human-eia-kit
|
KUB-1; CLI; SGP-2; AAG4; pADHC-9; TRPM-2; Apo-J; Apolipoprotein J
|
apolipoproteins Up-regulated in Azheimer's diseases brains Ku70-binding proteins 1 sulfated glycoproteins 2 aging-associated genes 4 complement lysis inhibitors testosterone-repressed prostate messages secreted disulfide-linked heterodimeric amyloid lipids bacteria leptin immunoglobulins endocytic receptors LDLs low-density lipoprotein-related LPR2 LPR8 8 endocytosis tissues mammals mammalian cells plasma serums semen cultures media medium developmental remodeling apoptotic neurodegeneration injury stress inhibits inhibition apoptosis carcinogenesis genes CLU ELISAs EIAs enzymes immunoassays kits measures measurements human supernatants |
2.154696132597
|
| 10910 |
(+)-CP 47,497
|
|
134308-14-8 |
≥98%
|
|
|
2011-05-05
|
13.627848173453
|
-cp-47-497
|
|
cannabinoid analgesia analgesic CB1 hypothermia motor depressant anticonvulsant Δ9-THC CBs analogs cbs synthetic cannabinoids |
13.627848173453
|
| 10913 |
(±)-CP 47,497
|
|
70434-82-1 |
≥98%
|
|
|
2011-05-05
|
29.260334883041
|
-cp-47-497
|
|
receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic 16851 |
29.260334883041
|
| 10908 |
(±)-CP 47,497-C8-homolog
Exclusive |
|
70434-92-3 |
≥98%
|
|
✓ |
2011-05-06
|
33.211843073581
|
-cp-47-497-c8-homolog
|
CAY10596; Cannabicyclohexanol
|
cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic |
33.211843073581
|
| 10686 |
(±)-CP 47,497-C8-homolog-d7 (solution)
Exclusive |
|
- |
≥99% deuterated forms (d1-d7)
|
|
✓ |
2011-03-14
|
21.771818898971
|
-cp-47-497-c8-homolog-d7-solution
|
Cannabicyclohexanol-d7
|
cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS GC LC standards stds 10914 |
21.771818898971
|
| 13216 |
(±)-CP 47,497-C8-homolog (solution)
Exclusive |
|
70434-92-3 |
≥98%
|
|
✓ |
2009-04-23
|
43.502412536909
|
-cp-47-497-c8-homolog-solution
|
CAY10596; Cannabicyclohexanol
|
cannabinoids analgesia analgesic CB1 hypothermia motor supressants anticonvulsant Δ9-THC C8 analog CP 47,497-C8 CP4 ,497-C8 cannabinoids cbs synthetic 10908 |
43.502412536909
|
| 10687 |
(±)-CP 47,497-d11 (solution)
Exclusive |
|
- |
≥99% deuterated forms (d1-d11)
|
|
✓ |
2011-02-16
|
23.337757971923
|
-cp-47-497-d11-solution
|
|
receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS 10907 |
23.337757971923
|
| 13219 |
(+)-CP 47,497 (solution)
|
|
134308-14-8 |
≥98%
|
|
|
2009-04-13
|
17.680171898900
|
-cp-47-497-solution
|
|
cannabinoid analgesia analgesic CB1 hypothermia motor depressant anticonvulsant Δ9-THC CBs analogs cbs synthetic cannabinoids 10910 |
17.680171898900
|
| 16851 |
(±)-CP 47,497 (solution)
|
|
70434-82-1 |
≥98%
|
|
|
2008-12-10
|
40.643750448281
|
-cp-47-497-solution
|
|
receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 cannabinoids cbs synthetic 10913 |
40.643750448281
|
| 90084 |
(−)-CP 55,940
|
|
83002-04-4 |
≥98%
|
|
|
2007-01-15
|
30.013067923302
|
-cp-55-940
|
|
CP 55940 CP-55940 CP-55,940 agonists cannabinoids CB1 CB2 THC receptors endocrinology cp55940 cp55,940 neurochemistry cbs synthetic |
30.013067923302
|
| 13241 |
(±)-CP 55,940
Exclusive |
|
83003-12-7 |
≥98%
|
|
✓ |
2009-05-20
|
24.597446286065
|
-cp-55-940
|
|
cannabinoids analgetic pain THC thermal mechanical chemicals receptors CB1 cannabimimetic potent non-selective CP55940 CP-55940 cbs synthetic |
24.597446286065
|
| 10011388 |
Cu/Zn SOD (human) Polyclonal Antibody
|
|
- |
23 kDa
|
|
|
2008-04-03
|
147.019160220994
|
cu-zn-sod-human-polyclonal-antibody
|
SOD1; Cu/Zn Superoxide Dimutase
|
SOD1 SOD2 SOD3 EC-SOD oxidative stress ROS superoxide antibodies antiserum WB western blots immunoblotting IP EIA IHC immunohistochemistry neurochemistry immunoprecipitation enzyme immunoassays neurochemistry blotting |
147.019160220994
|
| 581001 |
Cyclic AMP EIA Kit
|
|
- |
|
|
|
|
717.950782093348
|
cyclic-amp-eia-kit
|
Adenosine 3',5'-cyclic monophosphate EIA Kit; cAMP EIA Kit; Adenosine 3',5'-cyclic mononucleotide EIA Kit; Cyclic AMP ELISA Kit
|
solid plates cAMP adenosine measures kits eias enzyme immunoassays ELISAs second messengers neurochemistry neuroscience endocrinology assays |
717.950782093348
|
| 581002 |
Cyclic AMP EIA Kit (without Acetic Anhydride)
|
|
- |
|
|
|
|
575.332361878453
|
cyclic-amp-eia-kit-without-acetic-anhydride
|
cAMP EIA Kit (without Acetic Anhydride); Adenosine 3',5'-cyclic monophosphate EIA Kit (without Acetic Anhydride); Adenosine 3',5'-cyclic mononucleotide EIA Kit (without Acetic Anhydride); Cyclic AMP ELISA Kit (without Acetic Anhydride)
|
solid plates cAMP adenosine measures kits eias enzyme immunoassays ELISAs second messengers neurochemistry neuroscience endocrinology assays |
575.332361878453
|
| 581021 |
Cyclic GMP EIA Kit
|
|
- |
|
|
|
|
839.255819134486
|
cyclic-gmp-eia-kit
|
Guanosine 3',5'-cyclic mononucleotide EIA Kit; Cyclic GMP ELISA Kit; cGMP EIA Kit; Guanosine 3',5'-cyclic monophosphate EIA Kit
|
solid plates cGMP guanosine measures kits eias enzyme immunoassays ELISAs second messengers neurochemistry neuroscience endocrinology assays |
839.255819134486
|
| 581022 |
Cyclic GMP EIA Kit (without Acetic Anhydride)
|
|
- |
|
|
|
|
450.207665745856
|
cyclic-gmp-eia-kit-without-acetic-anhydride
|
Cyclic GMP ELISA Kit (without Acetic Anhydride); Guanosine 3',5'-cyclic monophosphate EIA Kit (without Acetic Anhydride); Guanosine 3',5'-cyclic mononucleotide EIA Kit (without Acetic Anhydride); cGMP EIA Kit (without Acetic Anhydride)
|
solid plates cAMP adenosine measures kits eias enzyme immunoassays ELISAs second messengers assays |
450.207665745856
|
| 13197 |
DAPT
|
|
208255-80-5 |
≥95%
|
|
|
2010-09-16
|
16.385745856353
|
dapt
|
GSI-IX
|
amyloids precursors proteins APP Notch beta amyloid Aβ Alzheimer’s disease inhibitors inhibits inhibition γ-secretase Aβ42 cells signaling signals differentiation GSIIX GSI IX Dipeptides |
16.385745856353
|
| 10603 |
DARPP-32 (Phospho-Thr34) Polyclonal Antibody
|
|
- |
|
|
|
2009-10-22
|
0.386740331491
|
darpp-32-phospho-thr34-polyclonal-antibody
|
|
gamma inhibits inhibitors neurotransmitters WB western blots blotting receptors dopamine cAMP inhibition immunoblotting DARPs DARP32 DARP 32 |
0.386740331491
|
| 90349 |
Decanoyl m-Nitroaniline
Exclusive |
|
72298-61-4 |
≥98%
|
|
✓ |
|
8.488437253354
|
decanoyl-m-nitroaniline
|
DemNA
|
FAAH substrates anandamides hydrolases colorimetric cannabinoids aea meta-nitroanilines fatty acids anandamide nitroanilines nitroanalines arachidonoyl ethanolamides ethanolamines neurochemistry neuroscience |
8.488437253354
|
| 10007903 |
D-erythro-Sphingosine C-20
|
|
6918-49-6 |
≥98%
|
|
|
2008-11-21
|
5.515801104972
|
d-erythro-sphingosine-c-20
|
|
sphingosines sphingolipids ceramides C-18 C18 C20 gangliosides brain development neurodegenerations |
5.515801104972
|
| 10010575 |
Desmethyltrimebutine-d3 (hydrochloride)
|
|
- |
≥99% deuterated product
|
|
|
2008-04-14
|
0E-12
|
desmethyltrimebutine-d3-hydrochloride
|
|
timebutine anesthetic SPI disorders spasmolytic gastrointestinal neurochemistry |
0E-12
|
| 90235 |
Dihomo-γ-Linolenoyl Ethanolamide
|
|
150314-34-4 |
>98%
|
|
|
|
6.629359766006
|
dihomo-linolenoyl-ethanolamide
|
|
endocannabinoids neurotransmitters dihomo-gamma-linolenoyl dihomo-g-linolenoyl dihomo-.gamma.-linolenoyl cannabinergic fatty acids neurochemistry neuroscience ethanolamines ethanolamides cannabinoids cbs synthetic |
6.629359766006
|
| 92355 |
Dihydrocapsaicin
|
|
19408-84-5 |
≥98%
|
|
|
|
4.867442778215
|
dihydrocapsaicin
|
|
capsicum peppers VR1 receptors non-myelinated polymodal C-type nociceptive nerve fibers calcium ion channels pain pathways CA2+ vanilloid heat-activated neurochemistry hot extracts burning neuroscience lipid-souble desensitization patyways |
4.867442778215
|
| 9000556 |
Dimebolin
Exclusive |
|
3613-73-8 |
≥98%
|
|
✓ |
2010-01-12
|
12.592592592592
|
dimebolin
|
Dimebon™
|
neurodegeneration Alzheimer's diseases Huntington's neuroprotection cognition inhibitors inhibition β-amyloid calcium channels NMDA glutamate receptors mitochondria dimebone dimeboline preparation 84 Dimebolin 12687-54-6 20684-30-4 inhibited Indoles |
12.592592592592
|
| 10011349 |
Dimebolin (hydrochloride)
|
|
97657-92-6 |
≥98%
|
|
|
2010-02-19
|
10.793650793650
|
dimebolin-hydrochloride
|
|
neurodegeneration Alzheimer's diseases Huntington's neuroprotection cognition inhibitors inhibits inhibition calcium channles β-amyloid β amyloid NMDA glutamate receptors mitochondria dimeboline dimebon neurochemistry neuroscience Indoles |
10.793650793650
|
| 90310 |
Docosahexaenoic Acid
|
|
6217-54-5 |
≥98%
|
|
|
|
78.465020257826
|
docosahexaenoic-acid
|
DHA; Cervonic Acid
|
polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 neurochemistry c22:6 22:6 |
78.465020257826
|
| 10005057 |
Docosahexaenoic Acid-d5
|
|
- |
≥99% deuterated product
|
|
|
2005-03-16
|
202.916675874770
|
docosahexaenoic-acid-d5
|
DHA-d5; Cervonic Acid-d5
|
standards deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 retinol neuronal membranes neonatal deprivation hypertension |
202.916675874770
|
| 10006865 |
Docosahexaenoic Acid methyl ester
|
|
2566-90-7 |
≥98%
|
|
|
2005-09-06
|
77.203351749540
|
docosahexaenoic-acid-methyl-ester
|
Cervonic Acid methyl ester; DHA methyl ester
|
polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 esters diets dietary supplements hypertension neonatal photoreceptor degeneration retinitis pigmentosa depiration neural tissues retina |
77.203351749540
|
| 10006829 |
Docosahexaenoic Acid Quant-PAK
|
|
- |
|
|
|
2005-08-08
|
45.867513812154
|
docosahexaenoic-acid-quant-pak
|
DHA Quant-PAK; Cervonic Acid Quant-PAK
|
Quant-PAKs polyunsaturated fatty acids PUFAs omega-3 brain .omega.-3 w-3 standards deuterium internal isotopes GC/MS GC-MS LC/MS LC-MS mass spectrometry deuterated retinol neuronal membranes neonatal deprivation hypertension neurochemistry packs |
45.867513812154
|
| 10007534 |
Docosahexaenoyl Ethanolamide
Exclusive |
|
162758-94-3 |
≥98%
|
|
✓ |
2006-02-17
|
22.962016574585
|
docosahexaenoyl-ethanolamide
|
DHEA; DEA
|
neurochemistry neuroscience endocannabinoids brain retina docosahexaenoic acids DHA fatty w-3 .omega.-3 neural tissues ethanolamines ethanolamides arachidonoyl AEA lipids extracts piglets diets rats CB1 receptors shaker-related voltage-gated potassium channels cannabinoids cbs synthetic DEA |
22.962016574585
|
| 9000328 |
Docosahexaenoyl Glycine
Exclusive |
|
132850-40-9 |
≥98%
|
|
✓ |
2009-01-28
|
15.670000000000
|
docosahexaenoyl-glycine
|
|
polunsaturated fatty acids PUFAs docosahexaenoic DHA glycines fish oils ALA brain retina neuron neuronal membrane ω-3 α-linolenic |
15.670000000000
|
| 10005823 |
Docosanoyl Ethanolamide
Exclusive |
|
94109-05-4 |
≥98%
|
|
✓ |
2006-01-11
|
13.245211786371
|
docosanoyl-ethanolamide
|
|
neurochemistry neuroscience N-acylethanolamides cannabinoids central CB1 peripheral CB2 non-CB receptor-mediated pharmacology memory weight loss appetite neurodegeneration tumor surveillance analgesia inflammation saturated ion channels ethanolamines cbs synthetic |
13.245211786371
|
| 90385 |
Docosatetraenoyl Ethanolamide
|
|
150314-35-5 |
≥98%
|
|
|
|
7.288651283718
|
docosatetraenoyl-ethanolamide
|
DEA
|
endocannabinoids neurotransmitters ethanolamides docosatetraenoic acid fatty acids neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic |
7.288651283718
|
| 13245 |
Donepezil
|
|
120014-06-4 |
≥95%
|
|
|
2010-03-08
|
3.829033149171
|
donepezil
|
Aricept®
|
acetylcholine neurotransmitters acetylcholinesterase inhibitors inhibits inhibition central nervous system Alzheimer's diseases cognition memory dementia Donezepil signaling signalling AchE CNS behavior (±)-E 2020 (+/-)-E 2020 E2020 |
3.829033149171
|
| 10009372 |
Dopamine Transporter (C-Term) Polyclonal Antibody
|
|
- |
|
|
|
2006-11-13
|
0E-12
|
dopamine-transporter-c-term-polyclonal-antibody
|
DAT
|
antibodies proteins diseases antibodies antisera antiserum IHC immunohistochemistry WB western blots blotting c-terminal keyhole limpet hemocyanin KLH accumulation catecholamine biosynthesis markers dopaminergic noradrenergic neurons depression schizophrenia parkinson's dieseases drug abuse chronic administration immunoblotting |
0E-12
|
| 10009373 |
Dopamine Transporter (Extracellular Loop 2) Polyclonal Antibody
|
|
- |
|
|
|
2006-11-13
|
0E-12
|
dopamine-transporter-extracellular-loop-2-polyclonal-antibody
|
DAT (Extracellular Loop 2)
|
antibodies proteins diseases antibodies antisera antiserum IHC immunohistochemistry WB western blots blotting c-terminal keyhole limpet hemocyanin KLH accumulation catecholamine biosynthesis markers dopaminergic noradrenergic neurons depression schizophrenia parkinson's dieseases drug abuse chronic administration immunoblotting |
0E-12
|
| 10009370 |
Dopamine β-hydroxylase (C-Term; human) Polyclonal Antibody
|
|
- |
|
|
|
2006-11-13
|
0E-12
|
dopamine-hydroxylase-c-term-human-polyclonal-antibody
|
DBH
|
antibodies proteins diseases antibodies antisera antiserum WB western blots blotting beta-hydroxylase neurons dopaminergic noradrenergic catecholamine biosynthesis markers depression schizophrenia parkinson's diseases drugs abuse immunoblotting |
0E-12
|
| 10009371 |
Dopamine β-hydroxylase (N-Term; human) Polyclonal Antibody
|
|
- |
|
|
|
2006-11-13
|
0E-12
|
dopamine-hydroxylase-n-term-human-polyclonal-antibody
|
DBH
|
antibodies proteins diseases antibodies antisera antiserum WB western blots blotting beta-hydroxylase neurons dopaminergic noradrenergic catecholamine biosynthesis markers depression schizophrenia parkinson's diseases drugs abuse immunoblotting |
0E-12
|
| 10005516 |
Doppel Blocking Peptide
|
|
- |
|
|
|
2004-10-01
|
1.075414364641
|
doppel-blocking-peptide
|
|
antibodies western blotting blots signaling signalling IHC WB formalin immunohistochemistry controls peptides proteins diseases GPI glycosylphosphatidylinositol central nervous system male fertility sertoli CNS spermatozoa nonglycosylated oligosaccharides |
1.075414364641
|
| 10005517 |
Doppel Polyclonal Antibody
|
|
- |
|
|
|
2004-09-24
|
6.339686924493
|
doppel-polyclonal-antibody
|
|
proteins diseases antibodies antisera antiserum GPI glycosylphosphatidylinositol central nervous system male fertility sertoli CNS spermatozoa nonglycosylated oligosaccharides WB western blots blotting IHC immunohistochemistry immunoblotting |
6.339686924493
|
| 10009785 |
Dynamin (Phospho-Ser774) Polyclonal Antibody
|
|
- |
|
|
|
2007-05-24
|
1.740331491713
|
dynamin-phospho-ser774-polyclonal-antibody
|
|
phosphopeptide phospho-specific western blots WB antibodies proteins blotting dephosphins phosphorylation synaptic vesicle endocytosis protein kinase 5 immunoblotting |
1.740331491713
|
| 10009786 |
Dynamin (Phospho-Ser778) Polyclonal Antibody
|
|
- |
|
|
|
2007-05-24
|
1.740331491713
|
dynamin-phospho-ser778-polyclonal-antibody
|
|
phosphopeptide phospho-specific western blots WB antibodies proteins blotting dephosphins phosphorylation synaptic vesicle endocytosis protein kinase 5 immunoblotting |
1.740331491713
|
| 10010571 |
Entacapone-d10
|
|
- |
≥98%
|
|
|
2008-04-14
|
11.600773480663
|
entacapone-d10
|
|
Parkinsons dieseases inhibitors inhibits inhibition SPI nitrocatechols catechol-o-methyl blood-brain barrier neurochemistry |
11.600773480663
|
| 101740 |
EP1 Receptor Polyclonal Antibody
|
|
- |
|
|
|
|
38.272182320441
|
ep1-receptor-polyclonal-antibody
|
Prostaglandin E2 Receptor 1; PGE2 Receptor 1
|
PGE2 prostaglandins receptors antibodies antisera antiserum western blots blotting wb icc immunocytochemistry neurochemistry immunoblotting |
38.272182320441
|
| 101760 |
EP3 Receptor Polyclonal Antibody
|
|
- |
|
|
|
|
33.555447513811
|
ep3-receptor-polyclonal-antibody
|
Prostaglandin E2 Receptor 3; PGE2 Receptor 3
|
PGE2 prostaglandins receptors antibodies antisera antiserum western blots blotting wb C-terminus WB ICC immunocytochemistry neurochemistry immunoblotting |
33.555447513811
|
| 10919 |
(±)-epi CP 47, 497
|
|
- |
≥98%
|
|
|
2011-05-05
|
13.604473642789
|
-epi-cp-47-497
|
3-trans CP 47,497
|
(±)-trans-CP 47,497 cannabinoids analogs receptors CB1 standards (±)-CP47,497 analgesic potency epimer THC .delta.-THC (±)-iso Δ-tetrahydrocannabidiol CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 13801 |
13.604473642789
|
| 13801 |
(±)-epi CP 47,497 (solution)
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-08-04
|
11.620194114805
|
-epi-cp-47-497-solution
|
3-trans CP 47,497
|
(±)-trans-CP 47,497 cannabinoids analogs receptors CB1 standards (±)-CP47,497 analgesic potency epimer THC .delta.-THC (±)-iso Δ-tetrahydrocannabidiol CP 47497 CP47497 CP-47497 CP-47,497 cbs synthetic 10919 |
11.620194114805
|
| 11241 |
Ethcathinone (hydrochloride)
New |
|
51553-17-4 |
≥98%
|
|
|
2012-01-18
|
139.642585869217
|
ethcathinone-hydrochloride
|
RMI 8201A; N-Ethylcathinone
|
71276-46-5 forensics phenethylamines cathinones designer drugs psychoactive recreational hydrochloride HCl amphetamines rats capsules tablets research N-monoethylcathinone RMI8201A RMI-8201A |
139.642585869217
|
| 10012088 |
Ethyl-L-NIO (hydrochloride)
|
|
150403-97-7 |
≥95%
|
|
|
2008-08-14
|
6.846657458563
|
ethyl-l-nio-hydrochloride
|
L-N5-(1-Iminobutyl)ornithine hydrochloride
|
nitric oxide synthase NOS iNOs nNOS selective inhibitors inhibits inhibition |
6.846657458563
|
| 10007433 |
FABP5 (mouse recombinant)
|
|
- |
>95%
|
|
|
2005-07-29
|
6.411692616775
|
fabp5-mouse-recombinant
|
Epidermal-FABP; Fatty Acid Binding Protein 5; E-FABP
|
protein-only proteins cytosolic acids lipophilic ligands uptake metabolism cellular membranes intracellular trafficking modulation enzymes lipids metabolic pathways cells growth differentiation antiparallel B .beta. strands barrel prostates bladder carcinomas atherosclerosis endocrinology neurochemistry |
6.411692616775
|
| 301600 |
Fatty Acid Amide Hydrolase Blocking Peptide
|
|
- |
|
|
|
|
17.851381215469
|
fatty-acid-amide-hydrolase-blocking-peptide
|
Oleamide Hydrolase; FAAH; Anandamide Amidohydrolase
|
hydrolases peptides hydrolysis controls acids amides WB western blots blotting IHC immunohistochemistry immunoblotting antibodies neurochemistry neuroscience |
17.851381215469
|
| 10010183 |
Fatty Acid Amide Hydrolase (human recombinant)
|
|
- |
Whole-cell lysate
|
|
|
2008-11-05
|
29.586385161799
|
fatty-acid-amide-hydrolase-human-recombinant
|
FAAH (human recombinant)
|
FAAHs endocannabinoid AEA cannabinoids 2-AG 2AG proteins FAAH-1 acids amides hydrolases |
29.586385161799
|
| 101600 |
Fatty Acid Amide Hydrolase Polyclonal Antibody
|
|
- |
|
|
|
|
24.641400947119
|
fatty-acid-amide-hydrolase-polyclonal-antibody
|
Oleamide Hydrolase; FAAH; Anandamide Amidohydrolase
|
WB western blots hydrolases antibodies antiserum antisera hydrolysis immunohistochemistry IHC immunoblotting neurochemistry neuroscience blotting |
24.641400947119
|
| 10010182 |
Fatty Acid Amide Hydrolase Western Ready Control
|
|
- |
66 kDa (His-tagged), 63 kDa (native)
|
|
|
2007-07-06
|
5.770911602210
|
fatty-acid-amide-hydrolase-western-ready-control
|
Oleamide Hydrolase; FAAH; Anandamide Aminohydrolase
|
fatty acid amides sleep nociception cancers liver brain testes uterus small intestine ocular tissues western blots blotting WB inhibitors |
5.770911602210
|
| 10004236 |
Fluprostenol serinol amide
|
|
- |
≥98%
|
|
|
2004-09-23
|
25.495878453039
|
fluprostenol-serinol-amide
|
Flu-SA
|
PGF2.alpha. PGF2alpha analogs agonists prostaglandins receptors amides cannabinoids CB1 CBs synthetic |
25.495878453039
|
| 70250 |
(±)-Flurbiprofen
|
|
5104-49-4 |
≥99%
|
|
|
|
83.073017188458
|
-flurbiprofen
|
Ansaid
|
cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases neurochemistry synthase-1 synthase-2 inhibits 51543-38-5 |
83.073017188458
|
| 10600 |
GABAA Receptor δ-subunit (N-Term) Polyclonal Antibody
|
|
- |
|
|
|
2009-10-22
|
0.386740331491
|
gabaa-receptor-subunit-n-term-polyclonal-antibody
|
γ-Aminobutyric Acid A Receptor
|
gamma inhibits inhibitors neurotransmitters WB western blots blotting IP IHC immunoprecipitation immunohistochemistry |
0.386740331491
|
| 10008346 |
Gabapentin
|
|
60142-96-3 |
≥98%
|
|
|
2006-04-20
|
25.639433701658
|
gabapentin
|
Neurontin®
|
antiepileptic drugs Gamma-aminobutyric acids GABA neurotransmitters receptors spinal cord analogs anticonvulsants analgeics neuropathics pain syndromes Complex Regional types CRPS1 multiple sclerosis dysesthesias cancers HIV infections CNS central nervous systems calcium channels .gamma.-aminobutyric g-aminobutyric neurochemistry |
25.639433701658
|
| 10009400 |
Gap-43 (Phospho-Ser41) Polyclonal Antibody
|
|
- |
|
|
|
2006-12-18
|
1.160220994475
|
gap-43-phospho-ser41-polyclonal-antibody
|
|
GAP43 development and plasticity neuronal growth cones axonal regeneration knockout animals amplify path finding signals mediate actin phosphorylation kinases C PKC modulates neurotransmitters LTP antibodies antisera antiserum WB western blots IHC immunohistochemistry frozen sections blotting proteins diseases phospho-specific immunoblotting |
1.160220994475
|
| 10566 |
Garcinol
New |
|
78824-30-3 |
≥95%
|
|
|
2011-10-25
|
11.209988941663
|
garcinol
|
Camboginol
|
inhibits inhibitors inhibition histones acetyltransferases HATs p300 PCAF GCN5 neurogenesis stem cells apoptosis cancers antiinflammatory anti-inflammatory inflammation neuroscience genes expressions regulations epigenetics |
11.209988941663
|
| 10007621 |
GFAP (human) EIA Kit
|
|
- |
|
|
|
2006-07-11
|
0E-12
|
gfap-human-eia-kit
|
Glial Fibrillary Acidic Protein (human) EIA Kit
|
SPI-Bio spibio kits enzyme immunoassays A05188 assays |
0E-12
|
| 10006306 |
Ghrelin (human acylated) EIA Kit
|
|
- |
|
|
|
2004-11-10
|
103.347343462246
|
ghrelin-human-acylated-eia-kit
|
Ghrelin (human acylated) ELISA Kit
|
spi-bio acylated immunoassays obesity growth hormones homeostasis ligands secretagogue A05106 receptors stomach hypothalmic spi-bio spibio A05106 adipokines endocrinology neurochemistry assays ghrelin assay |
103.347343462246
|
| 10006307 |
Ghrelin (rat acylated) EIA Kit
|
|
- |
|
|
|
2004-11-10
|
156.573650355170
|
ghrelin-rat-acylated-eia-kit
|
Ghrelin (rat acylated) ELISA Kit
|
spi-bio acylated immunoassays obesity growth hormones homeostasis ligands secretagogue receptors stomach hypothalmic spibio A05117 adipokines endocrinology neurochemistry assays ghrelin assay |
156.573650355170
|
| 10602 |
GluR1 (Phospho-Ser831) Polyclonal Antibody
|
|
- |
|
|
|
2009-10-22
|
0.386740331491
|
glur1-phospho-ser831-polyclonal-antibody
|
Glutamate Receptor Subunit 1
|
gamma inhibits inhibitors neurotransmitters WB western blots blotting receptors NMDAR AMPAR kinase immunoblotting |
0.386740331491
|
| 10601 |
GluR1 (Phospho-Ser845) Polyclonal Antibody
|
|
- |
|
|
|
2009-10-22
|
0.386740331491
|
glur1-phospho-ser845-polyclonal-antibody
|
Glutamate Receptor Subunit 1
|
gamma inhibits inhibitors neurotransmitters WB western blots immunoblotting receptors NMDA AMPA kinases IHC immunohistochemistry |
0.386740331491
|
| 10011347 |
Glycerophospho-N-Arachidonoyl Ethanolamine
Exclusive |
|
201738-25-2 |
≥97%
|
|
✓ |
2009-03-13
|
14.693112338857
|
glycerophospho-n-arachidonoyl-ethanolamine
|
Glycerophospho-Arachidonoyl Ethanolamide; Glycerophosphoanandamide; GP-NArE
|
anandamides arachidonoyl ethanolamide AEA NAE GDE1 cannabinoids neurotransmitters CB1 CB2 glycerophosphodiesterase 1 NAPE N-Acyl Phosphatidylethanolamide cbs synthetic |
14.693112338857
|
| 10011357 |
Glycerophospho-N-Oleoyl Ethanolamine
Exclusive |
|
201738-24-1 |
≥98%
|
|
✓ |
2009-02-20
|
22.960773480663
|
glycerophospho-n-oleoyl-ethanolamine
|
|
cannabinoids neurotransmitter PPARs neurochemistry neuroscience fatty acids amides hydrolase oleoyl ethanolamides methabolism obesity nutrition diet NAPE N-Acyl Phosphatidylethanolamide cannabinoids cbs synthetic |
22.960773480663
|
| 10009399 |
Glycine Receptor Polyclonal Antibody
|
|
- |
|
|
|
2006-12-18
|
0.109122928176
|
glycine-receptor-polyclonal-antibody
|
|
GLY inhibits inhibitors inhibition inhibitory transmitter brainstem spinal cord ligand-gated ion channels family LGICs chemical neurotransmission chloride conductance membranes hyperpolarization synapses cytoplasmic proteins gephyrin alcohol synaptic clustering NMDAR subunit antibodies antisera antiserum WB western blots blotting proteins diseases immunoblotting IHC immunohistochemistry |
0.109122928176
|
| 10224 |
GPR55 Polyclonal Antibody
|
|
- |
|
|
|
2010-01-19
|
38.641258879242
|
gpr55-polyclonal-antibody
|
G Protein-Coupled Receptor 55
|
proteins receptors antibodies western blots WB ICC signals signaling nucleotides THC amino acids blotting immunoblotting immunocytochemistry signalling cannabinoids cbs synthetic |
38.641258879242
|
| 10851 |
Guanabenz (hydrochloride)
New |
|
- |
≥98%
|
|
|
2011-09-30
|
0.603038674033
|
guanabenz-hydrochloride
|
Wytensin
|
adrenergic receptors hypertension imidazoline adipose tissues neurosciences cardiovascular diseases agonists 5051-62-7 α2 alpha2 I2 hydrochloride HCl |
0.603038674033
|
| 10010372 |
GW 842166X
|
|
666260-75-9 |
≥98%
|
|
|
2008-05-23
|
35.737209944751
|
gw-842166x
|
|
inflammatory pain arthritis neuropathic hyperalgesia CB2 cannabinoids agonists anandamide receptors neurochemistry cannabinoids cbs synthetic |
35.737209944751
|
| 13205 |
Halopemide
Exclusive |
|
59831-65-1 |
≥98%
|
|
✓ |
2009-04-21
|
16.019558011050
|
halopemide
|
R34301; NSC 354856
|
inhibitors phospholipases D PLD PLD1 PLD2 dopamine receptors inhibits inhibition potent cells DP nueraleptic |
16.019558011050
|
| 10995 |
Harmaline
New |
|
304-21-2 |
≥98%
|
|
|
2011-10-11
|
1.790779319947
|
harmaline
|
|
inhibitors monoamine oxidases MAOI receptor agonists inverse agonists NMDA herbal mixtures forensics bath salts spices plants N-methyl-D-aspartate inhibits inhibition adulterant CBs cannabinoids hallucinogenic tryptamines |
1.790779319947
|
| 13705 |
HCN1 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S70-28)
|
|
- |
|
|
|
2009-12-01
|
0E-12
|
hcn1-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s70-28
|
|
antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-1 HCN 1 |
0E-12
|
| 13707 |
HCN2 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S71-37)
|
|
- |
|
|
|
2009-12-01
|
0E-12
|
hcn2-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s71-37
|
|
antibodies western blots blotting immunoblotting WB immunohistochemistry IHC ions channels HCN-2 HCN 2 ICC immunocytochemistry immunoprecipitation IP |
0E-12
|
| 13708 |
HCN3 Cyclic Neuclotide-gated Channel Monoclonal Antibody (Clone S141-28)
|
|
- |
|
|
|
2009-12-01
|
0E-12
|
hcn3-cyclic-neuclotide-gated-channel-monoclonal-antibody-clone-s141-28
|
|
antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-3 HCN 3 |
0E-12
|
| 13709 |
HCN4 Cyclic Nucleotide-gated Channel Monoclonal Antibody (Clone S114-10)
|
|
- |
|
|
|
2009-12-02
|
0E-12
|
hcn4-cyclic-nucleotide-gated-channel-monoclonal-antibody-clone-s114-10
|
|
antibodies western blots blotting immunoblotting WB immunohistochemistry IHC immunocytochemistry ICC ions channels HCN-4 HCN 4 hyperpolarization-activated cation gene family hyperpolarization activated activity activates |
0E-12
|
| 10011038 |
Hemopressin
|
|
- |
|
|
|
2009-08-13
|
32.880710339384
|
hemopressin
|
|
peptides antagonist inhibitors inhibits inhibition hypertension binding asoactive vasoactive cannabinoids cbs synthetic |
32.880710339384
|
| 90342 |
Heptadecanoyl Ethanolamide
|
|
- |
≥98%
|
|
|
|
8.626643646409
|
heptadecanoyl-ethanolamide
|
|
pea cannabinoids palmitoyl ethanolamides anandamides neurochemistry neuroscience ethanolamines |
8.626643646409
|
| 90082 |
HU-210
|
|
112830-95-2 |
>98%
|
|
|
|
44.104514848065
|
hu-210
|
|
agonists analogs d9-THC marijuana CB1 CB2 receptors cannabinoids HU210 .DELTA.9-THC delta9-THC neuroscience neurochemistry endocrinology cannabinoids cbs synthetic |
44.104514848065
|
| 90083 |
HU-210 (solution)
|
|
112830-95-2 |
≥98%
|
|
|
2011-03-03
|
26.336929755327
|
hu-210-solution
|
|
agonists analogs d9-THC marijuana CB1 CB2 receptors cannabinoids HU210 .DELTA.9-THC delta9-THC neuroscience neurochemistry endocrinology cannabinoids cbs synthetic Tetrahydrocannabinol, Trans-(+-)-Isomer
Tetrahydrocannabinol, (6a-trans)-Isomer
Tetrahydrocannabinol (6aS-cis)-Isomer
Tetrahydrocannabinol (6aR-cis)-Isomer
Solvay Brand of Tetrahydrocannabinol
Tetrahydrocannabinol Trans-Isomer Tetrahydrocannabinol Trans Isomer delta(9)-Tetrahydrocannabinol
delta(1)-Tetrahydrocannabinol
9-ene-Tetrahydrocannabinol
9 ene Tetrahydrocannabinol
Tetrahydrocannabinol
delta(9)-THC delta(1)-THC Dronabinol Marinol THC |
26.336929755327
|
| 10006350 |
HU-211
|
|
112924-45-5 |
≥98%
|
|
|
2005-03-30
|
58.790282381829
|
hu-211
|
Dexanabinol
|
HU211 endocannabinoids cannabis CB2 pain inflammation NF-kB NF-.kappa.B inhibition antioxidants neurochemistry terpene-based psychomotor DELTA9-THC .DELTA.9-THC D9-THC neuroprotective cannabidiols CB1 inflammatory pharmacology neuroscience neurochemistry |
58.790282381829
|
| 90086 |
HU-308
|
|
256934-39-1 |
>98%
|
|
|
2005-03-16
|
35.176025663875
|
hu-308
|
|
endocannabinoids CB2 pain inflammation G-protein coupled receptors agonists hypotensives analgesics anti-inflammatory phenolic .DELTA.9-THC D9-THC CB1 FAAH fatty acid hydrolases substrates selective neuroscience neurochemistry GPCRs HU308 HU 308 cannabinoids |
35.176025663875
|
| 10005673 |
HU-331
|
|
137252-25-6 |
≥95%
|
|
|
2005-09-09
|
28.665938203397
|
hu-331
|
|
cannabidiols analogs antiproliferative activity endocannabinoids central CB1 peripheral CB2 non-CB receptor-mediated pharmacology receptors memory weight loss appetite neurodegeneration tumor surveillance analgesia inflammation hydroxylquinone antineoplastic human cancer cells lines inhibits inhibitors inhibition growth Raji Jurkat lymphomas in vitro HT-29 colon carcinomas neuroscience neurochemistry cannabinoids cbs sythetic |
28.665938203397
|
| 10010669 |
Hydroxy Bupropion-d9
|
|
- |
≥99% deuterated product
|
|
|
2009-04-17
|
11.113259668508
|
hydroxy-bupropion-d9
|
|
aminoketone ketones antideppressant dopamine smoking cessation treatment deuterateds deuteriums standards GC/MS LC/MS GC-MS LC-MS mass spectrometry |
11.113259668508
|
| 70280 |
(±)-Ibuprofen
|
|
15687-27-1 |
≥99%
|
|
|
|
26.545411574306
|
-ibuprofen
|
Motrin
|
PPAR cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits peroxisome proliferator-activated receptors neurochemistry |
26.545411574306
|
| 10137 |
Icilin
|
|
36945-98-9 |
≥98%
|
|
|
2004-04-27
|
12.468158379373
|
icilin
|
AG 3-5
|
cooling agent cold receptors CMR1 neurons transient receptors potential VR1 vanilloid receptos TRPM8 neurochemistry neuroscience |
12.468158379373
|
| 10215 |
IDFP
|
|
615250-02-7 |
≥98%
|
|
|
2009-03-09
|
15.622209944751
|
idfp
|
Isopropyl Dodecylfluorophosphonate
|
CB1 agonist nerve agent serins organophophorus MAGL inhibitors inhibits inhibition FAAH 2-AG 2AG AEA arachidonic acids MGL inhibitors cannabinoids |
15.622209944751
|
| 70275 |
IMMA
|
|
- |
≥98%
|
|
|
|
11.999785144260
|
imma
|
Indomethacin Morpholinylamide; BML-190
|
cannabinoids receptors CB2 neuroscience neurochemistry endocrinology |
11.999785144260
|
| 70270 |
Indomethacin
|
|
53-86-1 |
≥99%
|
|
|
|
30.082153361624
|
indomethacin
|
Indocin
|
cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin synthases synthase-1 synthase-2 PPARs peroxisome proliferator-activated receptors inhibits neurochemistry |
30.082153361624
|
| 10005518 |
IP Receptor (human) Polyclonal Antibody
|
|
- |
|
|
|
2004-10-21
|
24.633523634131
|
ip-receptor-human-polyclonal-antibody
|
Prostaglandin I2 Receptor; Prostacyclin Receptor; PGI2 Receptor
|
antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors immunoblotting atherosclerosis |
24.633523634131
|
| 160070 |
IP Receptor (mouse) Polyclonal Antibody
|
|
- |
|
|
|
2004-05-25
|
23.623009208102
|
ip-receptor-mouse-polyclonal-antibody
|
PGI2 Receptor; Prostacyclin Receptor; Prostaglandin I2 Receptor
|
antibodies antisera antiserum western blots blotting wb prostacyclins rat PGI2 prostaglandins receptors atherosclerosis neurochemistry immunoblotting |
23.623009208102
|
| 13325 |
Iso-Olomoucine
|
|
101622-50-8 |
≥98%
|
|
|
2011-07-27
|
2.253867403315
|
iso-olomoucine
|
|
cyclin dependent kinases Cdks cells cycles dopamine inhibitors inhibits inhibition inactive controls regulators iso olomoucine transporter diseases neurodegenerative signaling rats dorsal striatal synaptosomes cancers neuroscience |
2.253867403315
|
| 10008661 |
JP104
Exclusive |
|
- |
≥98%
|
|
✓ |
2006-09-05
|
8.845590155700
|
jp104
|
|
click chemistry probes FAAH fatty acids amides hydrolases inhibits inhibitors inhibition URB598 acyl anandamide AEA esters unsaturated carbamates neurochemistry |
8.845590155700
|
| 10008660 |
JP83
|
|
887264-44-0 |
≥98%
|
|
|
2006-08-30
|
8.441088397790
|
jp83
|
|
FAAH fatty acids amides hydrolases inhibits inhibitors inhibition URB597 acyl anandamide AEA esters unsaturated carbamates arachidonoyl ethanolamides neurochemistry |
8.441088397790
|
| 10266 |
JWH 007
Exclusive |
|
155471-10-6 |
≥98%
|
|
✓ |
2011-02-23
|
39.806735761424
|
jwh-007
|
|
agonists cannabinoids receptors CB1 CB2 Δ9-THC pain antinociception hypothermia catalepsy JWHs CBs JWH-007 JWH007 JWH-7 JWH 7 JWH7 |
39.806735761424
|
| 10486 |
JWH 007-d9
|
|
- |
≥99% deuterated product
|
|
|
2010-10-11
|
42.265883416430
|
jwh-007-d9
|
|
agonists cannabinoids receptors CB1 CB2 Δ9-THC pain antinociception hypothermia catalepsy deuterateds deuteriums mass spectrometry MS standards JWHs JWH007-d9 JWH-007-d9 cannabinoids cbs synthetic JWH7-d9 JWH 7-d9 JWH-7-d9 |
42.265883416430
|
| 9001058 |
JWH 011
Exclusive New |
|
155471-13-9 |
≥98%
|
|
✓ |
2011-09-06
|
35.616664171055
|
jwh-011
|
JWH 004 1-methylhexyl analog
|
JWH011 JWH-011 JWH11 JWH-11 JWH015 JWH-015 JWH15 JWH-15 JWHs analogs forensics sciences cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices synthetics central peripheral |
35.616664171055
|
| 10009018 |
JWH 015
|
|
155471-08-2 |
≥98%
|
|
|
2006-10-05
|
71.726170738024
|
jwh-015
|
|
agonists CB1 CB2 cannabinoids aminoalkylindole receptors MS multiple sclerosis WIN 55212-2 ACEA CD4+ T cells IFN-g IFN-.gamma. CD40 JAK STAT1 endocrinology neurochemistry JWH015 JWH-015 cannabinoids cbs synthetic JWH15 JWH-15 JWH 15 |
71.726170738024
|
| 10660 |
JWH 015-d7
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-02-21
|
49.700773480663
|
jwh-015-d7
|
|
agonists CB1 CB2 cannabinoids aminoalkylindole receptors MS multiple sclerosis WIN 55212-2 ACEA CD4+ T cells IFN-γ IFN-gamma CD40 JAK STAT1 endocrinology neurochemistry JWH015 JWH-015 cannabinoids cbs synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry deuteriums deuterateds standards JWH15-d7 JWH 15-d7 JWH-15-d7 |
49.700773480663
|
| 10900 |
JWH 018
|
|
209414-07-3 |
≥98%
|
|
|
2011-05-05
|
39.860919038187
|
jwh-018
|
|
cannabinoids CB1 CB2 agonists selective receptors WIN 55212-2 JWH-018 JWH018 cbs synthetic JWH 18 JWH-018 JWH18 JWH-18 13169 |
39.860919038187
|
| 9000844 |
JWH 018 2-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-10-26
|
31.132379618776
|
jwh-018-2-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs monohydroxylated cbs synthetic JWH-018 JWH018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
31.132379618776
|
| 10711 |
JWH 018 2-hydroxyindole metabolite-d9
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-02-25
|
24.113084443524
|
jwh-018-2-hydroxyindole-metabolite-d9
|
|
cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs monohydroxylated standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
24.113084443524
|
| 9001007 |
JWH 018 2'-naphthyl-N-(1,1-dimethylpropyl) isomer
New |
|
- |
≥98%
|
|
|
2012-01-13
|
129.938282085955
|
jwh-018-2-naphthyl-n-1-1-dimethylpropyl-isomer
|
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic isomers JWH018 JWH-018 JWH 18 JWH-18 JWH18 JWHs pejntyl chains indoles naphthyl moiety herbal blends central peripheral |
129.938282085955
|
| 9000851 |
JWH 018 4-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
46.814097970685
|
jwh-018-4-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics JWH-018 JWH018 209414-07-3 JWH018-metabolite JWH 018-metabolite one CBs M-1 M1 smoking mixtures spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
46.814097970685
|
| 10712 |
JWH 018 4-hydroxyindole metabolite-d9
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-02-25
|
33.195926243109
|
jwh-018-4-hydroxyindole-metabolite-d9
|
|
cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
33.195926243109
|
| 9000852 |
JWH 018 5-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
69.338314927368
|
jwh-018-5-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite two 2 smoking mixtures spices CBS M-2 M2 synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
69.338314927368
|
| 10713 |
JWH 018 5-hydroxyindole metabolite-d9
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-03-11
|
27.502696454894
|
jwh-018-5-hydroxyindole-metabolite-d9
|
|
cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS synthetic cannabimimetics urine urinary metabolites 1 glucuroconjugate forensics smoking mixtures spices standards M-2 M2 JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
27.502696454894
|
| 9000853 |
JWH 018 6-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
42.598628357426
|
jwh-018-6-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 CBs smoking mixture spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
42.598628357426
|
| 10714 |
JWH 018 6-hydroxyindole metabolite-d9
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-03-25
|
47.737945073679
|
jwh-018-6-hydroxyindole-metabolite-d9
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 CBs smoking mixture spices cbs synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-018 JWH018 JWH18 JWH-18 JWH 18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
47.737945073679
|
| 10697 |
JWH 018 6-methoxyindole analog
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-02-15
|
30.978954958867
|
jwh-018-6-methoxyindole-analog
|
|
analogs metabolites cannabinoids receptors agonists CBs JWH-018 JWH018 JWH18 JWH-18 JWH 18 |
30.978954958867
|
| 9000854 |
JWH 018 7-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
37.179710050102
|
jwh-018-7-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite four 4 M4 M-4 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
37.179710050102
|
| 10715 |
JWH 018 7-hydroxyindole metabolite-d9
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-07-26
|
29.253143271526
|
jwh-018-7-hydroxyindole-metabolite-d9
|
|
WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH-018 JWH018 209414-07-3 science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite three 3 M-3 M3 smoking mixture spices synthetic deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 CBs cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic sciences pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 4 M4 M-4 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
29.253143271526
|
| 9000799 |
JWH 018 adamantyl analog
Exclusive |
|
- |
≥97%
|
|
✓ |
2011-07-18
|
40.803083811230
|
jwh-018-adamantyl-analog
|
AB-001
|
JWH 018 JWH-018 JWHs analogs forensics sciences cannabinoids CBs receptors WIN 55,212-2 CB1 CB2 cannabimimetics |
40.803083811230
|
| 13824 |
JWH 018-d9 (solution)
|
|
- |
≥99% deuterated product
|
|
|
2010-06-21
|
54.097431772776
|
jwh-018-d9-solution
|
|
cannabinoids CB1 CB2 agonists selective receptors WIN 55,212-2 JWH-018 JWH018 deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cbs synthetic JWH018-d9 JWH-018-d9 JWH-18-d9 JWH 18-d9 JWH18-d9 JWH18d9 10901 |
54.097431772776
|
| 10690 |
JWH 018 N-(2-methylbutyl) isomer
Exclusive |
|
- |
≥97%
|
|
✓ |
2011-03-16
|
21.750250279686
|
jwh-018-n-2-methylbutyl-isomer
|
JWH 073 2-methylbutyl homolog
|
cannabinoids CBs receptors WIN 55,212-2 CB1 cannabimimetics analogs forensics standards JWH-073 JWH 73 JWH73 JWH-73 |
21.750250279686
|
| 10691 |
JWH 018 N-(3-methylbutyl) isomer
Exclusive |
|
- |
≥97%
|
|
✓ |
2011-02-07
|
25.015270666904
|
jwh-018-n-3-methylbutyl-isomer
|
JWH 073 3-methylbutyl homolog
|
cannabinoids agonist selective receptors WIN55212-2 WIN552122 WIN 55212-2 WIN 55,212-2 CB1 cannabimimetics analog forensics CBs JWH-073 JWH-73 JWH 73 JWH73 |
25.015270666904
|
| 11075 |
JWH 018 N-(4,5-epoxypentyl) analog
New |
|
- |
≥98%
|
|
|
2011-10-21
|
29.167137472777
|
jwh-018-n-4-5-epoxypentyl-analog
|
JWH 018 epoxide
|
cannabinoids CBs cannabimimetic CB1 CB2 receptor agonists spices forensics synthetic herbal central peripheral alkyl chains |
29.167137472777
|
| 10796 |
(±)-JWH 018 N-(4-hydroxypentyl) metabolite
Exclusive |
|
- |
≥97%
|
|
✓ |
2011-05-31
|
44.595594023696
|
-jwh-018-n-4-hydroxypentyl-metabolite
|
|
JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabinoids WIN 55,212-2 urinary metabolites forensics CBs WIN 55212-2 WIN55,212-2 WIN55212-2 monohydroxylation metabolism N-alkyl chains agonists peripheral central receptors smoking mixtures |
44.595594023696
|
| 10926 |
(±)-JWH 018 N-(4-hydroxypentyl) metabolite-d5
Exclusive |
|
- |
≥99% deuterated forms (d1-d5)
|
|
✓ |
2011-06-28
|
51.336977083511
|
-jwh-018-n-4-hydroxypentyl-metabolite-d5
|
|
JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabinoids WIN 55,212-2 urinary metabolites forensics CBs WIN 55212-2 WIN55,212-2 WIN55212-2 monohydroxylation metabolism N-alkyl chains agonists peripheral central receptors smoking mixtures GC/MS deuteriums standards deuterateds LC/MS GC-MS LC-MS mass spectrometry |
51.336977083511
|
| 11047 |
JWH 018 N-(5-bromopentyl) analog
New |
|
- |
≥98%
|
|
|
2012-01-19
|
136.655819724129
|
jwh-018-n-5-bromopentyl-analog
|
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic central peripheral analogs JWH-018 JWH018 JWH 18 JWH18 JWH-18 JWHs herbal blends bromine pentyl chains |
136.655819724129
|
| 10521 |
JWH 018 N-(5-chloropentyl) analog
New |
|
- |
≥95%
|
|
|
2012-01-17
|
147.981840723864
|
jwh-018-n-5-chloropentyl-analog
|
|
cannabinoids CBs cannabimimetics CB1 CB2, receptors agonists spices forensics synthetic JWH018 JWH-018 JWH 18 JWH18 JWH-18 JWHs herbal blends analogs chlorine pentyl chains |
147.981840723864
|
| 9000855 |
JWH 018 N-(5-hydroxypentyl) metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
111.610033422934
|
jwh-018-n-5-hydroxypentyl-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite five 5 CBs M-5 M5 smoking mixtures spices cbs synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
111.610033422934
|
| 10933 |
JWH 018 N-(5-hydroxypentyl) metabolite-d5
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-06-22
|
79.757840793639
|
jwh-018-n-5-hydroxypentyl-metabolite-d5
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 foresnsic science pain neuroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite two 2 smoking mixtures spices CBs M-5 M5 synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 bath salts LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums agonists selective M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
79.757840793639
|
| 9000856 |
JWH 018 N-pentanoic acid metabolite
Exclusive |
|
- |
≥95%
|
|
✓ |
2010-09-01
|
110.132510405829
|
jwh-018-n-pentanoic-acid-metabolite
|
|
cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 6 six CBs M6 M-6 smoking mixtures spices synthetic JWH018 JWH-018 JWH-18 JWH 18 JWH18 M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
110.132510405829
|
| 9000867 |
JWH 018 N-pentanoic acid metabolite-d4
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2010-09-15
|
280.977045593935
|
jwh-018-n-pentanoic-acid-metabolite-d4
|
|
JWH-018 JWH018 deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS cannabinoids receptors WIN 55,212-2 WIN55212-2 WIN 552122 WIN552122 WIN 55,2122 WIN55,2122 CB1 CB2 JWH-018 JWH018 JWH18 JWH-18 JWH18 cannabimimetics urine urinary metabolite glucuroconjugate forensics JWH-018 JWH018 209414-07-3 science pain nueroscience JWH-018-metabolite JWH018-metabolite JWH 018-metabolite 6 six CBs M6 M-6 smoking mixtures spices synthetic M2 M-2 M 2 JWH-018-M2 JWH-018-M-2 JWH-018-M M3 M-3 M 3 JWH-018-M3 JWH-018-M-3 JWH-018-M M4 M-4 M 4 JWH-018-M4 JWH-018-M-4 JWH-018-M M5 M-5 M 5 JWH-018-M5 JWH-018-M-5 JWH-018-M M6 M-6 M 6 JWH-018-M6 JWH-018-M-6 JWH-018-M |
280.977045593935
|
| 13169 |
JWH 018 (solution)
|
|
209414-07-3 |
≥98%
|
|
|
2009-03-12
|
68.923268613605
|
jwh-018-solution
|
|
cannabinoids CB1 CB2 agonists selective receptors WIN 55212-2 JWH-018 JWH018 cbs synthetic JWH 18 JWH-018 JWH18 JWH-18 10900 |
68.923268613605
|
| 13633 |
JWH 019
|
|
209414-08-4 |
≥98%
|
|
|
2010-01-14
|
50.127632658708
|
jwh-019
|
|
cannabinoids CB1 CB2 receptors THC JWH-019 JWH019 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinol cannabinmimetic indoles cannabinoids cbs synthetic JWH019 JWH-019 JWH19 JWH 19 JWH-19 |
50.127632658708
|
| 9000764 |
JWH 019 5-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-07-06
|
26.981218665814
|
jwh-019-5-hydroxyindole-metabolite
|
JWH 019-M2
|
JWH019 JWH-019 JWH-19 JWH 19 JWH19 cannabinoids cannabimimetic metabolites CB1 CB2 receptors agonists spice forensics synthetic smoking urinary urine serum neuroscience CBs |
26.981218665814
|
| 9000765 |
JWH 019 N-(6-hydroxyhexyl) metabolite
Exclusive New |
|
- |
≥98%
|
|
✓ |
2011-10-13
|
30.547854892471
|
jwh-019-n-6-hydroxyhexyl-metabolite
|
|
JWH019 JWH-019 JWH-19 JWH 19 JWH19 JWHs cannabinoids cannabimimetic metabolites CB1 CB2 CBs receptors agonists spices forensics synthetic smoking urinary urine serum herbal blends metabolized livers |
30.547854892471
|
| 10850 |
JWH 020
Exclusive |
|
209414-09-5 |
≥98%
|
|
✓ |
2011-06-02
|
43.933702363359
|
jwh-020
|
|
cannabinoids CBs cannabimimetic CB1 receptors agonists CB2 forensics bath salts JWH020 JWH-020 WIN55212-1 WIN55212-2 WIN-55212-1 WIN-55212-2 WIN552121 WIN552122 in vivo JWH 020 |
43.933702363359
|
| 9001056 |
JWH 022
Exclusive |
|
209414-16-4 |
≥98%
|
|
✓ |
2011-08-09
|
84.562414988077
|
jwh-022
|
|
JWH022 JWH-022 JWH22 JWH-22 JWHs cannabinoids CBs synthetic standards forensics sciences |
84.562414988077
|
| 10831 |
JWH 030
Exclusive New |
|
162934-73-8 |
≥98%
|
|
✓ |
2011-10-11
|
59.469825443952
|
jwh-030
|
|
JWH-030 JWH030 JWH30 JWH-30 JWH30 cannabimimetic cannabinoids synthetics CB1 CB2 CBs receptors forensics neuroscience naphtholyl pyrrole mouse mice inhibits inhibition inhibitors electrically induced vas deferens |
59.469825443952
|
| 10904 |
JWH 073
|
|
208987-48-8 |
≥97%
|
|
|
2011-05-06
|
40.353743785596
|
jwh-073
|
|
cannabinoid CB1 CB2 agonist selective receptors WN55212-2 WIN552122 WIN 552122 WIN 55212-2 jwh073 cannabinoids cbs synthetic JWH-073-d7 JWH073-d7 JWH73d7 10904 |
40.353743785596
|
| 10633 |
JWH 073 2-hydroxyindole metabolite
|
|
- |
≥98%
|
|
|
2011-01-11
|
37.668238301845
|
jwh-073-2-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics CBs JWH073 JWH-073 cannabinoids cbs synthetic JWH 73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
37.668238301845
|
| 10716 |
JWH 073 2-hydroxyindole metabolite-d7
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-03-10
|
19.228790996521
|
jwh-073-2-hydroxyindole-metabolite-d7
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites monohydroxylated forensics JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 glucuroconjugate JWH-073 JWH073 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
19.228790996521
|
| 10848 |
JWH 073 2-methylnaphthyl analog
Exclusive New |
|
- |
≥98%
|
|
✓ |
2011-10-11
|
28.319358014608
|
jwh-073-2-methylnaphthyl-analog
|
|
JWHs cannabinoids cannabimimetic CB1 CB2 CBs receptors agonists spices forensics synthetics herbal blends JWH-073 073 JWH73 JWH-73 JWHs 73 |
28.319358014608
|
| 9001017 |
JWH 073 2'-naphthyl-N-(1,1-dimethylethyl) isomer
New |
|
- |
≥98%
|
|
|
2012-01-12
|
119.645204472316
|
jwh-073-2-naphthyl-n-1-1-dimethylethyl-isomer
|
|
cannabinoids cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic CBs herbal blends research applications isomers JWH073 JWH-073 JHW 73 JWH73 JWH-73 JWHs naphthyl groups butyl chains central peripheral |
119.645204472316
|
| 9000861 |
JWH 073 4-hydroxyindole metabolite
|
|
- |
≥98%
|
|
|
2010-09-01
|
43.375395282530
|
jwh-073-4-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 1 JWH-073 JWH073 M-1 CBs smoking mixtures spices synthetic standards CBs JWH073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
43.375395282530
|
| 10717 |
JWH 073 4-hydroxyindole metabolite-d7
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-02-21
|
19.579435563740
|
jwh-073-4-hydroxyindole-metabolite-d7
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 1 JWH-073 JWH073 M-1 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
19.579435563740
|
| 9001076 |
JWH 073 4-methylnaphthyl analog
New |
|
- |
≥98%
|
|
|
2011-09-06
|
35.278436481376
|
jwh-073-4-methylnaphthyl-analog
|
JWH 122 N-butyl analog; 1-butyl-3-(1-(4-methyl)naphthoyl) indole
|
JWH073 JWH-073 JWH73 JWH-73 analogs hybrids forensics sciences cannabinoids CBs JWHs indoles cannabimimetics JWH 018 122 smoking incense spices forensics pains neuroscience |
35.278436481376
|
| 9000862 |
JWH 073 5-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
37.173574988467
|
jwh-073-5-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 2 JWH-073 JWH073 CBs M-2 agonists smoking mixtures spices cbs synthetic JWH073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
37.173574988467
|
| 10718 |
JWH 073 5-hydroxyindole metabolite-d7
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-03-11
|
21.566729128299
|
jwh-073-5-hydroxyindole-metabolite-d7
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics Metabolite 2 JWH-073 JWH073 M-2 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
21.566729128299
|
| 9000863 |
JWH 073 6-hydroxyindole metabolite
Exclusive |
|
- |
≥95%
|
|
✓ |
2010-09-01
|
33.166485782090
|
jwh-073-6-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 3 JWH-073 JWH073 M-3 CBs smoking mixtures spices synthetic JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
33.166485782090
|
| 10719 |
JWH 073 6-hydroxyindole metabolite-d7
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-03-11
|
19.228790996521
|
jwh-073-6-hydroxyindole-metabolite-d7
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 3 JWH-073 JWH073 M-3 CBs smoking mixtures spices synthetic LC-MS LC/MS GC-MS GC/MS mass spectrometry MS deuterateds deuteriums standards CBs JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
19.228790996521
|
| 9000864 |
JWH 073 7-hydroxyindole metabolite
Exclusive |
|
- |
98%
|
|
✓ |
2010-09-01
|
30.644219555686
|
jwh-073-7-hydroxyindole-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics JWH 073 Metabolite 4 JWH-073 CBs JWH073 M-4 mixtures smoking spices synthetic JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
30.644219555686
|
| 10720 |
JWH 073 7-hydroxyindole metabolite-d7
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-07-25
|
25.409004024282
|
jwh-073-7-hydroxyindole-metabolite-d7
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites forensics CBs deuterateds deuterium mass spectrometry MS LC/MS LC-MS GC-MS GC/MS WIN55212-2 WIN552122 pain neuroscience JWH 073 JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
25.409004024282
|
| 9000868 |
JWH 073-d7 (solution)
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2010-08-10
|
35.952230308723
|
jwh-073-d7-solution
|
|
deuterateds deuteriums CBs cannabinoids LC-MS LC/MS GC-MS GC/MS mass spectrometry MS standards JWH-073 JWHs JWH073 JWH73 JWH-73 JWH 73 cannabinoids CB1 receptors CB2 peripheral central cbs synthetic JWH073d7 JWH-073-d7 JWH073-d7 JWH73-d7 JWH-73-d7 JWH73-d7 JWH73d7 10905 |
35.952230308723
|
| 9001013 |
JWH 073 N-(1,1-dimethylethyl) isomer
New |
|
- |
≥98%
|
|
|
2012-01-12
|
119.645204472316
|
jwh-073-n-1-1-dimethylethyl-isomer
|
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWHs JWH073 JWH-073 central peripheral herbal blends butyl chains isomers |
119.645204472316
|
| 10795 |
(±)-JWH 073 N-(3-hydroxybutyl) metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-05-31
|
53.345126292079
|
-jwh-073-n-3-hydroxybutyl-metabolite
|
|
JWH-073 JWH073 JWH73 JWH-73 JWH73 cannabinoids metabolites cannabimimetic aminoalkyl chains adulterant CBs metabolism in vitro smoking mixtures |
53.345126292079
|
| 10927 |
(±)-JWH 073 N-(3-hydroxybutyl) metabolite-d5
Exclusive |
|
- |
≥99% deuterated forms (d1-d5)
|
|
✓ |
2011-07-25
|
46.084455221335
|
-jwh-073-n-3-hydroxybutyl-metabolite-d5
|
|
deuterateds deuterium GC-MS GC/MS LC-MS LC/MS mass spectrometry MS JWH073 JWH73 JWH-073 JWH-73 cannabinoids metabolites cannabimimetic aminoalkyl chains adulterant CBs metabolism in vitro smoking mixtures pain neuroscience |
46.084455221335
|
| 9000865 |
JWH 073 N-(4-hydroxybutyl) metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
85.111283486231
|
jwh-073-n-4-hydroxybutyl-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 5 JWH-073 smoking JWH073 CBs mixtures spices M-5 synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
85.111283486231
|
| 10934 |
JWH 073 N-(4-hydroxybutyl) metabolite-d5
Exclusive New |
|
- |
≥99% deuterated product
|
|
✓ |
2011-10-14
|
66.724011217090
|
jwh-073-n-4-hydroxybutyl-metabolite-d5
|
|
M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M deuterated deuterium metabolites cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugate forensics JWH 073 Metabolite 5 JWH-073 smoking JWH073 CBs mixtures spices |
66.724011217090
|
| 9000866 |
JWH 073 N-butanoic acid metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-09-01
|
94.707746633261
|
jwh-073-n-butanoic-acid-metabolite
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics JWH 073 Metabolite 6 JWH-073 CBs JWH073 M-6 smoking mixtures spices cbs synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
94.707746633261
|
| 9000870 |
JWH 073 N-butanoic acid metabolite-d5
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2010-09-20
|
88.435213297809
|
jwh-073-n-butanoic-acid-metabolite-d5
|
|
JWH 073 Metabolite 6-d5 JWH-073 JWH073 cannabinoids CBs receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine urinary metabolites glucuroconjugates forensics synthetic JWH-073 JWH073 JWH73 JWH-73 JWH73 deuterateds deuteriums mass spec GC-MS LC-MS GC/MS LC/MS M2 M-2 M 2 JWH-073-M2 JWH-018-M-2 JWH-073-M M3 M-3 M 3 JWH-073-M3 JWH-073-M-3 JWH-073-M M4 M-4 M 4 JWH-018-M4 JWH-073-M-4 JWH-073-M M5 M-5 M 5 JWH-073-M5 JWH-073-M-5 JWH-073-M M6 M-6 M 6 JWH-073-M6 JWH-073-M-6 JWH-073-M |
88.435213297809
|
| 13170 |
JWH 073 (solution)
|
|
208987-48-8 |
≥97%
|
|
|
2009-03-02
|
44.560786731709
|
jwh-073-solution
|
|
cannabinoid CB1 CB2 agonist selective receptors WN55212-2 WIN552122 WIN 552122 WIN 55212-2 jwh073 cannabinoids cbs synthetic JWH-073-d7 JWH073-d7 JWH73d7 10904 |
44.560786731709
|
| 10579 |
JWH 081
|
|
210179-46-7 |
≥98%
|
|
|
2010-10-22
|
76.572986461864
|
jwh-081
|
|
cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine forensics endocannabinoids indoles central peripheral receptors cannabinoids cbs synthetic JWH-081 JWH 81 JWH-81 JWH81 |
76.572986461864
|
| 9001045 |
JWH 081 3-methoxynaphthyl isomer
New |
|
- |
≥98%
|
|
|
2012-01-25
|
187.336528974017
|
jwh-081-3-methoxynaphthyl-isomer
|
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWH-081 JWH081 JWH81 JWH-81 JWH 81 central peripheral |
187.336528974017
|
| 9001047 |
JWH 081 6-methoxynaphthyl isomer
New |
|
824961-41-3 |
≥98%
|
|
|
2012-01-19
|
167.038438607436
|
jwh-081-6-methoxynaphthyl-isomer
|
JWH 166
|
cannabinoids CBs cannabimimetics central CB1 CB2 peripheral receptors agonists spices forensics synthetic isomers methoxy groups naphthyl rings research JWH081 JWH-081 JWH 81 JWH-81 JWH81 JWH166 JWH-166 JWHs |
167.038438607436
|
| 9001049 |
JWH 081 8-methoxynaphthyl isomer
New |
|
- |
≥98%
|
|
|
2012-01-11
|
148.684279342982
|
jwh-081-8-methoxynaphthyl-isomer
|
|
cannabinoids cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic CBs ten-fold ten fold reduced reduces affinity isomers methoxy groups naphthyl rings central peripheral |
148.684279342982
|
| 10511 |
JWH 081-d9
New |
|
- |
≥99% deuterated product
|
|
|
2011-09-08
|
66.443078325278
|
jwh-081-d9
|
|
cannabinoids receptors WIN 55212-2 CB1 CB2 cannabimimetics urine forensics endocannabinoids indoles central peripheral receptors cannabinoids CBs synthetic JWH-081 JWH 81 JWH-81 JWH81 standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS |
66.443078325278
|
| 9000768 |
JWH 081 N-(5-hydroxypentyl) metabolite
Exclusive |
|
- |
≥95%
|
|
✓ |
2011-08-05
|
95.818200155193
|
jwh-081-n-5-hydroxypentyl-metabolite
|
|
JWH-081 JWH081 JWH-81 JWH81 JWH 81 JWHs CBs cannabinoids forensics sciences metabolites cannabimimetics metabolites CB1 CB2 receptors agonists spices synthetics smoking urinary urine serum |
95.818200155193
|
| 10680 |
JWH 098
Exclusive |
|
316189-74-9 |
≥98%
|
|
✓ |
2011-04-20
|
51.161757491380
|
jwh-098
|
|
JWH-098 JWH98 JWH-98 JWH 98 cannabinoids cannabimimetics CBs CB1 receptors agonists CB2 pain spice forensics synthetic naphthalen-1-yl-(1-pentylindol-3-yl)methanone 1-propyl-2-methyl-3-(1-naphthoyl)indole 1,1-dimethylbutyl-1-deoxy-Delta(9)-THC 1-pentyl-3-(1-naphthoyl)indole naphthalenes JWH 133 JWH133 JWH-133 JWH-018 JWH018 JWH 018 JWH18 JWH015 JWH15 JWH 015 JWH-015 indoles |
51.161757491380
|
| 10512 |
JWH 122-d9
New |
|
- |
≥99% deuterated product
|
|
|
2011-09-08
|
41.408151914141
|
jwh-122-d9
|
|
JWHs JWH-122 JWH122 cannabinoids CB1 CB2 CBs CB-1 CB-2 receptors potent synthetic forensics pain central peripheral cannabinoids CBs synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS |
41.408151914141
|
| 10925 |
JWH 122 N-(5-hydroxypentyl) metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-06-17
|
50.501041928730
|
jwh-122-n-5-hydroxypentyl-metabolite
|
|
cannabinoids CBs receptors CB1 CB2 cannabimimetics analogs forensics JWH122 JWH-122 monohydroxylation N-alkyl chains naphthoylindole JWH 018 JWH018 JWH-018 JWH18 JWH-18 JWH 18 JWH073 JWH-073 JWH 073 JWH73 JWH-73 JWH 73 |
50.501041928730
|
| 10825 |
JWH 145
Exclusive New |
|
914458-19-8 |
≥95%
|
|
✓ |
2011-11-10
|
26.667005378671
|
jwh-145
|
|
JWH-145 JWH145 JWHs cannabinoids CBs CB1 CB2 herbals smoking forensics receptors agonists cannabimimetic aminoalkylindole JWH018 JWH-018 JWH 018 blends 73 18 JWH073 JWH-073 JWH 073 JWH73 JWH 73 JWH-73 JWH18 JWH-18 |
26.667005378671
|
| 11201 |
JWH 175
Exclusive New |
|
619294-35-8 |
≥98%
|
|
✓ |
2012-02-09
|
130.536276661375
|
jwh-175
|
|
CBs JWH-175 JWH175 JWHs CB1 CB2 cannabinoids JWH018 JWH-018 JWH 018 receptors agonist spices synthetic |
130.536276661375
|
| 10643 |
JWH 182
Exclusive New |
|
824960-02-3 |
≥97%
|
|
✓ |
2011-10-11
|
53.435623815085
|
jwh-182
|
|
JWH-182 JWHs CB1 CB2 CBs receptors agonists pains spices forensics synthetics cannabinoids cells animals |
53.435623815085
|
| 10902 |
JWH 200
|
|
103610-04-4 |
≥98%
|
|
|
2011-05-05
|
47.054774727766
|
jwh-200
|
|
cannabinoids receptors agonists CB1 pain antinociception cannabinoids cbs synthetic JWH200 JWH-200 10902 |
47.054774727766
|
| 10744 |
JWH 200 4-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-04-15
|
36.781428004611
|
jwh-200-4-hydroxyindole-metabolite
|
|
JWH-200 JWH200 cannabinoids receptors agonists pain antinociception CBs cannabimimetic metabolites CB1 CB2 spices forensics synthetic smoking urinary urine |
36.781428004611
|
| 10745 |
JWH 200 5-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-07-06
|
25.218674674828
|
jwh-200-5-hydroxyindole-metabolite
|
|
JWH-200 JWH200 cannabinoids receptors agonists pain antinociception CBs cannabimimetic metabolites CB1 CB2 spices forensics synthetic smoking urinary urine neuroscience |
25.218674674828
|
| 10903 |
JWH 200-d5
|
|
- |
≥99% deuterated product
|
|
|
2011-05-06
|
10.563329852221
|
jwh-200-d5
|
|
cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-200-d5 JWH200-d5 10903 |
10.563329852221
|
| 10682 |
JWH 200-d5 (solution)
|
|
- |
≥99% deuterated product
|
|
|
2011-01-07
|
33.996941087390
|
jwh-200-d5-solution
|
|
cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-200-d5 JWH200-d5 10903 |
33.996941087390
|
| 13171 |
JWH 200 (solution)
|
|
103610-04-4 |
≥98%
|
|
|
2009-03-25
|
45.758690559580
|
jwh-200-solution
|
|
cannabinoids receptors agonists CB1 pain antinociception cannabinoids cbs synthetic JWH200 JWH-200 10902 |
45.758690559580
|
| 10721 |
JWH 201
Exclusive |
|
864445-47-6 |
≥98%
|
|
✓ |
2011-02-24
|
77.624510665918
|
jwh-201
|
|
cannabinoids CB1 CB2 receptors CBs JWH201 JWH-201 JWH250 JWH-250 JWH 250 |
77.624510665918
|
| 9000736 |
JWH 203
|
|
864445-54-5 |
≥98%
|
|
|
2011-02-21
|
73.687547154631
|
jwh-203
|
|
cannabinoids receptors JWH 250 JWH203 JWH-203 CB1 CB2 cannabimimetics forensics pain CBs binding analgesic |
73.687547154631
|
| 10868 |
JWH 203 3-chlorophenyl isomer
Exclusive |
|
864445-56-7 |
≥98%
|
|
✓ |
2011-06-03
|
31.132707182320
|
jwh-203-3-chlorophenyl-isomer
|
JWH 237; JWH 203 3-chloro isomer
|
cannabinoids receptors JWH 250 JWH203 JWH-203 CB1 CB2 CBs cannabimimetics forensics pain bath salts phenylacetylindole analog |
31.132707182320
|
| 10867 |
JWH 203 4-chlorophenyl isomer
Exclusive |
|
864445-58-9 |
≥98%
|
|
✓ |
2011-06-02
|
36.822909760589
|
jwh-203-4-chlorophenyl-isomer
|
JWH 206; JWH 203 4-chloro isomer
|
cannabinoids CB1 CB2 receptors synthetic forensics pain bath salts CBs JWH203 JWH-203 JWH206 JWH-206 |
36.822909760589
|
| 10644 |
JWH 210
|
|
824959-81-1 |
≥98%
|
|
|
2011-02-01
|
119.609337313713
|
jwh-210
|
|
cannabimimetic cannabinoids alklyindoles CB1 CB2 receptors agonists CBs JWH-210 JWH210 |
119.609337313713
|
| 9001039 |
JWH 210 3-ethylnaphthyl isomer
New |
|
- |
≥98%
|
|
|
2011-11-30
|
74.802596125547
|
jwh-210-3-ethylnaphthyl-isomer
|
|
cannabinoids CBs cannabimimetic metabolites receptors agonists spices forensics synthetic smoking urinary urine serum JWHs JWH210 JWH-210 alkylindole herbal blends isomers ethyl chains naphthyl groups |
74.802596125547
|
| 9000771 |
JWH 210 5-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-08-10
|
44.869743788179
|
jwh-210-5-hydroxyindole-metabolite
|
|
JWH-210 JWH210 cannabinoids CBs cannabimimetic metabolites CB1 CB2 receptors agonists spices forensics synthetic smoking urinary urine serum |
44.869743788179
|
| 9001041 |
JWH 210 6-ethylnaphthyl isomer
New |
|
- |
≥98%
|
|
|
2012-01-31
|
206.657795692826
|
jwh-210-6-ethylnaphthyl-isomer
|
|
cannabinoids CBs cannabimimetic CB1 CB2 receptors agonists spices forensics synthetic smoking JWH210 JWH-210 JWHs isomers alkylindoles extracts herbal blends |
206.657795692826
|
| 10510 |
JWH 210-d9
New |
|
- |
≥99% deuterated product
|
|
|
2011-09-08
|
48.455738971633
|
jwh-210-d9
|
|
cannabimimetic cannabinoids alklyindoles CB1 CB2 receptors agonists CBs JWH-210 JWH210 JWHs standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS pain |
48.455738971633
|
| 10940 |
JWH 210 N-(4-hydroxypentyl) metabolite
New |
|
- |
≥95%
|
|
|
2012-01-19
|
126.559825701640
|
jwh-210-n-4-hydroxypentyl-metabolite
|
|
cannabinoids CBs cannabimimetics metabolites receptors agonists spices forensics synthetic smoking urinary urine serum JWH210 JWH-210 JWHs alkylindoles liver |
126.559825701640
|
| 11153 |
JWH 249
New |
|
864445-60-3 |
≥98%
|
|
|
2012-02-10
|
0E-12
|
jwh-249
|
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWH249 JWH-249 JWHs central peripheral |
0E-12
|
| 13634 |
JWH 250
|
|
864445-43-2 |
≥98%
|
|
|
2010-01-14
|
76.881878954195
|
jwh-250
|
|
cannabinoids CB1 CB2 receptors THC JWH-250 JWH250 Δ9-THC Δ9-tetrahydrocannabinols delta 9 tetrahydrocannabinols indoles cbs synthetic |
76.881878954195
|
| 9000766 |
JWH 250 5-hydroxyindole metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-07-20
|
35.722872928177
|
jwh-250-5-hydroxyindole-metabolite
|
|
JWH250 JWH-250 cannabinoids CBs cannabimimetics metabolite CB1 CB2 receptors agonists spices forensics synthetic smoking urinary urine serum |
35.722872928177
|
| 10661 |
JWH 250-d5
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-02-14
|
32.813926949452
|
jwh-250-d5
|
|
cannabinoids receptors agonists CB1 pain antinociception deuterateds deuterium GC/MS GC-MS LC/MS LC-MS mass spectrometry MS cannabinoids cbs synthetic JWH-250-d5 JWH250-d5 |
32.813926949452
|
| 10939 |
JWH 250 N-(4-hydroxypentyl) metabolite
Exclusive New |
|
- |
≥98%
|
|
✓ |
2011-10-24
|
46.770100893042
|
jwh-250-n-4-hydroxypentyl-metabolite
|
|
JWHs JWH-250 JWH250 metabolites cannabinoids CB1 CB2 CBs herbal smoke smoking forensics receptors agonist cannabimimetic metabolite metabolism |
46.770100893042
|
| 10938 |
JWH 250 N-(5-carboxypentyl) metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-07-19
|
77.234958111501
|
jwh-250-n-5-carboxypentyl-metabolite
|
|
JWHs JWH-250 JWH250 metabolites forensics sciences urinary urine synthetics cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices synthetics smoking urinary urine serum |
77.234958111501
|
| 9000767 |
JWH 250 N-(5-hydroxypentyl) metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-08-05
|
63.171820525698
|
jwh-250-n-5-hydroxypentyl-metabolite
|
|
JWH250 JWH-250 forensic sciences CBs cannabinoids JWHs cannabimimetics metabolites CB1 CB2 receptors agonists spices forensics synthetics smoking urinary urine serum |
63.171820525698
|
| 10578 |
JWH 251
|
|
864445-39-6 |
≥98%
|
|
|
2010-08-20
|
53.611618745255
|
jwh-251
|
|
cannabinoids receptors JWHs JWH-251 JWH251 WIN55212-2 WIN 55212-2 CB1 CB2 cannabimimetics urine forensics cannabinoids cbs synthetic |
53.611618745255
|
| 10722 |
JWH 302
Exclusive |
|
864445-45-4 |
≥95%
|
|
✓ |
2011-03-04
|
77.296232569548
|
jwh-302
|
|
cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine forensics CBs JWH302 JWH-302 indoles central peripheral GTPγS binding |
77.296232569548
|
| 10797 |
JWH 307
New |
|
914458-26-7 |
≥96%
|
|
|
2011-12-15
|
96.786584949347
|
jwh-307
|
|
JWH307 JWH-307 cannabinoids CBs CB1 CB2 herbal smoking forensics receptors agonists JWHs cannabimimetic psychological neurological nuerology toxicological toxicology |
96.786584949347
|
| 10829 |
JWH 368
New |
|
914458-31-4 |
≥98%
|
|
|
2011-12-14
|
77.487867180509
|
jwh-368
|
|
JWH368 JWH-368 cannabinoids CBs CB1 CB2 herbal smoking forensics sciences receptors agonists cannabimimetic JWHs |
77.487867180509
|
| 10828 |
JWH 369
New |
|
914458-27-8 |
≥95%
|
|
|
2012-01-25
|
121.627138556643
|
jwh-369
|
|
JWH369 JWH-369 cannabinoids cannabimimetics CB1 CB2 CBs receptors agonists spices forensics synthetic central peripheral mouse research |
121.627138556643
|
| 10827 |
JWH 370
New |
|
914458-22-3 |
≥95%
|
|
|
2011-11-10
|
31.736608786711
|
jwh-370
|
|
JWH370 JWH-370 JWHs cannabinoids CB1 CB2 herbal smoking forensics receptors agonists cannabimimetic aminoalkylindole JWH 018 JWH 18 JWH-018 JWH018 JWH073 JWH 73 JWH 073 JWH-073 analogs blends JWH-73 JWH73 JWH-18 JWH18 |
31.736608786711
|
| 13636 |
JWH 398
Exclusive |
|
- |
≥95%
|
|
✓ |
2010-10-22
|
73.228542786809
|
jwh-398
|
|
jwh398 cannabinoids receptors WIN 55,212-2 CB1 CB2 cannabimimetics urine forensics CBs JWH-398 cbs synthetic |
73.228542786809
|
| 9001024 |
JWH 398 3-chloronaphthyl isomer
New |
|
- |
≥98%
|
|
|
2012-01-11
|
109.267221717577
|
jwh-398-3-chloronaphthyl-isomer
|
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic JWH398 JWH-398 JWHs isomers herbal mixtures chlorine naphthyl rings central peripheral |
109.267221717577
|
| 9001028 |
JWH 398 8-chloronaphthyl isomer
New |
|
- |
≥98%
|
|
|
2012-01-13
|
112.335403648117
|
jwh-398-8-chloronaphthyl-isomer
|
|
cannabinoids CBs cannabimimetics CB1 CB2 receptors agonists spices forensics synthetic isomers herbal mixtures JWHs JWH-398 JWH398 central peripheral |
112.335403648117
|
| 13158 |
JZL 184
|
|
1101854-58-3 |
≥97%
|
|
|
2009-01-26
|
160.348107734806
|
jzl-184
|
|
2-AG 2AG MAGL inhibitors inhibits inhibition endocannabinoids pains analgesia MGL inhibitor JZL184 JZL-184 cannabinoids |
160.348107734806
|
| 13668 |
JZL 195
|
|
- |
≥98%
|
|
|
2010-02-10
|
120.234751381215
|
jzl-195
|
|
fatty acid amide hydrolase FAAH monoacylglycerol lipase MAGL endocannabinoids arachidonoyl ethanolamide AEA 2-arachidonoylglycerol 2-AG inibitors inhibition inhibits PF-3845 PF 3845 PF3845 JZL195 JZL-195 JZL184 antinociception pain catalepsy hypomotility CB1 2AG cannabinoids inhibitors cbs sythetic Methylenedioxybenzenes
1,3-Dioxaindans 1,3 Dioxaindans 1,3-Dioxindans 1,3 Dioxindans Benzodioxoles |
120.234751381215
|
| 13711 |
KCNQ1 Potassium Channel Monoclonal Antibody (Clone S37A-10)
|
|
- |
|
|
|
2009-12-02
|
0E-12
|
kcnq1-potassium-channel-monoclonal-antibody-clone-s37a-10
|
|
antibodies western blots WB immunoblotting blotting immunoprecipitation IP immunohistochemistry IHC KCNQ-1 IKs inner ears cardiac muscles channels Kv7.1 hyperpolarization-activated cation hyperpolarization activated activity activate |
0E-12
|
| 13712 |
KCNQ2 Potassium Channel Monoclonal Antibody (Clone S26A-23)
|
|
- |
|
|
|
2009-12-02
|
0E-12
|
kcnq2-potassium-channel-monoclonal-antibody-clone-s26a-23
|
|
antibodies western blots WB immunoblotting blotting immunoprecipitation IP immunohistochemistry IHC KCNQ-2 IKs inner ears cardiac muscles channels Kv7.1 familial neonatal convulsions benign hyperpolarization activated |
0E-12
|
| 13713 |
KCNQ4 Potassium Channel Monoclonal Antibody (Clone S43-6)
|
|
- |
|
|
|
2009-12-02
|
0E-12
|
kcnq4-potassium-channel-monoclonal-antibody-clone-s43-6
|
|
antibodies western blots blotting immunoblotting immunoprecipitation immunocytochemistry ICC IP KCNQ-4 proteins retigabine hyperpolarization-activated hyperpolarization activated activity activate cation antioconvuslants anti-convulsantd |
0E-12
|
| 10640 |
KM 233
Exclusive |
|
628263-22-9 |
≥98%
|
|
✓ |
2011-07-07
|
35.974917127071
|
km-233
|
|
KM233 KM-233 CBs cannabinoids CB2 agonists recptors CB1 gliomas anti tumors cancers |
35.974917127071
|
| 10009280 |
L-759,633
|
|
174627-50-0 |
>98%
|
|
|
2007-09-13
|
35.046546961326
|
l-759-633
|
|
L759633 cannabinoids receptors agonists CB1 CB2 endocrinology neurochemistry cannabinoids cbs synthetic |
35.046546961326
|
| 10008618 |
Lauric Acid Leelamide
|
|
- |
>98%
|
|
|
2006-09-05
|
0.520475138122
|
lauric-acid-leelamide
|
|
saturated fatty acids synthesized synthesis plants animals acetyl coenzymes CoA energy storage 12-carbons coconut nut oils COX-2 cyclooxygenase-2 cyclooxygenases expressions C:8-18 inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine leelamine cannabinoids cbs synthetic |
0.520475138122
|
| 13248 |
L-DOPA
|
|
59-92-7 |
≥95%
|
|
|
2010-02-03
|
3.530939226519
|
l-dopa
|
3,4-Dihydroxyphenylalanine; Pardopa; Levodopa; Syndopa
|
dopamine neurotransmitter locomotion Parkinson's disease stroke dopaflex (-)-dopa 3,4-dihydroxyphenylalanine parda larodopa laradopa levopa veldopa weldopa dopalina dopastral doparkine dopasol 3-(3,4-dihydroxyphenyl)-alanine ledopa DOPA phenylalanines alanines 1-(-)-dopa L-3,4-Dihydroxyphenylalanine
L 3,4 Dihydroxyphenylalanine
Medphano Brand of Levodopa
Roberts Brand of Levodopa
Roche Brand of Levodopa
3-Hydroxy-L-tyrosine
3 Hydroxy L tyrosine
Levodopa Larodopa Dopaflex Levopa L-Dopa L Dopa Dopar |
3.530939226519
|
| 10006148 |
Leelamine
|
|
1446-61-3 |
>98%
|
|
|
2006-05-10
|
0.520865561694
|
leelamine
|
Dehydroabietylamine
|
inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine cannabinoids cbs synthetic |
0.520865561694
|
| 10008614 |
Leelamine (hydrochloride)
|
|
- |
≥98%
|
|
|
2006-05-10
|
0.419208103131
|
leelamine-hydrochloride
|
Dehydroabietylamine
|
inhibitors inhibits inhibition pyruvate dehydrogenases kinases diterpene Sanskrit CB1 CB2 cannbinoids receptors central peripheral tertiary 3H CP55940 PDK antiinflammatory anti-inflammatory PLA2 phospholipases inflammation dehydroabietylamine cannabinoids cbs synthetic |
0.419208103131
|
| 10010572 |
Lercanidipine-d3 (hydrochloride)
|
|
- |
>99% deuterated product
|
|
|
2008-04-14
|
0E-12
|
lercanidipine-d3-hydrochloride
|
|
SPI blocker calcium dihydropyrine neurochemistry |
0E-12
|
| 13353 |
Lignoceric Acid
|
|
557-59-5 |
≥98%
|
|
|
2009-08-04
|
11.580796339375
|
lignoceric-acid
|
FL 88
|
fatty acids brains development cerebrosides sphingomyelin myelin galactoplipids peroxisome Zellweger cerebro-hepato-renal cerebrohepatorenal syndromes X chromosomes X-chromosomes chromosome-linked linked adrenoleukodystrophy lignin FL88 L 88 FL-88 L-88 |
11.580796339375
|
| 90155 |
Linoleoyl Ethanolamide
|
|
68171-52-8 |
>98%
|
|
|
|
7.189558011049
|
linoleoyl-ethanolamide
|
|
cannabinoids neurotransmitter ethanolamides fatty acids neurochemistry neuroscience ethanolamines linoleyl cbs synthetic |
7.189558011049
|
| 9000553 |
Linoleoyl Ethanolamide-d4
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2010-01-13
|
7.936983425414
|
linoleoyl-ethanolamide-d4
|
|
cannabinoids neurotransmitter ethanolamides fatty acids neurochemistry neuroscience ethanolamines linoleyl deuterateds deuteriums LC-MS GC/MS GC-MS mass spectrometry standards LC/MS MS cbs synthetic |
7.936983425414
|
| 9000326 |
Linoleoyl Glycine
|
|
2764-03-6 |
≥98%
|
|
|
2008-10-29
|
5.679337016575
|
linoleoyl-glycine
|
N-Linoleoyl Glycine; LinGly; Glycine Linoleamide
|
arachidonyl glycine fatty acids AEA FAAH inhibits inhibitor inhibition anandamide homologs |
5.679337016575
|
| 700570 |
L-Theanine Fluorometric Assay Kit
Exclusive |
|
- |
|
|
✓ |
2011-05-31
|
240.716457949662
|
l-theanine-fluorometric-assay-kit
|
5-N-ethyl-Glutamine; Glutamic Acid γ-ethyl amide; γ-ethylamino-L-Glutamic Acid; γ-Glutamylethylamide
|
kits assays measures measurements glutamines amino acids aa Camellia sinensis C. sinensis green teas japonica sasanqua mushrooms Xerocomus badius X. badius water-solubles non-proteins plants leaves umami humans immune systems .gamma..delta. gammadelta γδ T cells T-cells infection-fighting infections antigens ethylamine renal metabolites brains .alpha.-waves alpha-waves α-waves alertness schizophrenia neuroprotective effects glutamates receptors N-methyl-D-aspartate NMDA calcium Ca Ca2+ intracellular animals anthracyclines hypertensives rats antihypertensives blood pressures dopamines norepinephrines serotonins |
240.716457949662
|
| 10563 |
MDA 19
|
|
1048973-47-2 |
≥95%
|
|
|
2010-09-17
|
51.340761641673
|
mda-19
|
|
agonists cannabinoids CB2 CB1 pains 1104302-26-2 tactile allodynia paclitaxel spinal nerves ligation MDA-19 MDA19 CBs peripheral central MDAs central cannabinoids cbs synthetic cannabinoids Epidermal Growth Factor Receptor Protein-Tyrosine Kinase Receptors, Epidermal Growth Factor-Urogastrone Receptor Transforming Growth Factor alpha Transforming Growth Factor alpha Receptor
Epidermal Growth Factor Receptor Kinase Receptor Epidermal Growth Factor Receptor erbB 1 Proto Oncogene Protein Receptor Urogastrone Urogastrone Receptor Receptor TGF alpha TGF-alpha Receptor c-erbB-1 Protein Proto-Oncogene Receptor EGF EGF Receptor
|
51.340761641673
|
| 9001102 |
MDAI
New |
|
13274-81-2 |
≥95%
|
|
|
2011-11-04
|
27.510141190915
|
mdai
|
5,6-Methylenedioxy-2-aminoindane
|
designer drugs forensics MDA MDMA neuroscience neurotoxicity analogs amphetamine serotonin neurotoxin methamphetamine 12440-03-9 |
27.510141190915
|
| 10979 |
MDMA methylene homolog (hydrochloride)
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-06-22
|
34.462629087627
|
mdma-methylene-homolog-hydrochloride
|
3,4-Methylenedioxymethamphetamine methyl homolog
|
forensic sciences cannabinoids CBs pyrovalerones pentylones designer drugs forensics neuroscience psychoactive ecstasy HCl |
34.462629087627
|
| 10009518 |
MEK1 (Phospho-Thr292) Polyclonal Antibody
|
|
- |
|
|
|
2007-01-12
|
0E-12
|
mek1-phospho-thr292-polyclonal-antibody
|
MAP Kinase Kinase 1; MAPKK1
|
antibodies WB western blot MEK 1 phosphorylation MAP kinase cell growth differentiation threonine tyrosine phospho-specific blotting immunoblotting |
0E-12
|
| 10009517 |
MEK1 (Phospho-Thr386) Polyclonal Antibody
|
|
- |
|
|
|
2007-01-11
|
0E-12
|
mek1-phospho-thr386-polyclonal-antibody
|
MAPK1; MAP Kinase Kinase 1
|
antibodies WB western blot MEK 1 phosphorylation MAP kinase cell growth differentiation threonine tyrosine phospho-specific blotting immunoblotting |
0E-12
|
| 600180 |
Melanocortin-3 Receptor STEP Reporter Assay Kit (Luminescence)
Exclusive |
|
- |
|
|
✓ |
2010-01-05
|
9.503093922652
|
melanocortin-3-receptor-step-reporter-assay-kit-luminescence
|
MC3R
|
MC-3R melanocortins petides hormones proopiomelanocortins pituitary CNS central nervous systems skin placenta tissues MCR receptors G protein-coupled GPCRs cAMP Adenosine 3',5' cyclic mononucleotides messenger signal transduction pathways melanocortin-3 hypothalmus homeostasis fat lean mass hyperphagia MC4R melanocortin-4 adiposity MC3R-knockout mice mouse murine fatty acids oxidations blood pressure hypertension obesity glucose metabolisms insulin insensitivity agonists ligands Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated endocytosis solution-phase co-transfection plasmids secretory alkalines phosphatases substrates SEAP proteins lipids signal transduction luminescence-based cell-based assays kits CBAs high-throughput screening a-MSH alpha-MSH α-MSH |
9.503093922652
|
| 10006355 |
Melanocortin-4 Receptor Polyclonal Antibody
|
|
- |
|
|
|
2005-08-03
|
15.466270718232
|
melanocortin-4-receptor-polyclonal-antibody
|
MC4R
|
antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry melanocortins melanogenesis steroidogenesis sexual functions inflammations appetite regulations energy homeostasis G-proteins coupled receptors GPCRs MC1R MC2R MC3R MC5R transcripts brain genetic studies heteozygous mutations human obesity mammalian unglycosylated SDS-PAGE endocrinology immunoblotting |
15.466270718232
|
| 600190 |
Melanocortin-4 Receptor STEP Reporter Assay Kit (Luminescence)
Exclusive |
|
- |
|
|
✓ |
2010-01-05
|
10.453403314917
|
melanocortin-4-receptor-step-reporter-assay-kit-luminescence
|
MC4R
|
MC-4R melanocortins petides hormones proopiomelanocortins pituitary CNS central nervous systems skin placenta tissues MCR receptors G protein-coupled GPCRs cAMP Adenosine 3',5' cyclic mononucleotides messenger signal transduction pathways melanocortin-3 hypothalmus homeostasis fat lean mass hyperphagia MC4R melanocortin-4 adiposity MC3R-knockout mice mouse murine fatty acids oxidations blood pressure hypertension obesity glucose metabolisms insulin insensitivity agonists ligands sexual function antagonists fever suppression inflammatory mediators in vivo Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated endocytosis solution-phase co-transfection plasmids secretory alkalines phosphatases substrates SEAP proteins lipids signal transduction luminescence-based cell-based assays kits CBAs high-throughput screening a-MSH alpha-MSH α-MSH |
10.453403314917
|
| 10529 |
Methedrone (hydrochloride)
New |
|
879665-92-6 |
≥98%
|
|
|
2011-10-11
|
63.140864465314
|
methedrone-hydrochloride
|
4-Methedrone; Methoxyphedrine; PMMC; para-Methoxymethcathinone
|
cathinone analogs MAO inhibitors PMMC mephedrone PMMA 530-54-1 inhibits inhibition phenethylamines amphetamines cathinones derivatives psychoactive MDMA hydrochloride HCl |
63.140864465314
|
| 70660 |
Methyl Arachidonyl Fluorophosphonate
|
|
188404-10-6 |
>98%
|
|
|
|
48.292615101289
|
methyl-arachidonyl-fluorophosphonate
|
MAFP
|
phospholipases inhibitors cPLA2 iPLA2 MAFP fatty acids neuroscience neurochemistry |
48.292615101289
|
| 13775 |
Methyl-CpG-Binding Protein 2 Polyclonal Antibody
|
|
- |
|
|
|
2010-04-27
|
0E-12
|
methyl-cpg-binding-protein-2-polyclonal-antibody
|
MeCP2
|
antibodies domains cytosines dinucleotides methylations DNA proteins mammalian MED1 MeCP2 PCM1 MBDs MBDs MBD-1 MBD-2 MBD-3 MBD-4 MBD2 MBD3 MBD4 MBD 2/3 MBD-2/3 MBD 1 MBD 2 MBD 3 MBD 4 MBD2-3 MBD 2-3 |
0E-12
|
| 10624 |
Methylenedioxy Pyrovalerone
Exclusive |
|
687603-66-3 |
≥98%
|
|
✓ |
2011-01-07
|
41.186211080622
|
methylenedioxy-pyrovalerone
|
MDPV
|
3,4-methylenedioxypyrovalerone inhibitors neurotransmitters dopamine norepinephrine MDMA ecstasy forensics designer drugs Hemihydrate Apomorphine Hydrochloride Anhydrous Apomorphine Hydrochloride Chloride Apomorphine Apomorphin Teclapharm Apomorphine Chloride Berberine Alkaloids Camptothecine Camptothecin Umbellatine Apomorphine Britaject Berberine Alkaloids Berbines Apokinon |
41.186211080622
|
| 10679 |
Methylenedioxy Pyrovalerone-d8 (hydrochloride)
|
|
1246820-09-6 |
≥99% deuterated product
|
|
|
2011-02-15
|
37.891464123511
|
methylenedioxy-pyrovalerone-d8-hydrochloride
|
MDPV-d8
|
3,4-methylenedioxypyrovalerone inhibitors neurotransmitters dopamine norepinephrine MDMA ecstasy neuroscience forensics designer drugs deuterateds deuteriums GC/MS GC-MS LC/MS LC-MS mass spectrometry MS standards |
37.891464123511
|
| 10684 |
Methylenedioxy Pyrovalerone (hydrochloride)
|
|
24622-62-6 |
≥98%
|
|
|
2011-01-07
|
56.786631573859
|
methylenedioxy-pyrovalerone-hydrochloride
|
MDPV
|
3,4-methylenedioxypyrovalerone inhibitors neurotransmitters dopamine norepinephrine MDMA ecstasy neuroscience forensics designer drugs |
56.786631573859
|
| 70662 |
Methyl α-Linolenyl Fluorophosphonate
|
|
- |
>98%
|
|
|
|
22.170568271507
|
methyl-linolenyl-fluorophosphonate
|
MLnFP
|
PLA2s phospholipases A2 FAAH fatty acids amides hydrolase inhibitors cannabinoids CB receptors antagonists analogs MAFP MaLnFP M.alpha.LnFP MalphaLnFP alpha-linolenyl .alpha.-linolenyl neurochemistry neuroscience |
22.170568271507
|
| 70664 |
Methyl γ-Linolenyl Fluorophosphonate
|
|
- |
>98%
|
|
|
|
17.508112338858
|
methyl-linolenyl-fluorophosphonate
|
MγLnFP
|
PLA2s phospholipases A2 FAAH fatty acids amides hydrolases inhibitors cannabinoids CB receptor antagonists M.gamma.LnFP MgammaLnFP analogs MAFP neurochemistry neuroscience |
17.508112338858
|
| 11151 |
Mitragynine
New |
|
4098-40-2 |
≥95%
|
|
|
2011-12-01
|
96.260735880908
|
mitragynine
|
9-methoxy Corynantheidine
|
alkaloids forensics Mitragyna pain neuroscience opioids receptors agonists incense indoles plants noradreneric serotonergic metabolites 11047-39-5 36455-45-5 1383-32-0 6202-22-8 |
96.260735880908
|
| 10212 |
Monoacylglycerol Lipase (FL) Polyclonal Antibody
|
|
- |
|
|
|
2010-03-23
|
29.409715864245
|
monoacylglycerol-lipase-fl-polyclonal-antibody
|
MAGL; MGL
|
WB western blots hydrolases antibodies antiserum antisera hydrolysis immunohistochemistry IHC immunoblotting MGL monoacylglycerol neuroscience neurochemistry MAGL monoglycerol blotting |
29.409715864245
|
| 10007812 |
Monoacylglycerol Lipase (human recombinant)
|
|
- |
>95%
|
|
|
2008-04-01
|
53.800283149171
|
monoacylglycerol-lipase-human-recombinant
|
MAGL; MGL
|
neuroscience neurochemistry 2-AG endocannabinoids hydrolases proteins MAGLs MGLs recombinant |
53.800283149171
|
| 705192 |
Monoacylglycerol Lipase Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2009-10-22
|
62.555753749013
|
monoacylglycerol-lipase-inhibitor-screening-assay-kit
|
MAGL; MGL
|
neuroscience neurochemistry inhibitors inhibiting inhibition inhibits endocannabinoids serines hydrolases pain obesity monoglycerol |
62.555753749013
|
| 100035 |
Monoacylglycerol Lipase Polyclonal Antibody
|
|
- |
|
|
|
|
36.053911602209
|
monoacylglycerol-lipase-polyclonal-antibody
|
MAGL; MGL
|
WB western blots hydrolases antibodies antiserum antisera hydrolysis immunohistochemistry IHC immunoblotting MGL monoacylglycerol neuroscience neurochemistry MAGL monoglycerol blotting |
36.053911602209
|
| 10009566 |
Monoacylglycerol Lipase Western Ready Control
|
|
- |
Whole cell lysate
|
|
|
2007-01-31
|
9.678011049723
|
monoacylglycerol-lipase-western-ready-control
|
MGL; MAGL
|
hormone-sensitive lipases HSL kidney spleen heart liver testis stomach brain lung adrenal gland keletal muscle adipose tissue neurochemistry |
9.678011049723
|
| 10230 |
(+)-Muscarine (iodide salt)
|
|
24570-49-8 |
≥95%
|
|
|
2010-05-06
|
0.790883977900
|
-muscarine-iodide-salt
|
|
neurochemistry 300-54-9 2438-77-9 poisonous mushroom acetylcholine G proteins Alzheimer's disease signal transduction L-muscarine Amanita muscaria |
0.790883977900
|
| 13667 |
Muscimol
|
|
2763-96-4 |
≥98%
|
|
|
2010-05-28
|
6.727562154696
|
muscimol
|
Pantherine; Agarin
|
γ-aminobutyric acid GABA neurotransmitters GABAA GABAC GABAB agonists benzodiazepines memory neurochemistry neuroscience GABA-A Receptor alpha Subunit GABA Benzodiazepine Receptors GABA A Receptor gamma Subunit
GABA A Receptor delta Subunit GABA A Receptor alpha Subunit GABA Benzodiazepine Receptor
GABA A Receptor beta Subunit Benzodiazepine-GABA Receptor Benzodiazepine GABA Receptor
GABA-A Receptor rho Subunit GABA A Receptor rho Subunit Benzodiazepine Receptors
Benzodiazepine Receptor Receptors Muscimol Receptors, Diazepam Muscimol Receptor
Diazepam Receptor GABA A Receptors GABA-A Receptor GABA A Receptor
|
6.727562154696
|
| 10007704 |
N-(3-hydroxyphenyl)-Arachidonoyl amide
Exclusive |
|
183718-75-4 |
>98%
|
|
✓ |
2007-02-02
|
13.166132596685
|
n-3-hydroxyphenyl-arachidonoyl-amide
|
3-HPAA
|
neurochemistry neuroscience AM404 anologs N-(4-hydroxyphenyl)-arachidonoylamides AEA ethanolamides cycloxygenase-1 cyclooxygenase-2 COX-1 COX-2 inhibits inhibitors inhibition N-(3-hydroxyphenyl)-Arachidonoylamide 3-HPA cannabinoids cbs synthetic |
13.166132596685
|
| 10014 |
N-Ac-Tyr-Val-Ala-Asp-CMK
|
|
178603-78-6 |
>98%
|
|
|
2004-04-13
|
27.311325966850
|
n-ac-tyr-val-ala-asp-cmk
|
Ac-YVAD-CMK
|
inhibitors inhibits interleukins neuroprotective cerebral ischemia inhibition selective irreversible interleukin-1.beta.converting enzyme ICE Caspase-1-IL-1.beth. IL1beta neuroprotective cerebral ischemia alaninamides neurochemistry chloromethyl ketones |
27.311325966850
|
| 10009737 |
NAPE-PLD Blocking Peptide
|
|
- |
|
|
|
2007-04-16
|
1.018176795580
|
nape-pld-blocking-peptide
|
|
peptides WB western blots blotting IHC immunohistochemistry ICC immunocytochemistry N-acylethanolamines NAEs inflammatory regulations apoptosis tissues degenerations biosynthesized membranes phospholipid-dependent pathway enzymes enzymatic hydrolysiscatalyzing phospholipases D subtypes mRNA and proteins activity brain kidney testis neuroscience neurochemistry |
1.018176795580
|
| 11240 |
Naphyrone 1-naphthyl isomer (hydrochloride)
New |
|
- |
≥95%
|
|
|
2012-01-24
|
169.534477911646
|
naphyrone-1-naphthyl-isomer-hydrochloride
|
|
designer drugs forensics pyrovalerone cathinones dopamine serotonin norepinephrine bath salts isomers hydrochloride HCl analogs party pills |
169.534477911646
|
| 10517 |
Naphyrone (hydrochloride)
New |
|
850352-11-3 |
≥97%
|
|
|
2011-08-29
|
119.314385553262
|
naphyrone-hydrochloride
|
O-2482; NRG-1; Naphpyrovalerone; β-Naphyrone
|
analogs MDPV forensics sciences designer drugs 850352-53-3 pyrovalerones cathinones dopamine serotonins norepinephrines bath salts |
119.314385553262
|
| 10158 |
N-Arachidonoyl-3-hydroxy-γ-Aminobutyric Acid
|
|
- |
>98%
|
|
|
2004-03-04
|
8.698661755678
|
n-arachidonoyl-3-hydroxy-aminobutyric-acid
|
NAG-3H-ABA
|
amino acids bovines brains glycines congeners NAGly suppress responses pain NAG3HABA neurochemistry neuroscience |
8.698661755678
|
| 90057 |
N-Arachidonoyl Dopamine
|
|
199875-69-9 |
>98%
|
|
|
|
16.907932780847
|
n-arachidonoyl-dopamine
|
NADA
|
analogs capsaicin arachidonic acids amides VR1 receptors vannilloids cannabinoids aada cb1 cb2 analgesic N-arachidonoyl-dopamine neurochemistry neuroscience |
16.907932780847
|
| 10007431 |
N-Arachidonoyl Dopamine-d8
|
|
- |
≥99% deuterated product
|
|
|
2005-08-10
|
10.737403314917
|
n-arachidonoyl-dopamine-d8
|
NADA-d8
|
deuterateds analogs capsaicin arachidonic acids amides VR1 receptors vannilloids cannabinoids ada cb1 cb2 analgesic arachidonoyl-dopamine neurochemistry neuroscience deuterated deuterium GC/MS GC-MS LC/MS LC-MS mass 10007431 spectrometry cannabinoids cbs synthetic |
10.737403314917
|
| 90065 |
N-Arachidonoyl-L-Alanine
|
|
401941-73-9 |
>98%
|
|
|
2004-04-19
|
12.454599447514
|
n-arachidonoyl-l-alanine
|
NALA
|
amino acids bovines brains glycines congeners NAGly suppress responses pain neurochemistry neuroscience |
12.454599447514
|
| 10005455 |
N-Arachidonoyl-L-Serine
|
|
187224-29-9 |
>98%
|
|
|
2004-08-11
|
7.638297338021
|
n-arachidonoyl-l-serine
|
ARA-S
|
endocannabinoids antagonists cannabidiols neuroprotective neurotransmitters hypotensive effects antagonize antagonist neurochemistry neuroscience cannabinoids cbs synthetic |
7.638297338021
|
| 10005537 |
N-Arachidonoyl Taurine
Exclusive |
|
- |
>98%
|
|
✓ |
2004-11-18
|
9.314400157852
|
n-arachidonoyl-taurine
|
|
bovine brain NADA dopamine ARA-S ARAS N-arachidonoyl-L-serine lipidomics mass spectrometry MS rats N-fatty acyl amides amino acids neurochemistry neuroscience TRPV1 TRPV4 FAAH, cbs, cannabinoids, synthetic |
9.314400157852
|
| 90067 |
N-Arachidonoyl-γ-Aminobutyric Acid
|
|
128201-89-8 |
>98%
|
|
|
2004-02-26
|
8.800143646409
|
n-arachidonoyl-aminobutyric-acid
|
NAGABA
|
amino acids bovines brains glycines congeners NAGly suppress responses pain neurochemistry neuroscience |
8.800143646409
|
| 10007517 |
N-Arachidonyl Maleimide
|
|
876305-42-9 |
>98%
|
|
|
2006-07-31
|
16.884563535911
|
n-arachidonyl-maleimide
|
NAM
|
neurochemistry neuroscience 2-AG 2-arachidonoyl glycerol MGL MAGL monoacylglycerol lipase monoglycerol inhibition inhibits inhibitor pain inflammation anxiety endocannabinoids anandanides 2AG fatty acids CB1 CB2 central peripheral inhibitors cannabinoids cbs synthetic |
16.884563535911
|
| 13718 |
Nav1.7 Sodium Channel Monoclonal Antibody (Clone S68-6)
|
|
- |
|
|
|
2009-12-04
|
0E-12
|
nav1-7-sodium-channel-monoclonal-antibody-clone-s68-6
|
|
antibodies channels ions western blots blotting immunoblotting immunoprecipitation WB IP immunocytochemistry ICC pain sensitivity insensitivity sodiums voltage-gated voltage gated |
0E-12
|
| 10007739 |
N-Cyclohexanecarbonylpentadecylamine
|
|
702638-84-4 |
≥98%
|
|
|
2006-08-04
|
10.100269337016
|
n-cyclohexanecarbonylpentadecylamine
|
|
endocannabinoids neurons acidic PEAase palmitoyl ethanolamides amidases anandamides AEA fatty acyls inhibits inhibitors inhibition arachidonoyl neurochemistry neuroscience FAAH hydrolase cannabinoids inhibitors |
10.100269337016
|
| 10008317 |
N-Cyclohexanecarbonyltetradecylamine
|
|
- |
≥98%
|
|
|
2006-08-16
|
10.008901933701
|
n-cyclohexanecarbonyltetradecylamine
|
|
FAAH AEA anandamide PEAase inhibitors PEA palmitoylethanolamides ararchidonoyl acidic fatty acids amide hydrolases amidase inhibits inhibition cannabinoids |
10.008901933701
|
| 10005851 |
N-Decanoyl p-Nitroaniline
|
|
72298-63-6 |
≥98%
|
|
|
2004-12-07
|
7.035676795580
|
n-decanoyl-p-nitroaniline
|
DepNA
|
FAAH substrates anandamides hydrolases colorimetric cannabinoids aea para-nitroanalines fatty acids anandamide arachidonoyl ethanolamides neurochemistry neuroscience anilide |
7.035676795580
|
| 10010574 |
N-Desmethyltrimebutine (hydrochloride)
|
|
294882-33-0 |
≥99%
|
|
|
2008-04-14
|
0E-12
|
n-desmethyltrimebutine-hydrochloride
|
|
SPI trimebutine metabolites anesthetics disorders spasmolytic gastrointestinal neurochemistry |
0E-12
|
| 10007288 |
N-Docosanoyl Taurine
|
|
- |
≥98%
|
|
|
2005-12-29
|
0.906395027624
|
n-docosanoyl-taurine
|
|
neurochemistry neuroscience depression anxiety arachidonoyls amino acids conjugates N-arachidonoyl dopamines NADA N-arachidonoyl-L-serines ARA-S bovine brains taurines fatty lipidomic spinal cord wild types hydrolases FAAH substrates oleoyl ethanolamides endocannabinoids TRPV1 TRPV4 FAAH cannabinoids cbs synthetic |
0.906395027624
|
| 10004184 |
NESS 0327
Exclusive |
|
494844-07-4 |
>98%
|
|
✓ |
2008-05-27
|
38.872345554997
|
ness-0327
|
|
neurochemistry neuroscience cannabinoids antagonist CB1 CB2 SR 141716A rimonabant WIN 55212-5 pain obesity |
38.872345554997
|
| 10007286 |
N-Lignoceroyl Taurine
|
|
807370-75-8 |
>98%
|
|
|
2005-12-21
|
0.950473559589
|
n-lignoceroyl-taurine
|
|
neurochemistry neuroscience depression anxiety arachidonoyls amino acids conjugates N-arachidonoyl dopamines NADA N-arachidonoyl-L-serines ARA-S bovine brains taurines fatty lipidomic spinal cord wild types hydrolases FAAH substrates oleoyl ethanolamides endocannabinoids TRPV1 TRPV4 FAAH cannabinoids cbs synthetic |
0.950473559589
|
| 10607 |
NMDA Receptor NR1 Subunit Monoclonal Antibody
|
|
- |
|
|
|
2009-10-26
|
0.371546961325
|
nmda-receptor-nr1-subunit-monoclonal-antibody
|
|
inhibits inhibitors neurotransmitters WB western blots blotting receptors ion channels glutamate |
0.371546961325
|
| 10608 |
NMDA Receptor NR2A Subunit Polyclonal Antibody
|
|
- |
|
|
|
2009-10-26
|
0.371546961325
|
nmda-receptor-nr2a-subunit-polyclonal-antibody
|
|
inhibits inhibitors neurotransmitters WB western blots blotting receptors ion channels glutamate inhibition immunoprecipitation IP IHC Immunohistochemistry |
0.371546961325
|
| 10009759 |
NMDA Receptor NR2B Subunit (Phospho-Tyr1252) Polyclonal Antibody
|
|
- |
|
|
|
2007-02-09
|
1.582196132596
|
nmda-receptor-nr2b-subunit-phospho-tyr1252-polyclonal-antibody
|
|
antibodies WB western blots phospho-specific NMDA receptor NMDAR phosphorylation NR2B blotting immunoblotting |
1.582196132596
|
| 10009760 |
NMDA Receptor NR2B Subunit (Phospho-Tyr1336) Polyclonal Antibody
|
|
- |
|
|
|
2007-02-09
|
1.582196132596
|
nmda-receptor-nr2b-subunit-phospho-tyr1336-polyclonal-antibody
|
|
antibodies WB western blots phospho-specific NMDA receptor NMDAR phosphorylation NR2B blotting immunoblotting |
1.582196132596
|
| 10009761 |
NMDA Receptor NR2B Subunit (Phospho-Tyr1472) Polyclonal Antibody
|
|
- |
|
|
|
2007-02-22
|
5.497941988950
|
nmda-receptor-nr2b-subunit-phospho-tyr1472-polyclonal-antibody
|
|
antibodies WB western blots phospho-specific NMDA receptor phosphorylation NR2B blotting immunoblotting |
5.497941988950
|
| 10609 |
NMDA Receptor NR2B Subunit Polyclonal Antibody
|
|
- |
|
|
|
2009-10-26
|
0.371546961325
|
nmda-receptor-nr2b-subunit-polyclonal-antibody
|
N-methyl-D-aspartate Receptor
|
inhibits inhibitors neurotransmitters WB western blots immunoblotting receptors ion channels glutamate IP IHC immunohistochemistry immunoprecipitation |
0.371546961325
|
| 9001144 |
N,N-Dimethylcathinone (hydrochloride)
New |
|
10105-90-5 |
≥98%
|
|
|
2011-12-12
|
106.814633073045
|
n-n-dimethylcathinone-hydrochloride
|
Metamfepramone
|
forensics cathinone phenylethylamine phenethylamine neuroscience dimethylpropion dimepropion rats psychotropic hydrochloride hcl |
106.814633073045
|
| 10007287 |
N-Nervonoyl Taurine
|
|
- |
>98%
|
|
|
2005-12-29
|
0.950473559589
|
n-nervonoyl-taurine
|
|
neurochemistry neuroscience depression anxiety arachidonoyls amino acids conjugates N-arachidonoyl dopamines NADA N-arachidonoyl-L-serines ARA-S bovine brains taurines fatty lipidomic spinal cord wild types hydrolases FAAH substrates oleoyl ethanolamides endocannabinoids TRPV1 TRPV4 FAAH cannabinoids cbs synthetic |
0.950473559589
|
| 360871 |
nNOS Blocking Peptide
|
|
- |
|
|
|
|
7.812154696132
|
nnos-blocking-peptide
|
ncNOS; Neuronal Nitric Oxide Synthase; NOS I
|
western blots bNOS synthases immunoblotting controls peptides constitutive antibodies |
7.812154696132
|
| 360870 |
nNOS Electrophoresis Standard
|
|
- |
>95%
|
|
|
|
6.775395948434
|
nnos-electrophoresis-standard
|
ncNOS; Neuronal Nitric Oxide Synthase; NOS I
|
western blots immunoblotting bNOS synthases standards constitutive antibodies neurochemistry |
6.775395948434
|
| 160870 |
nNOS Polyclonal Antibody
|
|
- |
|
|
|
|
11.711721915285
|
nnos-polyclonal-antibody
|
ncNOS; Neuronal Nitric Oxide Synthase; NOS I
|
synthases Western blots brain bNOS neurotransmitters memory blotting constitutive human neurons antibodies WB ICC immunocytochemistry IHC immunohistochemistry antisera antiserum immunoprecipitation IP neurochemistry immunoblotting |
11.711721915285
|
| 60870 |
nNOS (rat recombinant)
|
|
- |
cell lysate 100,000 x g supernatant
|
|
|
|
6.669861878453
|
nnos-rat-recombinant
|
ncNOS; Neuronal Nitric Oxide Synthase; NOS I
|
neuronal enzymes constitutive nitric oxide synthase bNOS neurochemistry |
6.669861878453
|
| 60875 |
nNOS (rat recombinant) - Purified
|
|
- |
>95%
|
|
|
|
18.784735595895
|
nnos-rat-recombinant-purified
|
ncNOS; Neuronal Nitric Oxide Synthase; NOS I
|
neuronal enzymes constitutive nitric oxide synthase bNOS neurochemistry |
18.784735595895
|
| 10009632 |
nNOS Western Ready Control
|
|
- |
|
|
|
2007-05-30
|
7.995623081645
|
nnos-western-ready-control
|
NOS I; ncNOS
|
Western blotting WB citrulline nomenclature tissue neuronal brain N-terminus PSD-95 PSD-96 PZD neurochemistry |
7.995623081645
|
| 10115 |
N-Oleoyl Dopamine
|
|
105955-11-1 |
>98%
|
|
|
|
6.968823993686
|
n-oleoyl-dopamine
|
ODA
|
VR1 agonists CB1 receptors analogs vanilloids cannabinoids analgesic amides N-oleoyldopamine inhibits inhibitors inhibition 5-lipoxygenases 5-LOs binding selective FAAH hydrolases fatty acid neurochemistry neuroscience cbs synthetic |
6.968823993686
|
| 90269 |
N-Oleoyl Glycine
|
|
2601-90-3 |
>98%
|
|
|
|
2.941104972376
|
n-oleoyl-glycine
|
|
precursor oleoylamide fatty acids neurochemistry neuroscience oleoylglycine oleoyl-glycine |
2.941104972376
|
| 13058 |
N-Oleoyl-L-Serine
|
|
- |
≥98%
|
|
|
2008-10-17
|
2.381270718232
|
n-oleoyl-l-serine
|
|
lipids bones endogenous anabolic activity activities formation resorption cannabinoids cbs synthetic |
2.381270718232
|
| 10005609 |
N-Oleoyl Taurine
Exclusive |
|
52514-04-2 |
≥98%
|
|
✓ |
2005-01-05
|
6.681187845304
|
n-oleoyl-taurine
|
|
endocannibinoids fatty amides oleamides taurines amino-acyls lipidomics profiling fatty acids neurochemistry neuroscience TRPV1 TRPV4 FAAH cannabinoids cbs synthetic |
6.681187845304
|
| 781001 |
NOS Activity Assay Kit
|
|
- |
|
|
|
|
117.986593001841
|
nos-activity-assay-kit
|
|
iNOS eNOS nNOS nitric oxide synthases activity radiolabeled arginine inducible neuronal endothelial citrulline kits assays |
117.986593001841
|
| 10007697 |
N-Palmitoyl Dopamine
|
|
136181-87-8 |
>98%
|
|
|
2005-11-23
|
5.533591160221
|
n-palmitoyl-dopamine
|
PALDA
|
N-acyls fatty anologs N-araachidonoyl NADA N-oleoyl ODA bovine brains amides palmitic acids hybrids anandamides neurotransmitter pathways inactive vanilloid receptors 1 VR1 ligands hyperalgesics nocifensives responses in vivo entourage effects neurochemistry cannabinoids cbs synthetic |
5.533591160221
|
| 10009020 |
N-Palmitoyl Glycine
|
|
2441-41-0 |
≥98%
|
|
|
2009-12-01
|
9.929088397789
|
n-palmitoyl-glycine
|
N-Hexadecanoyl-Glycine; PalGly
|
pain inflammation AEA anandamides DRG nociception calcium influx arachidonoyl amides glycines |
9.929088397789
|
| 10005611 |
N-Palmitoyl Taurine
|
|
83982-06-3 |
>98%
|
|
|
2005-02-16
|
6.632880820836
|
n-palmitoyl-taurine
|
|
endocannabinoids fatty amides oleamides bovine brain lipidomics rat amino-acyl neurochemistry, cannabinoids cbs synthetic |
6.632880820836
|
| 70590 |
NS-398
|
|
123653-11-2 |
>98%
|
|
|
|
105.368845917740
|
ns-398
|
|
cyclooxygenases inhibitors NSAIDs COX-2 nonsteroidal anti-inflammatory drugs cox2 pghs2 pghs-2 prostaglandins synthases synthase-2 inhibits selective ns398 selectivity neurochemistry |
105.368845917740
|
| 10005610 |
N-Stearoyl Taurine
|
|
63155-80-6 |
>98%
|
|
|
2005-02-09
|
6.862715074980
|
n-stearoyl-taurine
|
|
endocannabinoids fatty amides oleamides amino-acyl bovine brain rat lipidomics neurochemistry neuroscience TRPV1 TRPV4 FAAH cannabinoids cbs synthetic |
6.862715074980
|
| 10032 |
N-(α-Linolenoyl) Tyrosine
|
|
259143-19-6 |
>98%
|
|
|
|
15.383613259668
|
n-linolenoyl-tyrosine
|
NALT
|
neurochemistry neuroscience fatty acids neurotransmitters dopamine CNS central nervous system anti-Parkinson's anti-Parkinsons diseases endocrinology |
15.383613259668
|
| 80587 |
Nω-propyl-L-Arginine
|
|
137361-05-8 |
>98%
|
|
|
|
13.891208563535
|
n-propyl-l-arginine
|
|
nNOS NOS selective inhibitors arginine nitric oxide synthase neurochemistry |
13.891208563535
|
| 10006803 |
O-1602
|
|
317321-41-8 |
>98%
|
|
|
2005-09-12
|
10.751519337016
|
o-1602
|
|
abnormal cannabidiols CB1 CB2 receptors vasorelaxation neurochemistry neuroscience central cannabinoids peripheral selective antagonists nonendothelium-dependant vasodilation nitric oxides NOs inhibits inhibitors inhibition vasorelaxant cannabinoids cbs synthetic |
10.751519337016
|
| 10006804 |
O-1821
|
|
35482-50-9 |
>97%
|
|
|
2005-09-12
|
18.792081031307
|
o-1821
|
|
abnormal cannabidiol central cannabinoids peripheral CB1 CB2 receptors vasorelaxation neurochemistry neuroscience antagonists synthetic regioisomer endothelium dependent vasodilation cannabinoids cbs synthetic |
18.792081031307
|
| 10004914 |
O-1918
|
|
536697-79-7 |
>98%
|
|
|
2005-09-09
|
9.388121546961
|
o-1918
|
|
antagonists abnormal cannabinoids cannabidiols cannabidiol-mediated synthetic regioisomers CB1 CB2 responsiveness psychotropics activity induces endothelium-dependent vasodilations NO-independent nitric oxides mechanisms analogs endothelial receptors inhibits inhibition inhibitors vasorelexants in vitro blocks induced activations PI3-kinases Akt pathway umbilical vein cells neuroscience neurochemistry O1918 0-1918 cannabinoids cbs synthetic |
9.388121546961
|
| 10009195 |
O-2545 (hydrochloride)
|
|
- |
>98%
|
|
|
2007-07-12
|
1.533701657459
|
o-2545-hydrochloride
|
|
cannabinoids water soluble agonists receptors CB1 CB2 lipophilic surfactants 874745-42-3 murine models intravenously IV 02545 intracerebroventricularly endocrinology neurochemistry cannabinoids cbs synthetic |
1.533701657459
|
| 91050 |
O-Arachidonoyl Ethanolamine (hydrochloride)
|
|
443129-35-9 |
>98%
|
|
|
|
33.231204419889
|
o-arachidonoyl-ethanolamine-hydrochloride
|
Virodhamine; O-AEA; Arachidonic Acid-(2-aminoethyl)-ester
|
endocannabinoids anandamides tetrahydrocannabinoids THC CB1 CB2 receptors arachidonoyl ethanolamides ligand ethanolamines neurochemistry neuroscience esters antagonists cannabinoids cbs synthetic |
33.231204419889
|
| 10010547 |
O-Arachidonoyl Glycidol
Exclusive |
|
439146-24-4 |
>98%
|
|
✓ |
2008-03-31
|
18.812883977900
|
o-arachidonoyl-glycidol
|
|
2-AG 2-arachidonoyl glycerol 2-oleoylglycerol N-arachidonoylethanolamine anandamide AEA FAAH endocannabinoid obesity pain neurodegenerative diseases monoacylglycerol lipase inhibits inhibitors inhibitions MAGL MGL cannabinoids |
18.812883977900
|
| 90265 |
Oleoyl Ethanolamide
|
|
111-58-0 |
>98%
|
|
|
|
18.113664825046
|
oleoyl-ethanolamide
|
Oleic Acid Ethanolamide; OEA
|
cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides cbs synthetic |
18.113664825046
|
| 10007823 |
Oleoyl Ethanolamide-d2
|
|
- |
≥99% deuterated product
|
|
|
2006-03-06
|
13.068480662984
|
oleoyl-ethanolamide-d2
|
OEA-d2; Oleic Acid Ethanolamide-d2
|
GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides cbs synthetic |
13.068480662984
|
| 9000552 |
Oleoyl Ethanolamide-d4
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2010-01-12
|
10.002320441988
|
oleoyl-ethanolamide-d4
|
Oleic Acid Ethanolamide-d4; OEA-d4
|
cannabinoids neurotransmitter chocolate fatty acids neurochemistry neuroscience ethanolamines ethanolamides deuterateds deuteriums MS mass spectrometry CBs LC-MS OEAs LC/MS GC/MS G-MS standards PPAR brain tissue neurochemistry neuroscience synthetic |
10.002320441988
|
| 10005459 |
Oleoyl Ethyl Amide
Exclusive |
|
85075-82-7 |
>98%
|
|
✓ |
2004-07-21
|
21.423348066299
|
oleoyl-ethyl-amide
|
N-Ethyloleamide; OEtA
|
endocannabinoids analogs FAAH fatty acid amide hydrolase analgesic inhibitors inhibitor inhibition acyl PEAase anxiolytic inhibits selective selectivity neuroscience neurochemistry cannabinoids cbs synthetic |
21.423348066299
|
| 71650 |
Oleoyl Oxazolopyridine
|
|
288862-58-8 |
>98%
|
|
|
|
12.563011049724
|
oleoyl-oxazolopyridine
|
CAY10400
|
FAAH fatty acid amide hydrolases inhibitors inhibition inhibits hydrolysis hydrolyze CAY-10400 neuroscience neurochemistry |
12.563011049724
|
| 62640 |
Oleyl Trifluoromethyl Ketone
|
|
177987-23-4 |
>98%
|
|
|
|
2.979889502762
|
oleyl-trifluoromethyl-ketone
|
OTK; Heptadecyl Trifluoromethyl Ketone
|
Trifluoromethyl ketone inhibitors inhibits analogs oleic fatty acids neurochemistry neuroscience |
2.979889502762
|
| 90262 |
Olvanil
|
|
58493-49-5 |
>98%
|
|
|
|
6.050239410681
|
olvanil
|
NE 19550; N-Vanillyloleamide
|
capsaicin capsicum vanilloids receptors agonists cannabinoids analgesia anandamides analgesic vanillylamines amides analogs neurochemistry neuroscience |
6.050239410681
|
| 10171 |
OMDM-1
|
|
- |
>98%
|
|
|
2004-02-05
|
11.400041436463
|
omdm-1
|
(S)-N-oleoyl Tyrosinol
|
endocannabinoids inhibitors AEA lipids anandamides analogs selective selectivity inhibits inhibition R-tyrosinol amides (R)-tyrosinol oleic acid reuptake OMDM1 neurochemistry neuroscience cannabinoids inhibitors |
11.400041436463
|
| 10179 |
OMDM-2
|
|
- |
>98%
|
|
|
2004-02-05
|
9.800618784530
|
omdm-2
|
(R)-N-oleoyl Tyrosinol
|
endocannabinoids inhibitors AEA lipids anandamides analogs selective selectivity inhibits inhibition R-tyrosinol amides (R)-tyrosinol oleic acid reuptake OMDM2 neurochemistry neuroscience cannabinoids inhibitors |
9.800618784530
|
| 300000 |
Optineurin (C-Term) Blocking Peptide
|
|
- |
|
|
|
|
12.680662983425
|
optineurin-c-term-blocking-peptide
|
NRP; FIP-2
|
western blots blotting WB peptides controls FIP2 apoptosis OPTN c-terminus 14.7k interacting protein-2 TNFalpha TNF.alpha. TNF-alpha TNF-.alpha. tumornecrosis factor neurochemistry neuroscience |
12.680662983425
|
| 100000 |
Optineurin (C-Term) Polyclonal Antibody
|
|
- |
|
|
|
|
28.524309392265
|
optineurin-c-term-polyclonal-antibody
|
NRP; FIP-2
|
apoptosis signaling transduction signalling 14.7k interacting protein-2 nemo-related proteins WB western blots blotting cell death glaucoma IOP intraocular pressure neurochemistry neuroscience CTerm ophthalmology immunoblotting |
28.524309392265
|
| 300002 |
Optineurin (INT) Blocking Peptide
|
|
- |
|
|
|
|
3.162983425414
|
optineurin-int-blocking-peptide
|
NRP; FIP-2
|
receptors controls peptides antibodies FIP2 WB western blot blotting 14.7K interacting protein-2 neurochemistry neuroscience |
3.162983425414
|
| 100002 |
Optineurin (INT) Polyclonal Antibody
|
|
- |
|
|
|
|
19.006629834254
|
optineurin-int-polyclonal-antibody
|
NRP; FIP-2
|
apoptosis signaling transduction signalling neurochemistry neuroscience fip2 tumor necrosis factors tnf glaucoma IOP intraocular pressure WB western blots blotting cell death 14.7k interacting protein-2nemo-related ophthalmology immunoblotting |
19.006629834254
|
| 600240 |
Orexin 1 Receptor STEP Reporter Assay Kit (Luminescence)
Exclusive |
|
- |
|
|
✓ |
2010-03-31
|
0.869820441989
|
orexin-1-receptor-step-reporter-assay-kit-luminescence
|
OX1R
|
hypercretins 1 orexins 2 A orexin-2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists |
0.869820441989
|
| 600250 |
Orexin 2 Receptor STEP Reporter Assay Kit (Luminescence)
Exclusive |
|
- |
|
|
✓ |
2010-03-31
|
1.019337016574
|
orexin-2-receptor-step-reporter-assay-kit-luminescence
|
OX2R
|
hypercretins 1 orexin 2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists |
1.019337016574
|
| 10008642 |
oxy-Arachidonoyl Ethanolamide
|
|
- |
>98%
|
|
|
2007-09-06
|
10.283609576427
|
oxy-arachidonoyl-ethanolamide
|
oxy-Anandamide; oxy-AEA
|
oxyanadamide arachidonylethanolamide AEA THC marijuana CB1 CB2 endocannabinoids receptors cannabinoids inhibitors |
10.283609576427
|
| 90350 |
Palmitoyl Ethanolamide
|
|
544-31-0 |
≥98%
|
|
|
|
27.096596685082
|
palmitoyl-ethanolamide
|
Palmidrol; PEA
|
endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines cannabinoids cbs synthetic |
27.096596685082
|
| 10007824 |
Palmitoyl Ethanolamide-d4
Exclusive |
|
1159908-45-8 |
≥99% deuterated product
|
|
✓ |
2006-03-06
|
30.176906077348
|
palmitoyl-ethanolamide-d4
|
Palmidrol-d4; PEA-7,7,8,8-d4
|
GC/MS deuteriums isotopes internal standards deuterateds LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cyclic cAMP ethanolamides anandamides AEA fatty acids neurochemistry ethanolamines cannabinoids cbs synthetic |
30.176906077348
|
| 9000551 |
Palmitoyl Ethanolamide-d4
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2010-01-20
|
8.388955538015
|
palmitoyl-ethanolamide-d4
|
Palmidrol-d4; PEA-hydroxyethyl-1,1,2,2-d4
|
endocannabinoids CB2 neurotransmitters receptors ligands PEAs N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines LC-MS GC-MS mass spetrometry standards deuterateds deuterium MS LC/MS GC/MS cannabinoids cbs synthetic |
8.388955538015
|
| 9000573 |
Palmitoyl Ethanolamide-d5
Exclusive |
|
- |
≥99% deuterated compound
|
|
✓ |
2010-03-04
|
5.932974217311
|
palmitoyl-ethanolamide-d5
|
PEA-15,15,16,16,16-d5; Palmidrol-d5
|
endocannabinoids CB2 neurotransmitters receptors ligands PEA N-(2-hydroxyethyl)-hexadecanamide cAMP ethanolamides anandamides AEA fatty acids neurochemistry neuroscience ethanolamines LC-MS GC-MS mass spetrometry standards deuterateds deuterium MS LC/MS GC/MS CBs synthetic |
5.932974217311
|
| 91354 |
Palmitoyl N-Isopropylamide
|
|
189939-61-5 |
>98%
|
|
|
|
6.115548539858
|
palmitoyl-n-isopropylamide
|
PIA
|
cannabinoids FAAH fatty acid amide hydrolase inhibits inhibitors inhibition ethanolamides palmitoyl-n-isopropylamide PEA neurochemistry neuroscience synthetic analogs hydrolysis ethanolamines |
6.115548539858
|
| 62175 |
Palmitoyl Serinol
|
|
126127-31-9 |
>98%
|
|
|
|
22.767748618784
|
palmitoyl-serinol
|
|
endocannabinoids 2PG CB1 receptors synthases FAAH fatty acids amides analogs hydrolases 2-PG glycerols adenyl cyclase inhibits inhibition re-uptake reuptake neurochemistry neuroscience cannabinoids cbs synthetic |
22.767748618784
|
| 62650 |
Palmityl Trifluoromethyl Ketone
|
|
141022-99-3 |
>98%
|
|
|
|
46.367403314918
|
palmityl-trifluoromethyl-ketone
|
PTK; Pentadeca Trifluoromethyl Ketone
|
ketones inhibitors analogs palmitic fatty acids inhibits inhibition lipoxygeanses LOs neurochemistry neuroscience |
46.367403314918
|
| 9000746 |
Pentylone (hydrochloride)
|
|
17763-01-8 |
≥98%
|
|
|
2011-04-20
|
50.368140286714
|
pentylone-hydrochloride
|
|
mephedrone MDMA ecstasy neuroscience forensics designer drugs MDPV valerophenone 1-pentanone pentanone 698963-77-8 |
50.368140286714
|
| 13279 |
PF-3845
|
|
1196109-52-0 |
≥98%
|
|
|
2010-01-27
|
37.992885205648
|
pf-3845
|
|
fatty acids hydrolase FAAH N-acyl ethanolamines NAEs endocannabinoids N-arachidonoyl ethanolamine anandamide AEA inhibitors inhibits inflammation pain PF3845 PF 3845 cannabinoids cbs synthetic Antibodies Monoclonal
Monoclonal Antibodies |
37.992885205648
|
| 10010907 |
PF-622
|
|
898235-65-9 |
>98%
|
|
|
2008-03-26
|
6.383455163621
|
pf-622
|
|
FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain fatty acids amides hydrolases neurochemistry |
6.383455163621
|
| 10010908 |
PF-750
|
|
959151-50-9 |
>98%
|
|
|
2008-03-25
|
11.288732734806
|
pf-750
|
|
FAAH inhibitors inhibits inhibition cannabinoids depression anxiety inflammation pain neurochemistry |
11.288732734806
|
| 9000849 |
Phenazepam
|
|
51753-57-2 |
≥98%
|
|
|
2011-02-14
|
12.435635359116
|
phenazepam
|
Fenazepam; BD 98
|
benzodiazepine agonists GABAA receptors anxiolytic sedative anticonvulsive anti-convulsive anti convulsive hypnotic tranquilizers |
12.435635359116
|
| 71655 |
PHOP
|
|
288862-83-9 |
>98%
|
|
|
2005-02-02
|
10.937995264403
|
phop
|
Phenyl hexanoyl oxazolopyridine; CAY10402
|
FAAH fatty acids amides hydrolases inhibits inhibitors inhibition cannabinoids CB1 CB2 hydrolysis hydrolyze CAY-10402 TGH triacylglycerols neurochemistry neuroscience cbs synthetic |
10.937995264403
|
| 589751 |
Prion Protein EIA Kit
|
|
- |
|
|
|
|
15.008586556169
|
prion-protein-eia-kit
|
Prion Protein ELISA Kit
|
proteins mad cow diseases bovine spongiform scrapie Creutzfeldt-jakob neurodegeneration measures kits eias enzyme encephalopathy immunoassays ELISAs BSE spi-bio spibio A05201 assays |
15.008586556169
|
| 10009030 |
Prion Protein Monoclonal Antibody (11C6)
|
|
- |
|
|
|
2006-07-11
|
4.900552486187
|
prion-protein-monoclonal-antibody-11c6
|
|
proteins antibodies antisera antiserum spi-bio spibio A03212 WB western blots blotting immunoblotting EIA enzyme immunoassays FC flow cytometry |
4.900552486187
|
| 189710 |
Prion Protein Monoclonal Antibody (12F10)
|
|
- |
|
|
|
|
8.691298342541
|
prion-protein-monoclonal-antibody-12f10
|
|
proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob A3221 neurodegeneration antibodies antisera antiserum neurochemistry neuroscience spi-bio spibio WB western blots blotting immunoblotting IHC immunohistochemistry |
8.691298342541
|
| 189750 |
Prion Protein Monoclonal Antibody (308)
|
|
- |
|
|
|
|
6.868093922651
|
prion-protein-monoclonal-antibody-308
|
|
proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum neurochemistry neuroscience spi-bio spibio A03200 WB western blots blotting immunoblotting IHC immunohistochemistry |
6.868093922651
|
| 189760 |
Prion Protein Monoclonal Antibody (8G8)
|
|
- |
|
|
|
|
7.645027624309
|
prion-protein-monoclonal-antibody-8g8
|
|
proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antisera antiserum antibodies WB western blots blotting IHC immunohistochemistry neurochemistry neuroscience spi-bio spibio A03220 immunoblotting |
7.645027624309
|
| 10009034 |
Prion Protein Monoclonal Antibody (BAR221)
|
|
- |
|
|
|
2006-07-11
|
5.227255985267
|
prion-protein-monoclonal-antibody-bar221
|
|
proteins antibodies antisera antiserum spi-bio spibio A03222 WB western blots blotting immunoblotting EIA enzyme immunoassays FC flow cytometry IHC immunohistochemistry |
5.227255985267
|
| 10009035 |
Prion Protein Monoclonal Antibody (BAR224)
|
|
- |
|
|
|
2006-07-11
|
23.976427255985
|
prion-protein-monoclonal-antibody-bar224
|
|
proteins antibodies antisera antiserum spi-bio spibio A03211 WB western blots blotting immunoblotting EIA enzyme immunoassays FC flow cytometry IHC immunohistochemistry |
23.976427255985
|
| 10009036 |
Prion Protein Monoclonal Antibody (BAR233)
|
|
- |
|
|
|
2006-07-11
|
9.393738489871
|
prion-protein-monoclonal-antibody-bar233
|
|
proteins antibodies antisera antiserum spi-bio spibio A03223 WB western blots blotting immunoblotting EIA enzyme immunoassays FC flow cytometry |
9.393738489871
|
| 10009037 |
Prion Protein Monoclonal Antibody (BAR236)
|
|
- |
|
|
|
2006-07-11
|
5.227255985267
|
prion-protein-monoclonal-antibody-bar236
|
|
proteins antibodies antisera antiserum spi-bio spibio A03224 WB western blots blotting immunoblotting EIA enzyme immunoassays FC flow cytometry |
5.227255985267
|
| 189720 |
Prion Protein Monoclonal Antibody (SAF-32)
|
|
- |
|
|
|
|
28.570441988950
|
prion-protein-monoclonal-antibody-saf-32
|
|
proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt- jakob neurodegeneration antibodies antisera antiserum saf32 neurochemistry neuroscience spi-bio spibio A03202 WB western blots blotting immunoblotting IHC immunohistochemistry Enzyme-linked immunosorbent assays FC flow cytometry |
28.570441988950
|
| 189730 |
Prion Protein Monoclonal Antibody (SAF-53)
|
|
- |
|
|
|
|
5.552486187845
|
prion-protein-monoclonal-antibody-saf-53
|
|
proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum saf53 neurochemistry neuroscience spi-bio spibio A03203 Enzyme-linked immunosorbent assays FC flow cytometry |
5.552486187845
|
| 189740 |
Prion Protein Monoclonal Antibody (SAF-54)
|
|
- |
|
|
|
|
5.552486187845
|
prion-protein-monoclonal-antibody-saf-54
|
|
proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum saf54 neurochemistry neuroscience spi-bio spibio A03204 IHC immunohistochemistry |
5.552486187845
|
| 189755 |
Prion Protein Monoclonal Antibody (SAF-61)
|
|
- |
|
|
|
|
6.598756906077
|
prion-protein-monoclonal-antibody-saf-61
|
|
proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum saf61 neurochemistry neuroscience spi-bio spibio A03205 Enzyme-linked immunosorbent assays FC flow cytometry |
6.598756906077
|
| 189770 |
Prion Protein Monoclonal Antibody (SAF-70)
|
|
- |
|
|
|
|
7.645027624309
|
prion-protein-monoclonal-antibody-saf-70
|
|
proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt- A03206 jakob neurodegeneration antibodies SAFTO WB western blots blotting antisera antiserum neurochemistry neuroscience spi-bio spibio immunoblotting |
7.645027624309
|
| 189765 |
Prion Protein Monoclonal Antibody (SAF-83)
|
|
- |
|
|
|
|
8.691298342541
|
prion-protein-monoclonal-antibody-saf-83
|
|
proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum saf83 neurochemistry neuroscience spi-bio spibio A03207 WB western blots blotting immunoblotting Enzyme-linked immunosorbent assays FC flow cytometry |
8.691298342541
|
| 189775 |
Prion Protein Monoclonal Antibody (SAF-84)
|
|
- |
|
|
|
|
19.154005524862
|
prion-protein-monoclonal-antibody-saf-84
|
|
proteins mad cow diseases bovine spongiform encephalogathy scrapie Creutzfeldt-jakob neurodegeneration antibodies antisera antiserum saf84 neurochemistry neuroscience spi-bio spibio A03208 WB western blots blotting immunoblotting IHC immunohistochemistry |
19.154005524862
|
| 13621 |
Pristimerin
Exclusive |
|
1258-84-0 |
≥98%
|
|
✓ |
2010-03-08
|
42.875840568271
|
pristimerin
|
Celastrol methyl ester; NSC 99281
|
monoacylglycerol lipases MAGLs monoglycerol MGLs cannabinoids 2-arachidonoyl glycerol 2-AG inhibitor 2-Picenecarboxylic acids cannabinoids cbs synthetic Triterpenes |
42.875840568271
|
| 500940 |
Progranulin (human) EIA Kit
|
|
- |
|
|
|
2011-04-26
|
27.290078623034
|
progranulin-human-eia-kit
|
|
PGRN autocrine growth factor embryonic development tissues repair tumorigenesis inflammation signaling pathways cells cycles progressions motility precursor proteins secreted glycosylated forms proteolytic cleavages extracellular proteases peptides granulins GRNs paragranulin secretory leukocytes inhibitors SLPI periphery regulates regulation inflammatory cascade anti-inflammatory pro-inflammatory tumors necrosis factors receptors TNFRs TNF-alpha TNF-.alpha. TNF-a TNF-α TNFalpha TNF.alpha. TNFa TNFα pathogenesis arthritis mice mouse serum visceral obesity plasma glucose dyslipidemia central nervous systems CNSs neurotrophic activity neuroinflammation mutations genes chromosomes 17 frontotemporal lobar degeneration FTLD dementia marker chronic ELISAs EIAs enzymes immunoassays immunometrics assays cultures supernatants |
27.290078623034
|
| 500950 |
Progranulin (mouse) EIA Kit
|
|
- |
|
|
|
2011-04-26
|
36.071109064866
|
progranulin-mouse-eia-kit
|
|
murine mice PGRN autocrine growth factor embryonic development tissues repair tumorigenesis inflammation signaling pathways cells cycles progressions motility precursor proteins secreted glycosylated forms proteolytic cleavages extracellular proteases peptides granulins GRNs paragranulin secretory leukocytes inhibitors SLPI periphery regulates regulation inflammatory cascade anti-inflammatory pro-inflammatory tumors necrosis factors receptors TNFRs TNF-alpha TNF-.alpha. TNF-a TNF-α TNFalpha TNF.alpha. TNFa TNFα pathogenesis arthritis mice mouse serum visceral obesity plasma glucose dyslipidemia central nervous systems CNSs neurotrophic activity neuroinflammation mutations genes chromosomes 17 frontotemporal lobar degeneration FTLD dementia marker chronic ELISAs EIAs enzymes immunoassays immunometrics assays cultures supernatants |
36.071109064866
|
| 12010 |
Prostaglandin D2
|
|
41598-07-6 |
>99%
|
|
|
|
180.514980639373
|
prostaglandin-d2
|
PGD2
|
Vasodilation prostaglandins brain sleep platelets aggregation. H-PGDS synthases mast cells hematopoietic allergic allergy asthmatic anaphylaxis hypotension inhibits inhibitors inhibition beta-trace .beta.-trace b-trace neurochemistry |
180.514980639373
|
| 12015 |
Prostaglandin D2-1-glyceryl ester
|
|
309260-52-4 |
>95% (as a 9:1 mixture of the 1- and 2-glyceryl esters)
|
|
|
2004-08-05
|
35.607513812154
|
prostaglandin-d2-1-glyceryl-ester
|
PGD2-1-glyceryl ester
|
endocannabinoids anandamides 2AG fatty acids porcine brain isomerase moiety cannabinoids cbs synthetic |
35.607513812154
|
| 312010 |
Prostaglandin D2-d4
|
|
- |
≥99% deuterated product
|
|
|
|
55.610165745856
|
prostaglandin-d2-d4
|
PGD2-d4
|
GC/MS deuterium isotopes PGD2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience |
55.610165745856
|
| 10007272 |
Prostaglandin D2-d4 Lipid Maps MS Standard
|
|
- |
≥99% deuterated compound
|
|
|
2009-02-26
|
47.598011049723
|
prostaglandin-d2-d4-lipid-maps-ms-standard
|
PGD2-d4
|
GC/MS deuterium isotopes PGD2-d4 internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience MS mass spectrometry standards |
47.598011049723
|
| 10010123 |
Prostaglandin D2-d9
|
|
- |
≥99% deuterated product
|
|
|
2007-10-25
|
93.132005831798
|
prostaglandin-d2-d9
|
PGD2-d9
|
GC/MS deuterium isotopes internal standards prostaglandins deuterated LC/MS GC-MS LC-MS mass spectrometry neurochemistry neuroscience allergy asthma |
93.132005831798
|
| 512031 |
Prostaglandin D2 EIA Kit
|
|
- |
|
|
|
2010-07-19
|
268.101938305709
|
prostaglandin-d2-eia-kit
|
PGD2 ELISA Kit
|
PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions |
268.101938305709
|
| 12012 |
Prostaglandin D2 Ethanolamide
|
|
398138-28-8 |
>96%
|
|
|
|
29.102312549329
|
prostaglandin-d2-ethanolamide
|
PGD2-EA
|
anandamides ethanolamides cannabinoids PGD2 prostaglandins AEA neurochemistry neuroscience ethanolamines prostamides |
29.102312549329
|
| 10007203 |
Prostaglandin D2 Ethanolamide Lipid Maps MS Standard
|
|
398138-28-8 |
>96%
|
|
|
2008-10-29
|
28.541617995264
|
prostaglandin-d2-ethanolamide-lipid-maps-ms-standard
|
PGD2-EA
|
anandamides ethanolamides cannabinoids PGD2 prostaglandins AEA neurochemistry neuroscience ethanolamines prostamides GC LC mass spectrometry MS standards |
28.541617995264
|
| 512041 |
Prostaglandin D2 Express EIA Kit
|
|
- |
|
|
|
2010-07-19
|
125.652167445813
|
prostaglandin-d2-express-eia-kit
|
PGD2 Express ELISA Kit
|
PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions |
125.652167445813
|
| 10192 |
Prostaglandin D2 serinol amide
|
|
- |
>98%
|
|
|
2004-05-13
|
39.763292817680
|
prostaglandin-d2-serinol-amide
|
PGD2-SA
|
PGD2 vasodilation prostaglandins brain sleep platelets aggregation anandamides serinols amides cannabinoids AEA |
39.763292817680
|
| 10006593 |
Prostaglandin D Synthase (hematopoietic-type; human recombinant)
|
|
- |
≥95%
|
|
|
2005-02-16
|
34.087328334649
|
prostaglandin-d-synthase-hematopoietic-type-human-recombinant
|
Hematopoietic-PGDS; H-PGDS; PGD Synthase (hematopoietic-type; human recombinant)
|
prostaglandins synthases PGDs PGD2 HPGDS H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators |
34.087328334649
|
| 10009625 |
Prostaglandin D Synthase (hematopoietic-type; human recombinant) Western Ready Control
|
|
- |
|
|
|
2007-07-19
|
24.699454419889
|
prostaglandin-d-synthase-hematopoietic-type-human-recombinant-western-ready-control
|
Hematopoietic-PGDS; H-PGDS
|
western blot WB PGH2 lipocalin-type hematopoietic peripheral tisses antigen-presenting cells mast megakaryocytes allergic HPGDS H-PGDS inflammatory diseases inhibits inhibitor inhibition E. coli |
24.699454419889
|
| 10004347 |
Prostaglandin D Synthase (hematopoietic-type; mouse recombinant)
Exclusive |
|
- |
≥85%
|
|
✓ |
2008-06-05
|
33.098225905463
|
prostaglandin-d-synthase-hematopoietic-type-mouse-recombinant
|
H-PGDS; Hematopoietic-PGDS
|
PGH2 lipocalin-type .beta.-trace prostaglandins hematopoietic enzymes PGD2 proteins recombinant inflammation activity high throughput screening inhibitors inhibits inhibition assays HPGDS H-PGDS |
33.098225905463
|
| 10007684 |
Prostaglandin D Synthase (lipocalin-type; human) EIA Kit
Exclusive |
|
- |
|
|
✓ |
2008-06-09
|
18.893540515653
|
prostaglandin-d-synthase-lipocalin-type-human-eia-kit
|
Lipocalin-PGDS ELISA Kit; L-PGDS EIA Kit
|
EIAs ELISAs Assays sandwich immunometric homodimer glycosylation catalyzes prostaglandins PGH2 PGD2 carrier proteins lipid-like molecules neurochemistry retinoids thyroid hormones body fluids cerebrospinal seminal plasma PTGDS beta-trace b-trace .beta.-trace betatrace btrace lpgds l-pgds assays |
18.893540515653
|
| 10004342 |
Prostaglandin D Synthase (lipocalin-type; human) Monoclonal Antibody (Clone 10A5)
|
|
- |
|
|
|
2004-03-04
|
26.870538674033
|
prostaglandin-d-synthase-lipocalin-type-human-monoclonal-antibody-clone-10a5
|
Lipocalin-PGDS; L-PGDS
|
prostaglandins inhibitors renal failure synthases lpgds antibodies antisera antiserum wb ihc western blots blotting immunohistochemistry b-trace beta-trace .beta.-trace l-pgds immunoblotting |
26.870538674033
|
| 10006788 |
Prostaglandin D Synthase (lipocalin-type; human recombinant)
|
|
- |
≥95%
|
|
|
2005-03-23
|
39.367700605103
|
prostaglandin-d-synthase-lipocalin-type-human-recombinant
|
L-PGDS; Lipocalin-PGDS
|
prostaglandins synthases PGDs PGD2 H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators neurochemistry lpgds l-pgds |
39.367700605103
|
| 10009741 |
Prostaglandin D Synthase (lipocalin type; human) Western Ready Control
|
|
- |
|
|
|
2007-04-30
|
6.126104972375
|
prostaglandin-d-synthase-lipocalin-type-human-western-ready-control
|
L-PGDS; Lipocalin-PGDS
|
GST lpgds l-pgds western blot WB neurochemistry hL-PGDS hLPGDS |
6.126104972375
|
| 10004344 |
Prostaglandin D Synthase (lipocalin-type; mouse) Polyclonal Antibody
|
|
- |
|
|
|
2004-03-10
|
7.867237569060
|
prostaglandin-d-synthase-lipocalin-type-mouse-polyclonal-antibody
|
L-PGDS; Lipocalin-PGDS
|
prostaglandins inhibitors renal failure synthases antibodies antisera antiserum wb ihc western blots blotting immunohistochemistry lpgds l-pgds immunoblotting |
7.867237569060
|
| 10006787 |
Prostaglandin D Synthase (lipocalin-type; mouse recombinant)
|
|
- |
≥95%
|
|
|
2005-03-23
|
41.216685082873
|
prostaglandin-d-synthase-lipocalin-type-mouse-recombinant
|
L-PGDS; Lipocalin-PGDS
|
prostaglandins synthases PGDs PGD2 H-PGDS enzymes peripheral tissues antigen-presenting cells mast megakaryocytes glutathiones glutathione-S-transferases allergen allergy allergic mediators neurochemistry lpgds l-pgds |
41.216685082873
|
| 160003 |
Prostaglandin D Synthase (lipocalin-type) Polyclonal Antibody
|
|
- |
|
|
|
|
29.164076120319
|
prostaglandin-d-synthase-lipocalin-type-polyclonal-antibody
|
L-PGDS; Lipocalin-PGDS
|
antibodies human pgds synthases western blots blotting prostaglandins pgd2 antisera antiserum wb lpgds l-pgds immunoblotting |
29.164076120319
|
| 10010548 |
Prostaglandin D Synthase (lipocalin-type; rat recombinant)
Exclusive |
|
- |
≥95%
|
|
✓ |
2008-07-01
|
38.236034849129
|
prostaglandin-d-synthase-lipocalin-type-rat-recombinant
|
L-PGDS; Lipocalin-PGDS
|
prostaglandins PGH2 beta-trace b-trace proteins assays neurochemistry rL-PGDS rlPGDS .beta.-trace beta-trace b-trace recombinant human cerebrospinal fluid PGs CSF GST-tags GST-tagged N-terminal lpgds l-pgds |
38.236034849129
|
| 13012 |
Prostaglandin E1 Ethanolamide
|
|
210976-81-1 |
>98%
|
|
|
|
37.707145488030
|
prostaglandin-e1-ethanolamide
|
PGE1-EA; Alprostadil Ethanolamide
|
anandamides ethanolamides cannabinoids PGE1 prostaglandins AEA neurochemistry neuroscience ethanolamines prostamides |
37.707145488030
|
| 10140 |
Prostaglandin E2-1-glyceryl ester
|
|
37497-47-5 |
>98% (as a 85:15 mixture of the 1- and 2-glyceryl esters)
|
|
|
|
48.040865561694
|
prostaglandin-e2-1-glyceryl-ester
|
PGE2-1-glyceryl ester
|
Prostaglandins PGE2-1-GE esters 2-AG 2-arachidonyl-glycerol metabolites COX-2 PGHS-2 cycloxygenases synthases PGE2-2-GE COX2 PGHS2 cannabinoids cbs synthetic |
48.040865561694
|
| 14012 |
Prostaglandin E2 Ethanolamide
Exclusive |
|
194935-38-1 |
>98%
|
|
✓ |
|
40.204841160221
|
prostaglandin-e2-ethanolamide
|
PGE2-EA; Dinoprostone Ethanolamide; Prostamide E2
|
anandamides ethanolamides cannabinoids PGE2 prostaglandins AEA analogs neurochemistry neuroscience ethanolamines prostamides |
40.204841160221
|
| 10007212 |
Prostaglandin E2 Ethanolamide Lipid Maps MS Standard
|
|
194935-38-1 |
>98%
|
|
|
2008-11-05
|
31.647041129527
|
prostaglandin-e2-ethanolamide-lipid-maps-ms-standard
|
Dinoprostone Ethanolamide; Prostamide E2; PGE2-EA
|
anandamides ethanolamides cannabinoids PGE2 prostaglandins AEA analogs neurochemistry neuroscience ethanolamines prostamides GC-MS GC/MS LC-MS LC/MS mass spectromatory standards |
31.647041129527
|
| 10193 |
Prostaglandin E2 serinol amide
Exclusive |
|
- |
≥98%
|
|
✓ |
2004-03-03
|
36.258397790055
|
prostaglandin-e2-serinol-amide
|
PGE2-SA
|
PGE2SA cannabinoids agonists CB1 receptors analogs 2-glyceryl neurochemistry neuroscience |
36.258397790055
|
| 10139 |
Prostaglandin F2α-1-glyceryl ester
|
|
43042-79-1 |
>98% (as a 9:1 mixture of the 2- and 1-glyceryl esters)
|
|
|
|
16.060359116022
|
prostaglandin-f2-1-glyceryl-ester
|
PGF2α-1-glyceryl ester
|
Prostaglandins PGF2alpha-1-GE PGF2.alpha.-1-GE esters 2-AG 2-arachidonoyl-glycerol COX-2 metabolites cyclooxygenases PGHS-2 synthases PGHS2 COX2 PGF2alpha-2-GE PGF2.alpha.-2-GE PGFa-2-GE PGF2a-1-GE cannabinoids cbs synthetic |
16.060359116022
|
| 10194 |
Prostaglandin F2α serinol amide
|
|
- |
>98%
|
|
|
2004-02-23
|
13.622338858195
|
prostaglandin-f2-serinol-amide
|
PGF2α-SA
|
PGF2alphaSA PGF2.alpha.SA PGF2alpha-SA PGF2.alpha.-SA cannabinoids agonists CB1 recptors analogs 2-glyceryl esters amides neuroscience |
13.622338858195
|
| 160630 |
Prostaglandin I Synthase Monoclonal Antibody (Clone isn-1)
|
|
- |
Protein-A purified
|
|
|
|
5.170662983425
|
prostaglandin-i-synthase-monoclonal-antibody-clone-isn-1
|
Prostacyclin Synthase; PGIS; PGI Synthase
|
synthases endothelium PGI2 prostaglandins antibodies antisera antiserum Bovine PGI synthase atherosclerosis neurochemistry IP immunoprecipitation IHC immunohistochemistry |
5.170662983425
|
| 100023 |
Prostaglandin I Synthase (murine) Polyclonal Antibody
|
|
- |
|
|
|
2004-06-30
|
10.323301104972
|
prostaglandin-i-synthase-murine-polyclonal-antibody
|
PGIS; Prostacyclin Synthase; PGI Synthase
|
antibodies antisera antiserum western blots blotting wb IHC immunohistochemistry prostaglandins prostacyclins synthases receptors atherosclerosis immunoblotting |
10.323301104972
|
| 160640 |
Prostaglandin I Synthase Polyclonal Antibody
|
|
- |
|
|
|
|
8.795432780847
|
prostaglandin-i-synthase-polyclonal-antibody
|
Prostacyclin Synthase; PGIS; PGI Synthase
|
PGIS prostacyclin synthases endothelium Western blots PGI2 prostaglandins blotting antisera antiserum immunoprecipitation IP antibodies atherosclerosis WB immunoblotting |
8.795432780847
|
| 10011435 |
PSD95 Monoclonal Antibody (Clone 6G6)
|
|
- |
|
|
|
2008-05-07
|
1.906077348066
|
psd95-monoclonal-antibody-clone-6g6
|
Postsynaptic Density Protein 95
|
antibodies ICC WB western blots immunocytochemistry proteins neurochemistry neurons memory learning neuronal AMPA immunoblotting autism TARPs blotting |
1.906077348066
|
| 10011436 |
PSD95 Monoclonal Antibody (Clone 7E3)
|
|
- |
|
|
|
2008-05-07
|
0.953038674033
|
psd95-monoclonal-antibody-clone-7e3
|
Postsynaptic Density Protein 95
|
antibodies WB western blots proteins neurochemistry neuronal neurons synapse memory learning PSD-95 immunoblotting receptors TARPs AMPA autism PSD 95 blotting |
0.953038674033
|
| 10009506 |
PSD95 Polyclonal Antibody
|
|
- |
|
|
|
2007-01-03
|
0.347645558861
|
psd95-polyclonal-antibody
|
Postsynaptic Density Protein of 95
|
antibodies WB western blot PDZ domain glutamate receptors signaling proteins synapse NMDAR phosphorylation proteins signalling blotting immunoblotting |
0.347645558861
|
| 10008594 |
PSN632408
Exclusive |
|
857652-30-3 |
>98%
|
|
✓ |
2006-08-01
|
84.541160220994
|
psn632408
|
|
GPR119 SNORF25 agonists oleoylethanolamide OEA obesity appetite food intake GPCR G protein-coupled receptors PSN632408 weight gain pancreas gastrointestinal tract brain endocrinology neurochemistry |
84.541160220994
|
| 10817 |
Pyrovalerone
Exclusive |
|
3563-49-3 |
≥95%
|
|
✓ |
2011-05-25
|
40.680014376032
|
pyrovalerone
|
Thymergix; Centroton; Valerophenone
|
inhibitors neurotransmitters dopamine norepinephrine controlled substances forensic analysis forensics bath salts 10836 valerophenone |
40.680014376032
|
| 10836 |
Pyrovalerone (hydrochloride)
|
|
1147-62-2 |
≥95%
|
|
|
2011-05-24
|
45.364385875727
|
pyrovalerone-hydrochloride
|
Centroton; Thymergix
|
inhibitors neurotransmitters dopamine norepinephrine controlled substances forensic analysis forensics bath salts inhibition 10817 free base inhibits 3563-49-3 |
45.364385875727
|
| 90070 |
R-1 Methanandamide
|
|
157182-49-5 |
>98%
|
|
|
|
20.680584056827
|
r-1-methanandamide
|
(R)-(+)-Arachidonyl-1'-Hydroxy-2'-Propylamide; AM356
|
cannabinoids neurotransmitters ligand AEA lipids CB1 CB2 receptor anandamide analogs agonists neurochemistry neuroscience |
20.680584056827
|
| 10004281 |
R-1 Methanandamide Phosphate
|
|
- |
>98%
|
|
|
2004-08-20
|
17.891049723757
|
r-1-methanandamide-phosphate
|
R-1MAP; (R)-(+)-Arachidonyl-1'-Hydroxy-2'-Propylamide Phosphate
|
endocannabinoids neurotransmitters ligands AEA lipids CB1 CB2 receptors anandamides analogs agonists phosphates LPA lysophatidic acids neurochemistry neuroscience R1 cannabinoids cbs synthetic |
17.891049723757
|
| 90074 |
R-2 Methanandamide
|
|
- |
>98%
|
|
|
|
9.283011049724
|
r-2-methanandamide
|
(R)-(-)-Arachidonyl-2'-Hydroxy-1'-Propylamide
|
cannabinoids neurotransmitter AEA lipids CB1 CB2 receptors anandamide analogs neurochemistry neuroscience |
9.283011049724
|
| 10491 |
(R)-AM1241
Exclusive |
|
444912-51-0 |
≥98%
|
|
✓ |
2010-05-27
|
39.482488234090
|
-r-am1241
|
(+)-AM1241
|
cannabinoids CB2 receptors CB1 agonists inverse agonists antinociception pains SR144528 rimonabant CBs |
39.482488234090
|
| 10645 |
RCS-4
|
|
- |
≥98%
|
|
|
2010-11-24
|
127.480315197521
|
rcs-4
|
|
cannabinoids receptors JWHs 018 CB1 CB2 cannabimimetics forensics CBs neurochemistry cannabinoids cbs synthetic |
127.480315197521
|
| 10865 |
RCS-4 2-methoxy isomer
|
|
- |
≥98%
|
|
|
2011-06-15
|
54.039667490549
|
rcs-4-2-methoxy-isomer
|
|
synthetic cannabinoids forensics receptors herbal spices incense JWH 250 JWH-250 JWH250 RCS4 RCS 4 analogs CB1 CB2 cannabimimetic indoles CBs |
54.039667490549
|
| 10866 |
RCS-4 3-methoxy isomer
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-06-15
|
45.111948033066
|
rcs-4-3-methoxy-isomer
|
|
cannabinoids receptors JWH 018 CB1 CB2 CBs cannabimimetics forensics synthetic bath salts JWH-018 JWH018 |
45.111948033066
|
| 10798 |
RCS-4-C4 homolog
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-04-21
|
58.428009777551
|
rcs-4-c4-homolog
|
BTM-4; SR-19; OBT-199; E-4
|
cannabinoids cannabimimetic metabolites CB1 CB2 receptors agonists spice forensics synthetics smoking urinary urine serum JWH018 JWH 018 JWH-018 JWH18 BTM4 BTM 4 E4 E 4 OBT199 OBT 199 SR19 SR 19 |
58.428009777551
|
| 10513 |
RCS-4-d9
New |
|
- |
≥99% deuterated product
|
|
|
2011-09-12
|
44.447019892911
|
rcs-4-d9
|
|
cannabinoids receptors JWHs 018 CB1 CB2 cannabimimetics forensics sciences CBs neurochemistry synthetic standards deuterated deuterium mass spectrometry LC-MS LC/MS GC-MS GC/MS MS |
44.447019892911
|
| 10935 |
RCS-4 N-(5-hydroxypentyl) metabolite
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-06-17
|
45.618204419889
|
rcs-4-n-5-hydroxypentyl-metabolite
|
|
cannabinoids cannabimimetic metabolites CB1 CB2 CBs receptors agonists spices forensics synthetic smoking urinary urine RCS4 RCS 4 JWHs glucuroconjugate forensics sciences neuroscience |
45.618204419889
|
| 10636 |
RCS-8
Exclusive |
|
- |
≥98%
|
|
✓ |
2010-11-02
|
110.680693566903
|
rcs-8
|
SR-18
|
cannabinoids receptors JWH 250 CB1 CB2 cannabimimetics forensics cannabinoids cbs synthetic Rabbit Aorta Contracting Substance
A2 Thromboxane Thromboxane A2 |
110.680693566903
|
| 10012554 |
Resolvin D1
Exclusive |
|
872993-05-0 |
≥95%
|
|
✓ |
2008-06-06
|
256.881973164956
|
resolvin-d1
|
RvD1; 17(S)-Resolvin D1
|
EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins |
256.881973164956
|
| 70255 |
(R)-Flurbiprofen
|
|
51543-40-9 |
≥99%
|
|
|
2004-06-11
|
5.745256511444
|
-r-flurbiprofen
|
E-7869; Tarenflurbil; Flurizan
|
cyclooxygenases inhibitors NSAIDs COX-1 COX-2 nonsteroidal anti-inflammatory drugs cox1 cox2 pghs1 pghs2 pghs-1 pghs-2 prostaglandin H synthases synthase-1 synthase-2 inhibits inhibition neurochemistry |
5.745256511444
|
| 10009411 |
Ribosomal S6 Kinase 2 Polyclonal Antibody
|
|
- |
|
|
|
2006-11-28
|
0E-12
|
ribosomal-s6-kinase-2-polyclonal-antibody
|
RSK2
|
wb western blotting blots antibodies p90 kinases RSK1 RSK2 RSK3 RSK4 downstream members extracellular signal-regulated ERK/MAPK cascade humans Coffin-Lowry syndrome mental retardation growth deficits defects tonic regulation GPCRs G protein-coupled signalling immunoblotting |
0E-12
|
| 9000484 |
Rimonabant
|
|
168273-06-1 |
≥98%
|
|
|
2009-06-17
|
70.164019337016
|
rimonabant
|
SR141716
|
SR 141716A SR141716A CB1 inverse agonists anti-obesity immunomodulation anti-proliferation appetite suppressants receptors weight control medication cannabinoids anti-proliferative immunodulatory cbs sythetic |
70.164019337016
|
| 10011132 |
Rolipram
|
|
61413-54-5 |
≥98%
|
|
|
2008-12-16
|
11.821048563680
|
rolipram
|
ZK 62711; SB 95952
|
inhibits inhibitor inhibition phosphodiesterase PDE4 cAMP inflammation leukocyte LPS TNF monocytes C5a LTC4 eosinophil neurons bones loss |
11.821048563680
|
| 90353 |
R-Palmitoyl-(1-methyl) Ethanolamide
|
|
142128-47-0 |
>98%
|
|
|
|
5.706824829379
|
r-palmitoyl-1-methyl-ethanolamide
|
R-1 PMA
|
PEA AEA ethanolamides R-1-PMA cannabinoids analogs (R)-methyl ethanolamines inhibitors inhibits CB2 receptors neurochemistry neuroscience |
5.706824829379
|
| 90357 |
R-Palmitoyl-(2-methyl) Ethanolamide
|
|
179951-56-5 |
>98%
|
|
|
|
5.360389809699
|
r-palmitoyl-2-methyl-ethanolamide
|
RP-2ME
|
PEA cannabinoids analogs anandamides methanandamides CB2 receptors ethanolamides inhibits inhibitors (R)-N-(2-hydroxypropyl)-hexadecanamide FAAH fatty acids hydrolases agonists neurochemistry neuroscience ethanolamines |
5.360389809699
|
| 10009227 |
(R)-SLV 319
|
|
656827-86-0 |
>98%
|
|
|
2007-09-05
|
0.216408839779
|
-r-slv-319
|
|
CB1 CB2 receptors cannabinoids antagonists inflammation |
0.216408839779
|
| 90072 |
S-1 Methanandamide
|
|
- |
>98%
|
|
|
|
9.503867403315
|
s-1-methanandamide
|
(S)-(-)-Arachidonyl-1'-Hydroxy-2'-Propylamide
|
cannabinoids neurotransmitters ligand AEA lipids CB1 CB2 receptors anandamides analogs agonists neurochemistry neuroscience |
9.503867403315
|
| 90076 |
S-2 Methanandamide
|
|
- |
>98%
|
|
|
|
18.562338858195
|
s-2-methanandamide
|
(S)-(+)-Arachidonyl-2'-Hydroxy-1'-Propylamide
|
cannabinoids neurotransmitter ligand AEA lipid CB1 CB2 receptors anandamide analogs agonists neurochemistry neuroscience |
18.562338858195
|
| 13603 |
S-Adenosylhomocysteine
|
|
979-92-0 |
≥98%
|
|
|
2010-04-22
|
9.582690607734
|
s-adenosylhomocysteine
|
SAH; AdoHcy
|
amino acids derivatives cysteine methyl cycle biosynthesis risk factors metabolic pathways cancers by-products by products neurodegenerative diseases Adenosylhomocysteine, S
S-Adenosylhomocysteine
S Adenosylhomocysteine |
9.582690607734
|
| 10490 |
(S)-AM1241
Exclusive |
|
444912-53-2 |
≥98%
|
|
✓ |
2010-05-27
|
44.391381093392
|
-s-am1241
|
(-)-AM1241
|
cannabinoids CB2 receptors CB1 agonists inverse agonist antinociception pains SR144528 rimonabant CBs |
44.391381093392
|
| 10096 |
SB 242084 (hydrochloride)
|
|
1049747-87-6 |
≥98%
|
|
|
2010-06-29
|
4.652028413575
|
sb-242084-hydrochloride
|
|
181632-25-7 serotonins 5-hydroxytryptamines 5-HT neurotransmitters neuroscience receptors gut central nervous system antagonists 5-HT2C dopamine adrenergic receptors brain anxiolytic neurochemistry CNS Antigens HLA-SB Antigens HLA-PL Antigens HLA-DP
HLA-SB Antigens HLA-PL Antigens HLA-DP Antigens
HLA SB Antigens HLA PL Antigens HLA DP Antigens
HLA-SB HLA-PL HLA-DP |
4.652028413575
|
| 11019 |
SB 366791
New |
|
472981-92-3 |
≥98%
|
|
|
2011-10-13
|
5.295556823889
|
sb-366791
|
|
pain TRPV1 antagonists hyperalgesia receptors neurons central peripheral nerves terminals thermal mechanical hyperalgesia bone cancers ganglion SB366791 SB-366791 |
5.295556823889
|
| 14060 |
SC-19220
|
|
19395-87-0 |
>96%
|
|
|
|
62.085182320441
|
sc-19220
|
|
PGE2 antagonists antinociceptives EP1 receptors selective prostaglandins SC19220 SC 19220 |
62.085182320441
|
| 10767 |
SETD2 (human recombinant)
New |
|
- |
≥95%
|
|
|
2012-01-19
|
81.098823852129
|
setd2-human-recombinant
|
p231HBP; Huntington Interacting Protein B; HYPB; KMT3A
|
epigenetics histones methyltransferases SET-domains containing SETD-2 SETD 2 huntingtin interacting proteins b HYBP trimethylation H3K36me3 mouse fibroblasts cells mono-methylation di-methylation WW hyperphosphorylation RNA polymerase II regulation diseases |
81.098823852129
|
| 13332 |
(S)-Glycyl-H-1152 (hydrochloride)
Exclusive |
|
913844-45-8 |
≥98%
|
|
✓ |
2010-01-27
|
51.846950276243
|
-s-glycyl-h-1152-hydrochloride
|
Rho Kinase Inhibitor IV
|
Rho kinases ROCK-I p160ROCK ROCK-II G protein Rho cytoskeletons adhesions proliferation smooth muscles contraction stem cells inhibitors inhibition inhibited Fasudil hydrochloride ROCK IV h1152 h-1152 h 1152 |
51.846950276243
|
| 10009312 |
SKF-96365 (hydrochloride)
|
|
130495-35-1 |
>98%
|
|
|
2007-01-19
|
49.686806629834
|
skf-96365-hydrochloride
|
|
calcium antagonists voltage-gated inhibits inhibitors inhibition acetylcholine-induced depolarization smooth muscles platelets neutrophils SFK9635 Ach-induced HCl neurochemistry |
49.686806629834
|
| 10009226 |
(±)-SLV 319
Exclusive |
|
362519-49-1 |
>98%
|
|
✓ |
2007-01-16
|
21.822596685082
|
-slv-319
|
|
CB1 CB2 Receptors Cannabinoids Antagonists Inflammations inflammatory neurochemistry lipophilic ligands cannabinoids cbs synthetic |
21.822596685082
|
| 10006518 |
S-Nitrosylated Protein Detection Kit
|
|
- |
|
|
|
2005-11-29
|
169.887066707591
|
s-nitrosylated-protein-detection-kit
|
SNO Detection
|
NOs nitric oxides synthases oxidation oxidative reactive nitrogen species RNS thiol SH groups signalling proteins kits measures measurements S-nitrosation nitrosation S-nitrosylation nitrosylation assays |
169.887066707591
|
| 700330 |
Sphingomyelinase Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2010-02-09
|
37.411236516705
|
sphingomyelinase-inhibitor-screening-assay-kit
|
SMase
|
assays kits measures measuring measurementsphingomyelinases SMases hydrolases enzymes sphingolipids metabolisms DNase I superfamily phosphocholines ceramides cellular cells stress pathophysiological lysosomal digestion ceramide-mediated signal transductions cytokine-induced apoptosis differentiation immune inflammatory lipoproteins aggregation vessels atherogenesis intracellular trafficking acidic neutral proliferation depressive disorders neurodegenerative disorders strokes Alzheimer's dementia diseases therapeutics cleavage conjugates free thiols |
37.411236516705
|
| 9000491 |
SR 144528
|
|
192703-06-3 |
≥98%
|
|
|
2009-08-05
|
71.692483118478
|
sr-144528
|
|
antagonist CB1 CB2 cannabinoids receptors inverse agonist inflammation leukocytes CP 55940 CP55940 55,940 CP55,940 pain initiation suppression immune activation sr144528 CBs synthetic |
71.692483118478
|
| 10683 |
SR 16584
New |
|
1150153-86-8 |
≥95%
|
|
|
2011-11-17
|
47.778732351136
|
sr-16584
|
|
antagonists receptors nicotinic acetylcholine receptors neuroscience nAChRs ligands ion channels central peripheral nerves nervous system subtypes SR-16584 SR16584 α3β4 α4β2 α7 |
47.778732351136
|
| 10009022 |
(S)-SLV 319
Exclusive |
|
464213-10-3 |
>98%
|
|
✓ |
2007-08-16
|
0.216408839779
|
-s-slv-319
|
|
CB1 CB2 receptors cannabinoids antagonists inflammation obesity neurochemistry inflammatory neuro-inflammatory neuroinflammatory (S)-SLV319 disorders ligands |
0.216408839779
|
| 90245 |
Stearoyl Ethanolamide
|
|
111-57-9 |
>98%
|
|
|
|
12.535421270718
|
stearoyl-ethanolamide
|
Stearic Acid Ethanolamide; Ceramid
|
anandamides N-acyl ethanolamines PLD fatty acids neurochemistry neuroscience ethanolamides |
12.535421270718
|
| 583751 |
Substance P EIA Kit
|
|
- |
|
|
|
|
243.551643646408
|
substance-p-eia-kit
|
Substance P ELISA Kit
|
solid plates Substance-P Sub-P neurokinin measures kits eias enzyme immunoassays ELISAs pain endocrinology neurochemistry neuroscience assays |
243.551643646408
|
| 10606 |
Synapsin I Polyclonal Antibody
|
|
- |
|
|
|
2009-10-23
|
3.504143646408
|
synapsin-i-polyclonal-antibody
|
|
gamma inhibits inhibitors neurotransmitters WB western blots blotting enzymes synthesis plasticity brain IHC IF IP immunohistochemistry immunoprecipitation immunofluorescence |
3.504143646408
|
| 10605 |
Synapsin I Polyclonal Antibody (neat serum)
|
|
- |
|
|
|
2009-10-23
|
0.386740331491
|
synapsin-i-polyclonal-antibody-neat-serum
|
|
gamma inhibits inhibitors neurotransmitters WB western blots blotting enzymes synthesis plasticity brain |
0.386740331491
|
| 13830 |
Synthetic Cannabinoid HPLC Mixture I
|
|
- |
≥95% for each compound
|
|
|
2010-05-13
|
39.243082614455
|
synthetic-cannabinoid-hplc-mixture-i
|
|
cannabinoids CBs endocannabinoids cannabidiols CP-47,497 cp 47,497 47,497-c8-homolog CP-47,497-C8 homolog analog CP-55,940 cp47,497 cp55,940 cp 55,940 HU-331 HU331 HU 331 HU308 HU 308 HU-308 JWH-015 jwh015 jwh 015 jwh 018 jwh018JWH-018 JWH-200 jwh200 jwh 200 jwh 250 jwh250 JWH-019 Win-55212-2 Jwh-250 win 55212-2 win55212 2 synthetic spices mixes synthetic |
39.243082614455
|
| 13850 |
Synthetic Cannabinoid HPLC Mixture II
|
|
- |
≥95% for each compound
|
|
|
2010-12-21
|
39.551017802333
|
synthetic-cannabinoid-hplc-mixture-ii
|
|
cannabinoids CBs synthetics mixtures receptors agonists synthetic |
39.551017802333
|
| 11337 |
Synthetic Cannabinoid HPLC Mixture V (AM Series)
New |
|
- |
≥95% for each compound
|
|
|
2012-02-02
|
101.640890116636
|
synthetic-cannabinoid-hplc-mixture-v-am-series
|
|
AM series AM-2201 AM-1220 AM-630 AM-1241 AM-694 AM-2233 AM2201 AM1220 AM630 AM1241 AM694 CBs cannbinoids mixtures AM2233 |
101.640890116636
|
| 70240 |
Tacrine (hydrochloride)
|
|
1684-40-8 |
>98%
|
|
|
|
7.605985267035
|
tacrine-hydrochloride
|
Romotal; Cognex
|
acetylcholinesterase inhibitors Alzheimer's disease serotonin noradrenalin AChE enzyme immunoassay reagents neurochemistry neuroscience |
7.605985267035
|
| 10009911 |
Tangeritin
|
|
481-53-8 |
≥98%
|
|
|
2008-12-16
|
11.958232044199
|
tangeritin
|
Ponkanetin; NSC 618905; NSC 53909
|
flavone cancers tumors cholesterol atherosclerosis ERKs p38 MAPKs JNKs AKTs LDLs triacylglycerol estradiol MDR1 pregnane X receptors IL-1 IL1 IL 1 melanoma insulinoma |
11.958232044199
|
| 11190 |
Termitomycamide B
New |
|
1254277-89-8 |
≥97%
|
|
|
2012-01-31
|
173.333333333333
|
termitomycamide-b
|
|
mushrooms extracts ER stress apoptosis endoplasmic reticulum neuroscience proteins misfolding Parkinson’s diseases Alzheimer’s prions fatty acids cells death termites termitomycamides Termitomyces titanicus Neuro2a |
173.333333333333
|
| 11191 |
Termitomycamide E
New |
|
1177258-62-6 |
≥98%
|
|
|
2012-01-27
|
173.333333333333
|
termitomycamide-e
|
2'-Deoxotermitomycamide A
|
mushrooms extracts ER stress apoptosis endoplasmic reticulum neuroscience proteins misfolding Parkinson’s diseases Alzheimer’s prions neuronal calcium homeostasis Termitomyces titanicus termites |
173.333333333333
|
| 10011127 |
Thioperamide Maleate
|
|
148440-81-7 |
≥98%
|
|
|
2009-03-26
|
0.960497237569
|
thioperamide-maleate
|
|
histamines H3 receptors antagonists seizures GABA 110-16-7 106243-16-7 selective croses blood-brain barrier |
0.960497237569
|
| 13623 |
Topiramate
|
|
97240-79-4 |
≥98%
|
|
|
2010-08-17
|
1.118121546961
|
topiramate
|
TPM; Topamax®; RWJ 17021; McN 4853; Epitomax
|
anticonvulsants seizures epilepsy migraines headaches McN-4853 McN4853 RWJ-17021 RWJ17021 epitoma topamac topimax topina topomax 1103510-60-6 administered orally sulfamates anti-convulsants prevention Instituto Farmacologico Brand of Fructose Fresenius Kabi Brand of Fructose
Grifols Brand of Fructose
Plast Apyr Levulosa Mein
Bieffe Brand of Fructose
Baxter Brand of Fructose
Levulosado Bieffe Medit
Braun Brand of Fructose Ern Brand of Fructose Levulosa Fleboplast Fleboplast Levulosa Levulosado Vitulia Levulosado Braun Levulosa Grifols Levulosa Baxter Levulosa, Apir Levulosa Braun Levulosa Mein Levulosa Ibys Apir Levulosa Levulosa Ife Levulose Levulosa Fructose |
1.118121546961
|
| 11120 |
TPPU
Exclusive New |
|
1222780-33-7 |
≥98%
|
|
✓ |
2011-10-26
|
6.444971864129
|
tppu
|
|
soluble epoxide hydrolase sEH inflammation hypertension cardiovascular disease neuroscience inhibitors inhibits inhibition pharmacokinetics |
6.444971864129
|
| 10011659 |
Trolox
|
|
53188-07-1 |
≥98%
|
|
|
2008-12-02
|
295.447856353591
|
trolox
|
6-hydroxy-2,5,7,8-tetramethylchroman-2-Carboxylic Acid
|
antioxidants vitamins E oxidative injury injuries neurodegeneration aging cancers adjunctive |
295.447856353591
|
| 10009398 |
Tryptophan Hydroxylase (Phospho-Ser260) Polyclonal Antibody
|
|
- |
|
|
|
2006-12-18
|
0.948077348066
|
tryptophan-hydroxylase-phospho-ser260-polyclonal-antibody
|
TPH
|
TPH260 hydroxylases catalyzes 5-hydroxylation biosynthesis indoleamines serotonin melatonin brain mammals neurons Raphe nuclei pineal gland neurotransmitter phosphorylation cyclic AMP cAMP-dependent kinases PKA Ca2+/calmodulin kinase II CaM K II phosphorylates antibodies antisera antiserum WB western blots blotting proteins diseases phospho-specific immunoblotting |
0.948077348066
|
| 10009397 |
Tryptophan Hydroxylase (Phospho-Ser58) Polyclonal Antibody
|
|
- |
|
|
|
2006-12-18
|
0.790064456721
|
tryptophan-hydroxylase-phospho-ser58-polyclonal-antibody
|
TPH
|
TPH58 hydroxylases catalyzes 5-hydroxylation biosynthesis indoleamines serotonin melatonin brain mammals neurons Raphe nuclei pineal gland neurotransmitter phosphorylation cyclic AMP cAMP-dependent kinases PKA Ca2+/calmodulin kinase II CaM K II phosphorylates antibodies antisera antiserum WB western blots blotting proteins diseases phospho-specific immunoblotting |
0.790064456721
|
| 10009396 |
Tryptophan Hydroxylase Polyclonal Antibody
|
|
- |
|
|
|
2006-12-13
|
0.948077348066
|
tryptophan-hydroxylase-polyclonal-antibody
|
TPH
|
hydroxylases catalyzes biosynthesis serotonin melatonin brain mammals neurons Raphe nuclei pineal gland antibodies antisera antiserum WB western blots blotting IHC immunohistochemistry frozen sections proteins diseases immunoblotting |
0.948077348066
|
| 10559 |
Tubastatin A (trifluoroacetate salt)
Exclusive |
|
- |
≥95%
|
|
✓ |
2011-02-08
|
60.463449585635
|
tubastatin-a-trifluoroacetate-salt
|
|
HDAC6 inhibitors histones deacetylases neuroprotection neurons epigenetics TFA inhibition inhibited neuronal protection α-tubulin alpha tubulin .alpha.tubulin a-tubulin tubastatin-A Acids Hydroxamic Hydroxamic Acids
Acid Hydroxamic Hydroxamic Acid
|
60.463449585635
|
| 10009412 |
Tyrosine Hydroxylase (Phospho-Ser19) Polyclonal Antibody
|
|
- |
|
|
|
2006-11-28
|
1.740331491713
|
tyrosine-hydroxylase-phospho-ser19-polyclonal-antibody
|
TH
|
wb western blotting blots if immunofluorescence ihc immunohistochemistry antibodies rate-limiting enzymes synthesis catecholamines dopamine norepinephrine markers dopaminergic noradrenergic neurons depression schizophrenia parkinson's diseases drug abuse signaling phosphorylation phospho-specific regulation cells identification immunoblotting |
1.740331491713
|
| 10009413 |
Tyrosine Hydroxylase (Phospho-Ser31) Polyclonal Antibody
|
|
- |
|
|
|
2006-11-28
|
0.580110497237
|
tyrosine-hydroxylase-phospho-ser31-polyclonal-antibody
|
TH
|
wb western blotting blots if immunofluorescence ihc immunohistochemistry antibodies rate-limiting enzymes synthesis catecholamines dopamine norepinephrine markers dopaminergic noradrenergic neurons depression schizophrenia parkinson's diseases drug abuse signaling phosphorylation phospho-specific regulation cells identification phospho-specific immunoblotting |
0.580110497237
|
| 10009414 |
Tyrosine Hydroxylase (Phospho-Ser40) Polyclonal Antibody
|
|
- |
|
|
|
2008-07-07
|
0.870165745856
|
tyrosine-hydroxylase-phospho-ser40-polyclonal-antibody
|
TH
|
wb western blotting blots if immunofluorescence ihc immunohistochemistry antibodies rate-limiting enzymes synthesis catecholamines dopamine norepinephrine markers dopaminergic noradrenergic neurons depression schizophrenia parkinson's diseases drug abuse signaling phosphorylation phospho-specific regulation cells identification immunoblotting |
0.870165745856
|
| 10604 |
Tyrosine Hydroxylase Polyclonal Antibody
|
|
- |
|
|
|
2009-10-23
|
0.386740331491
|
tyrosine-hydroxylase-polyclonal-antibody
|
TH
|
gamma inhibits inhibitors neurotransmitters WB western blots blotting enzymes synthesis dopamine norepinephrine immunoblotting IHC immunohistochemistry IF immunofluorescence |
0.386740331491
|
| 10010245 |
U-83836E
|
|
137018-55-4 |
≥98%
|
|
|
2008-07-08
|
0.160220994475
|
u-83836e
|
|
antioxidant anti-oxidant oxidative injury stress free radicals ischemia diabetes a-tocopherol .alpha.-tocopherol 122003-11-6 PNU-83836E PNU83836E |
0.160220994475
|
| 10045 |
UCM707
|
|
390824-20-1 |
>98%
|
|
|
2004-01-30
|
22.976160220994
|
ucm707
|
|
cannabinoids neurotransmitter inhibitors AEA lipids CB1 UR1 receptors anandamide hydrolysis fatty acids neurochemistry neuroscience |
22.976160220994
|
| 13261 |
URB447
Exclusive |
|
1132922-57-6 |
≥98%
|
|
✓ |
2009-06-18
|
32.550309392265
|
urb447
|
|
CB1 CB2 cannabinoids antagonists obesity SR 141716A SR141716A rimonabant blood brains barrier URB appetite suppressant receptors URB-447 URB blocking peptides 447 cannabinoids cbs synthetic |
32.550309392265
|
| 10046 |
URB597
|
|
546141-08-6 |
>98%
|
|
|
|
54.148442993470
|
urb597
|
|
FAAH fatty acid amide hydrolases inhibitors URB-597 anandamides lipids inhibition selective selectivity AEA inhibits hydrolysis hydrolyze arachidonoyl cannabinoids ethanolamides neuroscience neurochemistry |
54.148442993470
|
| 10007457 |
URB602
|
|
565460-15-3 |
>98%
|
|
|
2005-09-06
|
40.770787292817
|
urb602
|
|
monoglycerol lipase MGL inhibition inhibits inhibitors rat brain enzymes enhanced stress-induced analgesia novel drugs pain stress management CNS central nervous system monoacylglycerol neuroscience neurochemistry cannabinoids cbs synthetic |
40.770787292817
|
| 10007691 |
URB754
|
|
86672-58-4 |
>98%
|
|
|
2005-11-04
|
24.893955801105
|
urb754
|
|
neurochemistry neuroscience 2-AG 2-archidonoyl glyerol MGL monoacylglycerol lipase monoglyceride lipase endocannabinoids FAAH fatty acid amide hydrolase inhibitors inhibition inhibits monoglycerol MAGL neurochemistry cannabinoids |
24.893955801105
|
| 10674 |
URB937
Exclusive |
|
- |
≥98%
|
|
✓ |
2011-03-08
|
17.586224677716
|
urb937
|
|
FAAH anandamide AEA inhibitors peripheral pain Cannabinoids
|
17.586224677716
|
| 700620 |
Urea Fluorometric Assay Kit
New |
|
- |
|
|
|
2011-08-31
|
95.065620018036
|
urea-fluorometric-assay-kit
|
|
kits assays measures measurements carbamide cycle protein amino acids aa metabolisms catabolism deaminated ammonia livers N-acetylglutamate blood kidneys urine nitrogen countercurrent exchange systems nephrons kidneys creatinine prerenal hperuremia cardiac decompensation water depletion renal glomerulonephritis chronic nephritis polycystic nephrosclerosis tubular necrosis urinary tract toxic metabolites ammonium hyperammonemia plasma detoxification neurological brain neuroprotection serum urease hydrolysis carbon dioxide CO2 detector fluorescence fluorescent |
95.065620018036
|
| 10006731 |
VDM11
|
|
313998-81-1 |
>98%
|
|
|
2005-07-13
|
7.874125230202
|
vdm11
|
|
analogs arachidonoyls ethanolamides AEA anadamides potentiates activity inhibits inhibition reuptake neurons FAAH fatty amides acyls hydrolases transport CB1 CB2 cannabinoids VR1 vanilloid receptors AM404 glutamergic synaptic transmission hippocampal mechanisms sodium channels neurochemistry neuroscience |
7.874125230202
|
| 9000976 |
Vigabatrin
|
|
68506-86-5 |
≥95%
|
|
|
2011-05-04
|
16.287348066298
|
vigabatrin
|
γ-Vinyl GABA; Sabril™
|
60643-86-9 neurotransmitters γ-aminobutyric acids GABA inhibitors seizures epilepsy neuroscience gamma-vinyl-gamma-aminobutyric gamma vinyl aminobutyric
gamma-vinyl-GABA Sabrilex Sabril |
16.287348066298
|
| 10009023 |
(+)WIN 55212-2 (mesylate)
|
|
131543-23-2 |
>98%
|
|
|
2006-10-05
|
47.709641060716
|
-win-55212-2-mesylate
|
|
WIN-2 agonists cannabinoids CB1 CB2 neurons rat glutamates SR141716A IP3 Xestospongin C 55212-3 WIN-3 inflammatory neuropeptides CGRP trigeminal neurochemistry ganglions TG exocytosis WIN55,212-2 endocrinology WIN55212-2 cannabinoids cbs synthetic |
47.709641060716
|
| 10736 |
(±)WIN 55212 (mesylate)
New |
|
137795-17-6 |
≥98%
|
|
|
2012-01-11
|
110.382203395478
|
-win-55212-mesylate
|
|
cannabinoids CB1 CB2 receptors pain neuroscience agonists antagonists aminoalkylindole CBs enantiomers (+)WIN 55212-2 (-)WIN 55215-3 SR144528 SR-144528 SR 144528 racemic mesylate central peripheral |
110.382203395478
|
| 10011213 |
WWL70
Exclusive |
|
947669-91-2 |
>97%
|
|
✓ |
2008-04-15
|
9.642836095764
|
wwl70
|
|
serine hydrolase ABHD6 inhibitors inhibits inhibition 2-AG endocannabinoids .alpha./.beta. a/b alpha/beta neurochemistry cannabinoids inhibitors |
9.642836095764
|
| 10790 |
Xanomeline oxalate
|
|
141064-23-5 |
≥98%
|
|
|
2011-06-14
|
0.382872928177
|
xanomeline-oxalate
|
Lumeron; Memcor; LY246708
|
agonists muscarinic receptors acetylcholine psychosis antipsychotic memory neurotransmitters neurological Alzheimer’s diseases M1-preferring |
0.382872928177
|
| 80340 |
α-Guanidinoglutaric Acid
|
|
73477-53-9 |
≥98%
|
|
|
|
2.612246777163
|
-guanidinoglutaric-acid
|
GGA
|
nitric oxide synthase inhibitors nNOS NO seizure brain neurochemistry |
2.612246777163
|
| 78050 |
(−)-(α)-Kainic Acid
|
|
487-79-6 |
>98%
|
|
|
2004-04-08
|
65.327900552486
|
-kainic-acid
|
|
neuroexcitatory seizures neuroexcitotoxics epileptogenics alga algae neurochemistry neuroscience |
65.327900552486
|
| 90215 |
α-Linolenoyl Ethanolamide
Exclusive |
|
57086-93-8 |
>98%
|
|
✓ |
|
10.168516179952
|
-linolenoyl-ethanolamide
|
|
cannabinoids neurotransmitters ethanolamides fatty acids CB alpha-linolenoyl .alpha.-linolenoyl cannabinergic neurochemistry neuroscience ethanolamines, cbs, synthetic |
10.168516179952
|
| 9001195 |
α-Pyrrolidinobutiophenone (hydrochloride)
New |
|
13415-54-8 |
≥95%
|
|
|
2012-01-27
|
142.495838792477
|
-pyrrolidinobutiophenone-hydrochloride
|
α-PBP
|
13415-82-2 hydrochloride HCl forensics phenethylamines amphetamines cathinones designer drugs butyrophenones ketones MPBP party pills synthetic anti-psychotic anti-emetic antipsychotic antiemetic anti psychtic anti emetic α-pyrrolidinobutyrophenone |
142.495838792477
|
| 9001083 |
α-Pyrrolidinopentiphenone (hydrochloride)
Exclusive New |
|
5485-65-4 |
≥98%
|
|
✓ |
2011-10-11
|
60.351186131782
|
-pyrrolidinopentiphenone-hydrochloride
|
α-PVP; 2-(1-pyrrolidinyl)-Valerophenone; O-2387
|
14530-33-7 designer drugs forensics pyrovalerone bath salts inhibits inhibitors inhibition transporters neurotransmitters dopamine norepinephrine uptake monoamine analogs alpha PVP APVP hydrochloride HCl psychoactive stimulant |
60.351186131782
|